data_2kuk_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kuk _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 79.7 m . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.375 0.607 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.16 -17.15 57.91 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.952 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.727 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 31.5 mp0 -89.05 163.76 15.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -121.18 150.48 41.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.349 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -132.37 64.9 1.59 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -57.75 -27.04 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 110.804 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -88.94 5.8 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.494 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.32 30.0 69.7 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 132.26 15.09 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.07 144.95 26.65 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.794 0.807 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.58 -25.23 22.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.735 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -105.09 142.27 35.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.155 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.807 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -72.0 166.63 21.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.807 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 71.0 19.64 77.27 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.326 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.3 m -142.41 153.79 44.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.479 0.657 . . . . 0.0 110.394 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.07 149.54 50.1 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.398 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -81.0 64.44 5.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.532 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.777 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.9 m-20 -80.1 -61.64 0.43 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.752 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.777 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -90.71 65.57 1.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.443 2.096 . . . . 0.0 111.891 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.461 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.9 t90 -47.84 139.91 8.85 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 50.1 Cg_endo -94.36 50.76 1.25 Allowed 'Cis proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.091 -1.629 . . . . 0.0 112.675 0.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.2 t -126.54 149.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.52 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.0 m -90.8 148.69 22.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.771 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.406 HG21 ' HG3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -115.74 121.72 43.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.571 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.728 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 26.3 ttm180 -95.93 108.84 21.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.06 36.19 21.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.941 0.877 . . . . 0.0 110.041 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.6 11.45 83.02 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.837 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.7 mp -125.95 133.32 24.81 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 117.27 0.535 . . . . 0.0 109.991 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.6 Cg_exo -70.86 45.39 0.57 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.857 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.3 m . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 121.393 0.615 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.93 -19.81 50.49 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.437 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.596 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.0 mp0 -89.26 170.29 10.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.38 0.609 . . . . 0.0 111.31 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.72 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 p -146.61 65.41 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.571 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.84 -24.63 62.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.957 0.408 . . . . 0.0 110.902 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -88.35 2.66 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.08 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 73.29 29.15 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.67 131.17 13.84 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 12' ' ' THR . 1.8 t -82.67 139.98 33.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.901 0.858 . . . . 0.0 110.444 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.45 -23.62 22.07 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.603 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.491 HG23 ' SG ' ' A' ' 10' ' ' CYS . 1.6 t -93.6 167.16 11.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.522 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -93.94 159.34 15.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.854 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.81 71.44 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.816 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 76.7 m -141.61 154.71 45.58 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.672 0.749 . . . . 0.0 110.954 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.37 151.71 50.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.429 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.27 64.49 6.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.085 0.469 . . . . 0.0 111.748 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.77 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.0 m-20 -78.97 -61.28 0.51 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.77 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -91.98 66.86 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.408 2.072 . . . . 0.0 112.04 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.462 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.8 t90 -47.74 139.97 8.53 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.854 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 57.4 Cg_endo -94.25 49.32 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.635 0.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.572 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -123.92 151.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.475 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -93.67 149.36 21.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.628 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -115.95 121.85 43.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.775 178.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.734 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 33.7 ttm180 -102.12 112.6 25.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.7 t30 60.17 39.59 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.001 0.905 . . . . 0.0 109.934 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.86 16.39 80.45 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.79 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.4 mt -133.79 131.77 21.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 117.055 0.428 . . . . 0.0 110.382 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.1 Cg_exo -71.39 50.1 1.21 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.112 2.541 . . . . 0.0 112.494 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 122.103 0.954 . . . . 0.0 110.231 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.711 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 92.4 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.72 -19.5 52.48 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.69 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.7 mp0 -88.44 166.64 14.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.465 0.65 . . . . 0.0 111.264 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 p -124.27 151.64 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.26 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 p -133.16 65.23 1.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.15 -31.2 67.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.917 0.389 . . . . 0.0 110.614 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -88.88 12.2 15.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.076 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.509 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.98 31.83 80.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.324 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.32 133.4 16.17 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -92.7 144.69 25.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.508 0.67 . . . . 0.0 109.843 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.79 -24.38 22.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.626 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -98.9 137.42 37.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.988 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -70.83 158.79 35.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.57 -19.28 20.47 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.431 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.6 m -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.826 0.822 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -132.94 150.47 52.16 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.411 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.0 t -80.54 64.62 5.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.691 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.773 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.2 m-20 -79.55 -62.26 0.43 Allowed Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 87.9 Cg_endo -91.37 67.03 1.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.416 2.077 . . . . 0.0 111.717 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.445 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.24 139.66 7.43 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.445 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 51.6 Cg_endo -94.92 51.2 1.24 Allowed 'Cis proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.592 0.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.57 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.3 t -125.81 149.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.2 m -90.74 151.06 21.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.681 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -130.34 135.57 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.99 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.711 ' CZ ' ' HA ' ' A' ' 1' ' ' CYS . 13.7 ptt180 -132.38 131.09 41.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 61.53 35.3 17.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.079 0.943 . . . . 0.0 109.236 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.88 84.64 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.053 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.02 131.28 11.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.624 0.249 . . . . 0.0 110.581 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.18 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.99 2.46 . . . . 0.0 111.78 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.762 -179.68 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 63.4 m . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.27 -24.94 8.52 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.264 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.6 172.84 8.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.834 0.826 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -122.61 174.17 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.039 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.06 59.06 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.533 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -56.66 -30.68 63.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.207 0.527 . . . . 0.0 110.662 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.06 11.49 20.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.372 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.31 34.32 87.61 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.43 132.02 16.8 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.37 146.1 23.96 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.824 0.821 . . . . 0.0 111.766 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -88.86 -26.46 21.62 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.78 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -91.87 135.35 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.122 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -72.72 157.4 37.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.62 2.43 50.2 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.858 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.7 m -109.86 157.4 19.25 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.408 0.623 . . . . 0.0 110.142 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.518 HG21 ' OD1' ' A' ' 18' ' ' ASP . 1.9 t -135.02 146.95 49.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.792 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -81.76 63.57 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.43 -60.64 0.52 Allowed Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.901 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.0 Cg_endo -89.24 63.14 2.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.249 1.966 . . . . 0.0 111.881 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.451 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 53.9 t90 -46.37 139.34 6.01 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.7 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 45.8 Cg_endo -94.18 50.24 1.33 Allowed 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.103 -1.624 . . . . 0.0 112.623 0.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.54 150.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.191 0.519 . . . . 0.0 111.77 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 98.3 m -92.75 153.09 19.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.674 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -133.57 117.35 16.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.608 ' NH1' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -89.36 100.61 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.608 ' HB2' ' NH1' ' A' ' 25' ' ' ARG . 3.5 t30 66.67 35.65 5.13 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.014 0.821 . . . . 0.0 109.196 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.51 85.59 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.31 121.95 38.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 117.154 0.477 . . . . 0.0 110.472 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 64.3 Cg_endo -73.78 44.62 0.96 Allowed 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.955 2.437 . . . . 0.0 113.075 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.308 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.64 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 37.4 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.0 79.81 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.918 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.64 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.6 mp0 -87.83 161.69 17.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.904 0.859 . . . . 0.0 112.301 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -110.97 150.47 29.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.302 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.5 p -137.29 67.65 1.43 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.441 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.09 -25.94 61.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.064 0.459 . . . . 0.0 110.987 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 p -88.6 2.44 53.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.178 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.445 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.29 34.13 79.57 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.12 136.83 19.18 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -105.08 142.49 34.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.739 0.78 . . . . 0.0 110.638 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.61 -25.25 21.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.55 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.454 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 25.9 m -88.57 141.5 28.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.847 ' ND2' HH12 ' A' ' 25' ' ' ARG . 13.0 t30 -64.64 151.7 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.643 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 65.1 2.46 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.999 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 57.6 m -111.58 143.5 42.35 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.82 0.819 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.0 151.31 50.7 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.776 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t -76.97 62.23 2.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.108 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.826 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 70.7 m-20 -72.66 -62.0 1.51 Allowed Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.753 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 Cg_endo -92.49 67.95 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.541 2.16 . . . . 0.0 111.414 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.443 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.6 t90 -47.9 140.07 8.88 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.495 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 43.8 Cg_endo -95.33 54.28 1.02 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.593 0.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.624 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.2 t -127.91 145.58 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.13 0.49 . . . . 0.0 111.993 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.6 m -89.46 150.08 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 19' ' ' PRO . 1.4 p -136.74 128.36 28.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.958 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.847 HH12 ' ND2' ' A' ' 13' ' ' ASN . 6.2 tpt180 -89.42 110.21 21.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.36 40.91 23.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.999 0.904 . . . . 0.0 109.257 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 22.53 78.74 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.422 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.12 133.51 24.9 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 122.687 -0.302 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 48.54 1.85 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.842 2.361 . . . . 0.0 112.482 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.531 -179.541 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 69.4 m . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.36 26.79 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.36 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -89.74 179.69 5.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.974 0.893 . . . . 0.0 112.161 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -135.17 148.35 49.68 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.777 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 p -129.34 65.06 1.47 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.006 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.09 -30.08 65.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.087 0.47 . . . . 0.0 110.542 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -89.88 9.1 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.291 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.568 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 67.62 33.57 81.32 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.04 134.25 17.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.273 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -98.81 145.6 26.78 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 -28.22 19.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.162 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -92.07 143.5 26.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.517 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -74.26 160.79 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.54 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.62 24.76 75.28 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.511 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.5 m -137.16 153.86 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.584 0.707 . . . . 0.0 110.749 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.624 HG22 ' HG1' ' A' ' 24' ' ' THR . 1.9 t -135.52 147.48 48.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.484 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.568 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.7 t -82.02 64.08 6.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.106 0.479 . . . . 0.0 111.355 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.525 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.79 -60.76 0.39 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.149 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.6 Cg_endo -88.13 63.12 3.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.238 1.959 . . . . 0.0 111.913 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.466 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.16 139.63 7.22 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.01 50.32 1.3 Allowed 'Cis proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.719 0.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -126.03 149.13 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.0 111.75 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 76.6 m -89.78 149.78 22.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.308 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.624 ' HG1' HG22 ' A' ' 16' ' ' THR . 0.5 OUTLIER -123.1 125.49 45.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 39.5 ttm180 -108.66 114.87 29.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 59.6 34.11 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.916 0.865 . . . . 0.0 109.798 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.2 82.47 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.692 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 28' ' ' LEU . 3.0 mm? -128.91 131.99 24.09 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 117.131 0.465 . . . . 0.0 110.176 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.7 Cg_exo -72.25 49.06 1.3 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.165 2.577 . . . . 0.0 112.527 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.213 -179.495 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 -24.85 11.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.53 175.08 7.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.825 0.822 . . . . 0.0 112.193 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -129.1 147.28 50.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.139 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.5 p -120.88 63.78 0.86 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -57.31 -36.26 70.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -92.38 19.98 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.976 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 60.15 35.22 87.13 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.719 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 142.34 27.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.47 146.01 43.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.234 0.54 . . . . 0.0 109.798 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -89.56 -28.49 19.55 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.223 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 133.05 42.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.425 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.19 153.83 42.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.398 0.618 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.23 9.39 60.58 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.186 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.8 m -112.3 150.54 30.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.716 0.77 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 151.43 50.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.681 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.6 t -81.38 65.46 6.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.266 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.789 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.2 m-20 -78.27 -63.46 0.44 Allowed Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.846 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.789 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.2 Cg_endo -92.17 66.68 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.455 2.103 . . . . 0.0 111.748 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 57.1 t90 -46.8 139.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.752 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 51.0 Cg_endo -94.51 50.94 1.24 Allowed 'Cis proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.094 -1.627 . . . . 0.0 112.522 0.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.612 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 t -122.87 147.42 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.233 0.539 . . . . 0.0 111.879 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 72.1 m -90.97 148.09 22.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.368 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 19' ' ' PRO . 1.1 p -129.52 133.45 47.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.525 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 42.1 ptt85 -127.2 126.22 42.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.55 39.41 27.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.784 0.802 . . . . 0.0 109.683 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.26 74.39 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.211 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' A' ' 30' ' ' VAL . 95.1 mt -142.15 126.63 10.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.628 0.252 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 77.6 Cg_endo -77.5 44.83 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.946 2.431 . . . . 0.0 112.322 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 28' ' ' LEU . 3.1 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.63 ' SG ' ' HG3' ' A' ' 25' ' ' ARG . 70.8 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.13 55.9 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.686 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.499 ' CD ' ' HG1' ' A' ' 12' ' ' THR . 10.0 mp0 -89.55 168.44 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.628 0.727 . . . . 0.0 112.077 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -123.38 151.71 42.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.223 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.1 p -132.87 66.38 1.56 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.672 0.272 . . . . 0.0 111.568 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.46 -26.57 63.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.976 0.417 . . . . 0.0 110.845 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -89.03 4.64 47.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.022 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.514 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.89 30.92 69.94 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.45 133.32 15.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.176 -0.512 . . . . 0.0 109.621 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -94.26 142.83 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.638 0.733 . . . . 0.0 110.103 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.04 -24.3 22.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.788 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.499 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 11.2 m -96.08 139.26 32.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.493 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -70.54 159.16 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.96 78.59 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.319 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.828 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 98.2 m -140.41 151.34 44.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.545 0.688 . . . . 0.0 110.616 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -135.53 148.24 49.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.253 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.3 t -80.46 65.13 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.092 0.472 . . . . 0.0 111.385 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.796 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.4 m-20 -77.82 -62.61 0.52 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 86.5 Cg_endo -92.4 67.85 0.76 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.46 2.107 . . . . 0.0 111.725 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.451 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.5 t90 -47.38 139.6 7.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.641 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 51.7 Cg_endo -94.85 51.75 1.19 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.575 0.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.603 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 t -125.37 148.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.828 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -91.4 151.61 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 p -131.84 131.49 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.924 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.63 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 81.3 mtt-85 -89.3 87.45 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.96 52.45 2.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.989 0.899 . . . . 0.0 109.66 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.9 7.97 87.38 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.846 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.02 118.87 41.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.32 0.56 . . . . 0.0 110.383 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.95 44.53 0.8 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.871 2.381 . . . . 0.0 112.828 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 25' ' ' ARG . 9.7 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 121.877 0.846 . . . . 0.0 110.671 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.591 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 85.4 m . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.507 0.67 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.85 -18.53 57.25 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.86 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.591 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 43.1 mp0 -88.01 162.27 16.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.892 0.853 . . . . 0.0 112.106 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -120.75 151.96 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.469 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -136.32 68.64 1.43 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.27 -25.2 63.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p -88.45 2.22 53.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.993 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 71.21 32.02 65.84 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 132.71 15.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.042 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.76 141.93 28.14 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.591 0.71 . . . . 0.0 109.93 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.2 -23.49 22.38 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.991 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -100.65 138.98 36.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.797 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -68.96 157.65 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.91 -4.02 67.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.399 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.745 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.3 m -121.91 151.56 40.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.465 0.65 . . . . 0.0 110.344 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.422 HG23 ' OD1' ' A' ' 18' ' ' ASP . 2.2 t -130.86 147.05 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.067 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.14 62.48 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.81 -60.08 0.46 Allowed Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 90.9 Cg_endo -88.29 65.4 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.199 1.932 . . . . 0.0 111.714 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 60.8 t90 -47.57 139.78 8.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 52.0 Cg_endo -94.99 52.59 1.13 Allowed 'Cis proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.686 0.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.489 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.9 t -128.82 148.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.123 0.487 . . . . 0.0 111.869 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.745 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.9 m -89.3 152.33 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.128 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -130.39 124.7 32.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.787 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.8 ttt85 -90.68 103.62 16.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.9 t30 59.43 37.35 23.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.011 0.91 . . . . 0.0 109.557 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.39 6.16 81.37 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.581 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.38 120.54 42.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.438 0.619 . . . . 0.0 110.379 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.08 45.14 1.3 Allowed 'Trans proline' 0 N--CA 1.47 0.12 0 C-N-CA 122.838 2.359 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.349 -179.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.022 0.439 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.57 -26.78 6.19 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.665 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -91.58 170.51 9.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.028 0.918 . . . . 0.0 113.182 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -116.87 177.21 4.79 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.173 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.43 58.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.497 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -56.74 -30.97 64.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.749 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -90.6 12.02 20.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.279 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.41 33.63 85.41 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.26 133.24 18.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.04 144.43 25.48 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.841 0.829 . . . . 0.0 111.584 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -88.98 -26.39 21.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.967 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.504 HG22 HH22 ' A' ' 25' ' ' ARG . 3.5 m -92.2 135.75 33.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.249 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.6 156.83 38.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.01 26.69 73.91 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.954 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 78.1 m -136.03 153.63 51.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.294 0.568 . . . . 0.0 110.478 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.412 HG22 ' OD2' ' A' ' 18' ' ' ASP . 1.5 t -135.93 146.38 47.25 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.935 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -78.55 63.85 3.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.605 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.838 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 71.6 m-20 -73.8 -62.33 1.14 Allowed Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.251 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.838 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 60.7 Cg_endo -92.36 69.01 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.454 2.102 . . . . 0.0 111.728 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.449 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 54.5 t90 -48.11 140.3 9.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.454 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 47.7 Cg_endo -95.06 51.4 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.189 -1.588 . . . . 0.0 112.494 0.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.2 t -125.18 146.33 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.588 . . . . 0.0 112.327 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.8 m -89.62 151.65 21.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.956 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.04 125.59 25.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.504 HH22 HG22 ' A' ' 12' ' ' THR . 42.9 ttm-85 -96.53 108.52 21.11 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.96 42.7 25.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.916 0.865 . . . . 0.0 109.727 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.59 18.17 79.35 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.829 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 94.4 mt -128.58 131.88 24.02 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.083 0.442 . . . . 0.0 110.455 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.6 Cg_exo -71.83 47.55 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.179 2.586 . . . . 0.0 113.102 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 25' ' ' ARG . 14.3 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.548 0.69 . . . . 0.0 111.152 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.6 m . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.31 -29.29 6.7 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.24 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.42 167.51 12.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.875 0.845 . . . . 0.0 111.946 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -118.03 174.7 6.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.773 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.3 p -150.39 66.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.87 -26.01 63.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.087 0.47 . . . . 0.0 110.782 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.91 3.77 50.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.21 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.505 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.05 32.75 69.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.417 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.35 132.9 15.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.02 141.2 29.71 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.78 0.8 . . . . 0.0 111.277 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.67 -27.42 20.14 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.858 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.39 131.46 35.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.257 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -69.78 154.26 42.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.372 0.606 . . . . 0.0 109.943 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 67.85 25.12 74.28 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.243 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.2 m -133.41 154.99 50.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.301 0.572 . . . . 0.0 110.276 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.441 HG23 ' OD1' ' A' ' 18' ' ' ASP . 2.8 t -135.52 146.69 48.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.167 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.9 t -82.56 63.3 6.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.09 -60.79 0.47 Allowed Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.187 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 22' ' ' VAL . 88.3 Cg_endo -88.58 64.56 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.154 1.903 . . . . 0.0 111.727 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.477 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 62.3 t90 -47.81 139.85 8.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.51 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 49.1 Cg_endo -94.03 51.17 1.18 Allowed 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.859 0.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.497 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.5 t -126.52 148.91 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.948 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.7 m -89.45 153.99 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.099 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.03 129.53 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.976 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.415 ' HB3' HG11 ' A' ' 30' ' ' VAL . 49.2 ttm-85 -97.78 101.6 13.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.67 45.37 13.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.875 0.845 . . . . 0.0 109.988 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.04 19.45 79.61 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.728 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.8 mt -129.55 130.23 23.25 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.29 45.54 0.65 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.136 2.557 . . . . 0.0 112.971 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 25' ' ' ARG . 14.8 p . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 122.363 1.078 . . . . 0.0 110.64 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.78 -20.47 50.51 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.512 ' CD ' ' HG1' ' A' ' 12' ' ' THR . 10.1 mp0 -89.22 168.48 12.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.716 0.77 . . . . 0.0 111.933 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -123.97 155.78 37.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.849 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 p -137.92 67.52 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.689 0.28 . . . . 0.0 111.733 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -59.54 -25.11 64.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.694 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -88.52 3.13 51.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.955 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.36 31.33 68.64 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.36 132.91 15.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.265 -0.468 . . . . 0.0 109.772 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -93.89 142.06 27.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.575 0.702 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.23 -23.7 22.29 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.829 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.512 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 6.7 m -94.64 139.25 31.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.55 158.03 36.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.763 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.95 75.52 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.903 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.772 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 89.2 m -130.4 149.89 51.88 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.732 0.777 . . . . 0.0 110.571 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.507 HG21 ' OD2' ' A' ' 18' ' ' ASP . 1.5 t -135.6 146.09 47.58 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.4 t -79.2 63.16 3.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.083 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.749 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 43.5 m-20 -76.36 -61.3 0.81 Allowed Pre-proline 0 C--N 1.318 -0.792 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.48 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.749 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.8 Cg_endo -90.29 66.85 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.347 2.031 . . . . 0.0 111.866 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.455 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.9 t90 -47.85 140.0 8.81 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.633 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.3 Cg_endo -94.6 50.78 1.27 Allowed 'Cis proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.101 -1.625 . . . . 0.0 112.589 0.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.535 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.0 t -125.2 147.52 29.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.273 0.559 . . . . 0.0 111.936 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.772 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 100.0 m -89.35 151.11 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.146 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -123.03 130.05 52.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.322 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 14.8 ttp180 -117.87 119.95 36.4 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 58.76 40.41 23.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.928 0.871 . . . . 0.0 109.977 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.82 26.23 74.71 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.579 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 91.7 mt -144.6 134.21 11.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.0 Cg_exo -72.6 47.48 1.17 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 123.023 2.482 . . . . 0.0 112.594 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.788 0.804 . . . . 0.0 110.395 -179.646 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.688 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 39.3 m . . . . . 0 CA--C 1.518 -0.284 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.16 78.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.656 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.688 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 28.8 mp0 -88.06 159.34 18.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.911 0.863 . . . . 0.0 111.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -109.92 148.47 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.507 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.67 66.65 1.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.12 -30.0 65.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.953 0.406 . . . . 0.0 110.726 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -88.81 9.64 23.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.471 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.57 34.12 88.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.25 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.04 134.07 17.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -95.96 143.48 27.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.598 0.713 . . . . 0.0 110.18 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.13 -24.33 22.25 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.819 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -99.07 137.98 36.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.425 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.707 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.5 t-20 -71.61 156.54 39.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.988 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.707 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.36 12.38 84.29 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.972 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.0 m -129.76 152.26 49.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.519 HG21 ' OD1' ' A' ' 18' ' ' ASP . 2.7 t -132.07 145.72 51.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.421 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.471 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.77 62.17 4.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.468 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.625 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.51 -61.23 0.48 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.95 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 7.7 Cg_endo -87.64 66.07 3.81 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.439 2.093 . . . . 0.0 111.268 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.46 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 61.7 t90 -48.31 140.06 9.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.567 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 54.2 Cg_endo -95.03 53.89 1.04 Allowed 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.774 0.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 38.2 t -130.13 146.95 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.124 0.488 . . . . 0.0 111.986 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -88.89 152.14 21.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.916 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.92 132.56 40.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.947 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttt85 -94.22 103.93 15.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.39 44.78 14.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.811 0.815 . . . . 0.0 109.997 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.48 73.76 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.249 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.28 143.98 45.91 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 50.05 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.32 -0.713 0 CA-C-O 121.464 0.65 . . . . 0.0 110.419 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.3 -30.4 7.76 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.392 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 167.89 12.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.895 0.855 . . . . 0.0 111.783 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -117.75 175.89 5.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.826 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.3 p -150.26 62.38 0.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.069 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.14 -29.64 65.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -91.15 10.45 26.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.302 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 66.19 35.33 90.28 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.81 133.63 19.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 t -100.93 144.18 30.18 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 111.694 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -89.7 -28.71 19.25 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.861 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.14 132.69 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.474 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.694 HD21 ' H ' ' A' ' 14' ' ' GLY . 1.1 t-20 -70.18 152.65 44.02 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.694 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 67.08 22.65 72.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.157 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 80.9 m -123.02 155.64 36.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.593 0.711 . . . . 0.0 110.696 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -135.62 147.06 48.5 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.1 t -83.67 63.52 7.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.817 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.474 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.66 -60.79 0.44 Allowed Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.081 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' VAL . 93.8 Cg_endo -87.76 62.63 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.118 1.878 . . . . 0.0 111.771 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 57.3 t90 -46.91 139.58 6.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.638 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.5 Cg_endo -93.82 49.8 1.36 Allowed 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.104 -1.624 . . . . 0.0 112.698 0.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.0 t -124.47 149.59 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 111.854 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 84.8 m -89.57 154.97 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.346 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.74 134.97 43.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.197 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 35.7 ttp180 -132.46 124.98 29.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t30 58.75 36.11 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.984 0.897 . . . . 0.0 109.683 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.75 28.25 72.28 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.451 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 85.2 mt -148.63 137.5 11.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.15 50.85 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.215 2.61 . . . . 0.0 111.858 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 122.285 1.041 . . . . 0.0 110.713 -178.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 33.0 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.98 -16.64 60.62 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.403 ' CD ' ' HG1' ' A' ' 12' ' ' THR . 13.4 mp0 -88.09 166.81 14.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.843 0.83 . . . . 0.0 111.978 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -122.02 150.43 42.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.016 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.55 66.45 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.531 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.06 -26.57 62.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.94 4.02 49.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.546 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.94 32.24 69.86 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 133.83 16.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.814 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 143.32 28.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.654 0.74 . . . . 0.0 110.331 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.32 -25.35 21.68 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.317 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.403 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 3.4 m -89.72 136.17 33.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.343 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -70.26 156.14 39.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.263 0.554 . . . . 0.0 110.296 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.48 -5.36 45.28 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.176 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.1 m -113.48 150.79 32.35 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.619 0.723 . . . . 0.0 110.203 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -135.1 151.96 51.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.774 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.2 t -80.88 64.58 5.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.097 0.475 . . . . 0.0 111.708 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.768 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.2 m-20 -79.13 -61.95 0.47 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.748 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.768 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 85.0 Cg_endo -91.36 66.36 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.345 2.03 . . . . 0.0 111.738 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.451 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.4 139.6 7.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.666 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 50.3 Cg_endo -94.7 51.56 1.19 Allowed 'Cis proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.194 -1.586 . . . . 0.0 112.628 0.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.577 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.7 t -126.06 148.76 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.031 0.443 . . . . 0.0 111.688 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.2 m -90.72 148.06 22.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.761 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.488 HG22 ' HD3' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -123.82 125.29 44.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.739 178.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.631 HH11 ' HB2' ' A' ' 26' ' ' ASN . 2.4 tmt_? -102.85 113.88 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.631 ' HB2' HH11 ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.97 41.26 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.897 0.748 . . . . 0.0 110.241 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.9 79.76 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.666 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.47 126.47 17.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.952 0.376 . . . . 0.0 110.355 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.9 50.55 2.15 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.915 2.41 . . . . 0.0 112.611 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.827 -179.369 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.1 m . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -24.3 8.08 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.653 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.89 173.03 8.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 112.307 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 p -125.31 172.39 9.63 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.071 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 p -150.96 59.03 0.92 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.551 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -57.25 -29.57 63.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.086 0.469 . . . . 0.0 110.589 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -89.89 11.01 21.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.285 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.62 33.14 80.1 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.15 131.2 14.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.102 -0.549 . . . . 0.0 109.574 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.528 ' SG ' HG21 ' A' ' 12' ' ' THR . 2.0 t -85.11 144.0 28.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.742 0.782 . . . . 0.0 111.155 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -88.74 -26.22 21.89 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.528 HG21 ' SG ' ' A' ' 10' ' ' CYS . 13.1 t -103.05 144.67 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -74.88 162.95 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.562 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.88 29.19 74.3 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.913 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 97.2 m -142.5 157.28 44.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.511 0.672 . . . . 0.0 111.062 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.47 HG22 ' OD1' ' A' ' 18' ' ' ASP . 2.9 t -134.54 146.89 50.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.023 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.11 62.84 6.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.275 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.37 -60.4 0.47 Allowed Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 92.4 Cg_endo -88.71 63.98 2.9 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.228 1.952 . . . . 0.0 111.89 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.471 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 56.4 t90 -47.51 140.25 7.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.8 Cg_endo -94.03 49.18 1.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.562 0.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -125.05 149.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.256 0.551 . . . . 0.0 111.779 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.7 m -89.91 154.62 19.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.206 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -128.86 129.83 46.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.429 178.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.509 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.9 ttm180 -116.86 118.15 31.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.61 42.08 27.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.897 0.855 . . . . 0.0 109.76 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.22 75.57 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.72 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.27 132.21 13.38 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.833 0.317 . . . . 0.0 110.356 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.26 47.89 1.67 Allowed 'Trans proline' 0 N--CA 1.471 0.2 0 C-N-CA 122.823 2.349 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 122.282 1.039 . . . . 0.0 110.464 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 61.5 m . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.68 54.22 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.531 ' HG2' ' HB ' ' A' ' 12' ' ' THR . 21.7 mp0 -88.68 178.53 6.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -134.44 163.76 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.78 63.46 1.3 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.686 0.279 . . . . 0.0 111.622 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -58.16 -25.75 61.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 p -88.69 4.88 45.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.98 30.69 67.56 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.5 131.56 14.36 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.557 ' SG ' HG23 ' A' ' 12' ' ' THR . 2.2 t -83.52 141.3 31.72 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.917 0.865 . . . . 0.0 110.896 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -89.28 -24.89 21.94 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.744 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.557 HG23 ' SG ' ' A' ' 10' ' ' CYS . 4.6 t -95.85 158.07 15.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.338 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -87.6 156.19 19.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.336 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.53 23.09 78.47 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.597 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 99.6 m -141.86 155.8 45.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.581 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -135.45 151.17 50.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.679 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.7 t -80.97 64.08 5.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 0.0 111.694 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.775 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-20 -78.6 -61.25 0.55 Allowed Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.735 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.775 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 95.4 Cg_endo -91.85 66.59 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.505 2.137 . . . . 0.0 112.116 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.46 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.6 t90 -47.46 139.88 7.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.775 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 49.9 Cg_endo -94.26 49.18 1.51 Allowed 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.191 -1.587 . . . . 0.0 112.559 0.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 21.7 t -123.95 151.49 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.647 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 90.1 m -93.47 150.14 20.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.08 121.16 39.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.795 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.628 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.2 ttm-85 -98.48 109.36 22.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.28 43.19 17.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 110.176 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.96 81.21 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.033 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.32 129.77 22.41 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 117.237 0.518 . . . . 0.0 110.29 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.34 48.71 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.903 2.402 . . . . 0.0 112.846 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 122.066 0.936 . . . . 0.0 110.314 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 38.1 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.561 0.696 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.3 -14.06 65.59 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.076 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.593 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 39.8 mp0 -87.9 162.66 16.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.0 111.949 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -118.35 150.13 40.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.995 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.33 67.07 1.54 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.661 0.267 . . . . 0.0 111.528 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.23 -26.32 62.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.043 0.449 . . . . 0.0 110.853 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 3.38 50.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.002 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.31 31.71 68.7 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.23 133.14 16.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.436 . . . . 0.0 109.901 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.81 144.78 25.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.698 0.761 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.77 -25.49 22.24 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.575 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -101.4 138.8 37.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.3 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.756 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.2 t-20 -71.52 160.3 32.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.756 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 83.55 -17.22 26.24 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.614 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 66.2 m -110.94 152.67 26.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.599 0.714 . . . . 0.0 110.464 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -134.45 151.67 51.31 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.652 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.6 t -79.6 64.51 4.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.803 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.759 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.4 m-20 -78.68 -61.74 0.51 Allowed Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.7 Cg_endo -91.29 67.19 1.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.506 2.137 . . . . 0.0 111.736 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.444 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.84 139.77 8.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.581 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 52.9 Cg_endo -95.11 53.29 1.08 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.115 -1.619 . . . . 0.0 112.71 0.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.3 t -128.76 148.2 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 111.777 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.5 m -89.94 150.36 22.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.671 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -129.1 122.43 29.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.807 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.79 HH11 ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -89.57 107.87 19.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.79 ' HB2' HH11 ' A' ' 25' ' ' ARG . 2.3 t-20 60.68 36.47 19.5 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.037 0.836 . . . . 0.0 109.342 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.59 8.03 85.32 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.795 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 mp -116.68 124.1 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 117.526 0.663 . . . . 0.0 110.655 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 6.5 Cg_exo -74.01 47.73 1.57 Allowed 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.281 2.654 . . . . 0.0 112.573 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.725 0.774 . . . . 0.0 110.491 -179.688 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.551 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 80.1 m . . . . . 0 CA--C 1.511 -0.548 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.16 -21.3 46.4 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.879 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.9 mp0 -88.86 169.38 11.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.65 . . . . 0.0 111.356 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -125.04 164.74 19.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.84 65.65 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.428 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.6 -24.61 61.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 0.0 110.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -88.26 2.08 53.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.983 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.423 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 72.96 29.27 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 131.76 14.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.476 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -84.83 140.8 30.92 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.876 0.846 . . . . 0.0 110.861 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.39 -24.58 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . 0.476 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.5 t -90.99 165.38 13.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -93.19 156.89 16.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.612 0.72 . . . . 0.0 111.109 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 19.51 72.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.111 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 81.3 m -136.28 155.74 49.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.528 0.68 . . . . 0.0 110.685 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -135.33 151.77 50.84 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.423 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.04 63.89 5.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.09 0.471 . . . . 0.0 111.738 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.771 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.4 m-20 -77.21 -61.44 0.67 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 91.3 Cg_endo -92.31 66.89 0.81 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 111.853 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.1 t90 -47.15 139.64 7.19 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.791 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.71 50.16 1.39 Allowed 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.145 -1.606 . . . . 0.0 112.51 0.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.588 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.14 151.1 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.8 m -94.46 150.65 20.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.804 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.495 HG23 ' HD3' ' A' ' 19' ' ' PRO . 1.1 p -124.47 124.84 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.158 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.664 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 2.7 ptp180 -104.37 117.56 34.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.55 36.04 22.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.847 0.832 . . . . 0.0 109.801 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.52 15.35 81.49 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.576 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.68 126.47 26.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 117.209 0.505 . . . . 0.0 110.378 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 43.25 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.975 2.45 . . . . 0.0 112.419 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.35 1.071 . . . . 0.0 109.966 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' CYS . . . . . 0.586 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 55.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.28 63.6 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.586 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 45.7 mp0 -87.93 162.76 16.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.816 0.817 . . . . 0.0 112.067 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.4 p -118.46 151.94 36.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.948 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -135.09 66.02 1.54 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.634 0.254 . . . . 0.0 111.543 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -58.07 -27.15 63.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.969 0.414 . . . . 0.0 110.765 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -88.98 5.15 45.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.165 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.91 31.81 69.9 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.18 133.04 16.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.038 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.77 145.28 24.92 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.62 0.724 . . . . 0.0 110.11 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -88.68 -24.74 22.66 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.694 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -103.62 139.56 38.74 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASN . . . . . 0.79 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -72.08 162.67 29.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.79 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 81.99 -13.14 39.43 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.607 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.731 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.2 m -115.15 153.79 30.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.466 0.651 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -134.68 151.27 50.89 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.828 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -80.05 64.45 4.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.765 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.1 m-20 -79.43 -61.73 0.46 Allowed Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 89.7 Cg_endo -90.79 67.03 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.45 2.1 . . . . 0.0 111.722 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 60.0 t90 -47.84 139.78 8.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.5 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 53.4 Cg_endo -95.15 52.65 1.13 Allowed 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.093 -1.628 . . . . 0.0 112.714 0.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.562 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.0 t -128.77 148.93 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.046 0.45 . . . . 0.0 111.683 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' CYS . . . . . 0.731 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 79.9 m -89.95 149.25 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.709 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.433 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -127.05 128.55 46.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.523 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 76.6 ttt180 -106.04 115.44 30.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.38 42.28 21.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.98 0.895 . . . . 0.0 109.457 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.04 24.64 75.81 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.489 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.1 mt -135.62 128.67 18.13 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 122.678 -0.307 . . . . 0.0 110.493 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.33 49.37 2.02 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 123.229 2.619 . . . . 0.0 112.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.396 -179.445 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 79.7 m . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.375 0.607 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.16 -17.15 57.91 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.952 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.727 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 31.5 mp0 -89.05 163.76 15.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -121.18 150.48 41.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.349 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -132.37 64.9 1.59 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -57.75 -27.04 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 110.804 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -88.94 5.8 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.494 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.32 30.0 69.7 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 132.26 15.09 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.07 144.95 26.65 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.794 0.807 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.58 -25.23 22.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.735 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -105.09 142.27 35.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.155 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.807 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -72.0 166.63 21.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.807 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 71.0 19.64 77.27 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.326 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.3 m -142.41 153.79 44.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.479 0.657 . . . . 0.0 110.394 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.07 149.54 50.1 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.398 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.494 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -81.0 64.44 5.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.532 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.777 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.9 m-20 -80.1 -61.64 0.43 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.752 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.777 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -90.71 65.57 1.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.443 2.096 . . . . 0.0 111.891 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.461 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.9 t90 -47.84 139.91 8.85 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 50.1 Cg_endo -94.36 50.76 1.25 Allowed 'Cis proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.091 -1.629 . . . . 0.0 112.675 0.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.564 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.2 t -126.54 149.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.52 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.86 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.0 m -90.8 148.69 22.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.771 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.406 HG21 ' HG3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -115.74 121.72 43.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.571 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.728 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 26.3 ttm180 -95.93 108.84 21.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.06 36.19 21.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.941 0.877 . . . . 0.0 110.041 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.6 11.45 83.02 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.837 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.7 mp -125.95 133.32 24.81 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 117.27 0.535 . . . . 0.0 109.991 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.6 Cg_exo -70.86 45.39 0.57 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.857 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.734 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.3 m . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 121.393 0.615 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.93 -19.81 50.49 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.437 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.596 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.0 mp0 -89.26 170.29 10.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.38 0.609 . . . . 0.0 111.31 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.72 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 p -146.61 65.41 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.571 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.84 -24.63 62.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.957 0.408 . . . . 0.0 110.902 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -88.35 2.66 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.08 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.429 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 73.29 29.15 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.67 131.17 13.84 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.491 ' SG ' HG23 ' A' ' 12' ' ' THR . 1.8 t -82.67 139.98 33.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.901 0.858 . . . . 0.0 110.444 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.45 -23.62 22.07 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.603 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.491 HG23 ' SG ' ' A' ' 10' ' ' CYS . 1.6 t -93.6 167.16 11.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.522 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -93.94 159.34 15.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.854 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.36 22.81 71.44 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.816 179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 76.7 m -141.61 154.71 45.58 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.672 0.749 . . . . 0.0 110.954 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.37 151.71 50.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.429 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.27 64.49 6.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.085 0.469 . . . . 0.0 111.748 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.77 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.0 m-20 -78.97 -61.28 0.51 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.77 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -91.98 66.86 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.408 2.072 . . . . 0.0 112.04 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.462 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.8 t90 -47.74 139.97 8.53 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.854 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.462 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 57.4 Cg_endo -94.25 49.32 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.635 0.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.572 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -123.92 151.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.475 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.816 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -93.67 149.36 21.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.628 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.433 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -115.95 121.85 43.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.775 178.555 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.734 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 33.7 ttm180 -102.12 112.6 25.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.7 t30 60.17 39.59 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.001 0.905 . . . . 0.0 109.934 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.86 16.39 80.45 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.79 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.4 mt -133.79 131.77 21.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 117.055 0.428 . . . . 0.0 110.382 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.1 Cg_exo -71.39 50.1 1.21 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.112 2.541 . . . . 0.0 112.494 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 122.103 0.954 . . . . 0.0 110.231 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.711 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 92.4 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.72 -19.5 52.48 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.69 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.7 mp0 -88.44 166.64 14.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.465 0.65 . . . . 0.0 111.264 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 p -124.27 151.64 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.26 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 p -133.16 65.23 1.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.15 -31.2 67.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.917 0.389 . . . . 0.0 110.614 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -88.88 12.2 15.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.076 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.509 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.98 31.83 80.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.324 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.32 133.4 16.17 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -92.7 144.69 25.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.508 0.67 . . . . 0.0 109.843 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.79 -24.38 22.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.626 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -98.9 137.42 37.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.988 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -70.83 158.79 35.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.57 -19.28 20.47 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.431 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.6 m -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.826 0.822 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -132.94 150.47 52.16 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.411 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.509 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.0 t -80.54 64.62 5.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.691 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.773 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.2 m-20 -79.55 -62.26 0.43 Allowed Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.773 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 87.9 Cg_endo -91.37 67.03 1.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.416 2.077 . . . . 0.0 111.717 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.445 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.24 139.66 7.43 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.445 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 51.6 Cg_endo -94.92 51.2 1.24 Allowed 'Cis proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.592 0.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.57 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.3 t -125.81 149.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.2 m -90.74 151.06 21.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.681 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -130.34 135.57 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.99 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.711 ' CZ ' ' HA ' ' A' ' 1' ' ' CYS . 13.7 ptt180 -132.38 131.09 41.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 61.53 35.3 17.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.079 0.943 . . . . 0.0 109.236 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.88 84.64 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.053 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 94.1 mt -143.02 131.28 11.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.624 0.249 . . . . 0.0 110.581 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.18 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.99 2.46 . . . . 0.0 111.78 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.762 -179.68 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 63.4 m . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.27 -24.94 8.52 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.264 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.6 172.84 8.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.834 0.826 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -122.61 174.17 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.039 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.06 59.06 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.533 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -56.66 -30.68 63.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.207 0.527 . . . . 0.0 110.662 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.06 11.49 20.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.372 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.31 34.32 87.61 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.43 132.02 16.8 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.37 146.1 23.96 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.824 0.821 . . . . 0.0 111.766 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -88.86 -26.46 21.62 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.78 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -91.87 135.35 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.122 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -72.72 157.4 37.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.62 2.43 50.2 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.858 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.7 m -109.86 157.4 19.25 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.408 0.623 . . . . 0.0 110.142 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.518 HG21 ' OD1' ' A' ' 18' ' ' ASP . 1.9 t -135.02 146.95 49.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.792 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -81.76 63.57 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.529 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.43 -60.64 0.52 Allowed Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.901 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.0 Cg_endo -89.24 63.14 2.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.249 1.966 . . . . 0.0 111.881 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.451 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 53.9 t90 -46.37 139.34 6.01 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.7 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 45.8 Cg_endo -94.18 50.24 1.33 Allowed 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.103 -1.624 . . . . 0.0 112.623 0.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.518 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.54 150.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.191 0.519 . . . . 0.0 111.77 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.603 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 98.3 m -92.75 153.09 19.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.674 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -133.57 117.35 16.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.608 ' NH1' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -89.36 100.61 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.617 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.608 ' HB2' ' NH1' ' A' ' 25' ' ' ARG . 3.5 t30 66.67 35.65 5.13 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.014 0.821 . . . . 0.0 109.196 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.51 85.59 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.31 121.95 38.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 117.154 0.477 . . . . 0.0 110.472 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.462 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 64.3 Cg_endo -73.78 44.62 0.96 Allowed 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.955 2.437 . . . . 0.0 113.075 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.308 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.64 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 37.4 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.0 79.81 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.918 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.64 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.6 mp0 -87.83 161.69 17.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.904 0.859 . . . . 0.0 112.301 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -110.97 150.47 29.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.302 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.5 p -137.29 67.65 1.43 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.441 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.09 -25.94 61.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.064 0.459 . . . . 0.0 110.987 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 p -88.6 2.44 53.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.178 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.29 34.13 79.57 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.12 136.83 19.18 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -105.08 142.49 34.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.739 0.78 . . . . 0.0 110.638 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.61 -25.25 21.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.55 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.454 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 25.9 m -88.57 141.5 28.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.051 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.847 ' ND2' HH12 ' A' ' 25' ' ' ARG . 13.0 t30 -64.64 151.7 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.643 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.599 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 65.1 2.46 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.999 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 57.6 m -111.58 143.5 42.35 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.82 0.819 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.0 151.31 50.7 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.776 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.445 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t -76.97 62.23 2.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.108 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.826 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 70.7 m-20 -72.66 -62.0 1.51 Allowed Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.753 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.826 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 Cg_endo -92.49 67.95 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.541 2.16 . . . . 0.0 111.414 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.443 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.6 t90 -47.9 140.07 8.88 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.495 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.443 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 43.8 Cg_endo -95.33 54.28 1.02 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.593 0.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.624 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.2 t -127.91 145.58 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.13 0.49 . . . . 0.0 111.993 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.726 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.6 m -89.46 150.08 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.455 HG22 ' HG3' ' A' ' 19' ' ' PRO . 1.4 p -136.74 128.36 28.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.958 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.847 HH12 ' ND2' ' A' ' 13' ' ' ASN . 6.2 tpt180 -89.42 110.21 21.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.36 40.91 23.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.999 0.904 . . . . 0.0 109.257 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 22.53 78.74 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.422 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.12 133.51 24.9 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 122.687 -0.302 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 48.54 1.85 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.842 2.361 . . . . 0.0 112.482 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.531 -179.541 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.494 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 69.4 m . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.36 26.79 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.36 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -89.74 179.69 5.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.974 0.893 . . . . 0.0 112.161 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -135.17 148.35 49.68 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.777 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 p -129.34 65.06 1.47 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.006 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.09 -30.08 65.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.087 0.47 . . . . 0.0 110.542 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -89.88 9.1 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.291 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.568 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 67.62 33.57 81.32 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.04 134.25 17.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.273 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -98.81 145.6 26.78 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 -28.22 19.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.162 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -92.07 143.5 26.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.517 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -74.26 160.79 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.54 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.62 24.76 75.28 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.511 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.5 m -137.16 153.86 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.584 0.707 . . . . 0.0 110.749 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.624 HG22 ' HG1' ' A' ' 24' ' ' THR . 1.9 t -135.52 147.48 48.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.484 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.568 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.7 t -82.02 64.08 6.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.106 0.479 . . . . 0.0 111.355 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.525 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.79 -60.76 0.39 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.149 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.525 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.6 Cg_endo -88.13 63.12 3.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.238 1.959 . . . . 0.0 111.913 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.466 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.16 139.63 7.22 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.01 50.32 1.3 Allowed 'Cis proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.719 0.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.494 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -126.03 149.13 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.0 111.75 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.686 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 76.6 m -89.78 149.78 22.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.308 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.624 ' HG1' HG22 ' A' ' 16' ' ' THR . 0.5 OUTLIER -123.1 125.49 45.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.494 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 39.5 ttm180 -108.66 114.87 29.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 59.6 34.11 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.916 0.865 . . . . 0.0 109.798 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.2 82.47 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.692 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.517 HD12 ' HA ' ' A' ' 28' ' ' LEU . 3.0 mm? -128.91 131.99 24.09 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 117.131 0.465 . . . . 0.0 110.176 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.7 Cg_exo -72.25 49.06 1.3 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.165 2.577 . . . . 0.0 112.527 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.213 -179.495 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 -24.85 11.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.53 175.08 7.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.825 0.822 . . . . 0.0 112.193 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -129.1 147.28 50.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.139 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.5 p -120.88 63.78 0.86 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -57.31 -36.26 70.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -92.38 19.98 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.976 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.571 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 60.15 35.22 87.13 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.719 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 142.34 27.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.47 146.01 43.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.234 0.54 . . . . 0.0 109.798 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -89.56 -28.49 19.55 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.223 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 133.05 42.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.425 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.19 153.83 42.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.398 0.618 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.23 9.39 60.58 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.186 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.8 m -112.3 150.54 30.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.716 0.77 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 151.43 50.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.681 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.571 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.6 t -81.38 65.46 6.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.266 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.789 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.2 m-20 -78.27 -63.46 0.44 Allowed Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.846 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.789 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.2 Cg_endo -92.17 66.68 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.455 2.103 . . . . 0.0 111.748 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.447 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 57.1 t90 -46.8 139.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.752 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 51.0 Cg_endo -94.51 50.94 1.24 Allowed 'Cis proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.094 -1.627 . . . . 0.0 112.522 0.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.612 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 t -122.87 147.42 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.233 0.539 . . . . 0.0 111.879 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 72.1 m -90.97 148.09 22.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.368 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 19' ' ' PRO . 1.1 p -129.52 133.45 47.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.525 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.57 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 42.1 ptt85 -127.2 126.22 42.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.55 39.41 27.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.784 0.802 . . . . 0.0 109.683 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.26 74.39 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.211 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.432 ' HB3' HG21 ' A' ' 30' ' ' VAL . 95.1 mt -142.15 126.63 10.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.628 0.252 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.477 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 77.6 Cg_endo -77.5 44.83 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.946 2.431 . . . . 0.0 112.322 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.432 HG21 ' HB3' ' A' ' 28' ' ' LEU . 3.1 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.63 ' SG ' ' HG3' ' A' ' 25' ' ' ARG . 70.8 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.13 55.9 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.686 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.499 ' CD ' ' HG1' ' A' ' 12' ' ' THR . 10.0 mp0 -89.55 168.44 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.628 0.727 . . . . 0.0 112.077 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -123.38 151.71 42.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.223 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.1 p -132.87 66.38 1.56 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.672 0.272 . . . . 0.0 111.568 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.46 -26.57 63.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.976 0.417 . . . . 0.0 110.845 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -89.03 4.64 47.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.022 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.514 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.89 30.92 69.94 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.45 133.32 15.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.176 -0.512 . . . . 0.0 109.621 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -94.26 142.83 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.638 0.733 . . . . 0.0 110.103 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.04 -24.3 22.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.788 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.499 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 11.2 m -96.08 139.26 32.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.493 179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -70.54 159.16 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.65 22.96 78.59 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.319 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.828 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 98.2 m -140.41 151.34 44.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.545 0.688 . . . . 0.0 110.616 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -135.53 148.24 49.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.253 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.3 t -80.46 65.13 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.092 0.472 . . . . 0.0 111.385 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.796 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.4 m-20 -77.82 -62.61 0.52 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 86.5 Cg_endo -92.4 67.85 0.76 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.46 2.107 . . . . 0.0 111.725 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.451 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.5 t90 -47.38 139.6 7.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.641 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 51.7 Cg_endo -94.85 51.75 1.19 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.575 0.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.603 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 t -125.37 148.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.828 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -91.4 151.61 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 p -131.84 131.49 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.924 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.63 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 81.3 mtt-85 -89.3 87.45 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.96 52.45 2.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.989 0.899 . . . . 0.0 109.66 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.9 7.97 87.38 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.846 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.02 118.87 41.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.32 0.56 . . . . 0.0 110.383 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.95 44.53 0.8 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.871 2.381 . . . . 0.0 112.828 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.421 HG12 ' HD2' ' A' ' 25' ' ' ARG . 9.7 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 121.877 0.846 . . . . 0.0 110.671 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.591 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 85.4 m . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.507 0.67 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.85 -18.53 57.25 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.86 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.591 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 43.1 mp0 -88.01 162.27 16.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.892 0.853 . . . . 0.0 112.106 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -120.75 151.96 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.469 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -136.32 68.64 1.43 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.27 -25.2 63.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p -88.45 2.22 53.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.993 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 71.21 32.02 65.84 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 132.71 15.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.042 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.76 141.93 28.14 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.591 0.71 . . . . 0.0 109.93 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.2 -23.49 22.38 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.991 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -100.65 138.98 36.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.797 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -68.96 157.65 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 79.91 -4.02 67.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.399 178.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.745 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.3 m -121.91 151.56 40.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.465 0.65 . . . . 0.0 110.344 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.422 HG23 ' OD1' ' A' ' 18' ' ' ASP . 2.2 t -130.86 147.05 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.067 -179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.14 62.48 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.509 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.81 -60.08 0.46 Allowed Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 90.9 Cg_endo -88.29 65.4 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.199 1.932 . . . . 0.0 111.714 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.45 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 60.8 t90 -47.57 139.78 8.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.45 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 52.0 Cg_endo -94.99 52.59 1.13 Allowed 'Cis proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.686 0.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.489 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.9 t -128.82 148.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.123 0.487 . . . . 0.0 111.869 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.745 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.9 m -89.3 152.33 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.128 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.419 HG22 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -130.39 124.7 32.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.787 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.478 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.8 ttt85 -90.68 103.62 16.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.9 t30 59.43 37.35 23.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.011 0.91 . . . . 0.0 109.557 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.39 6.16 81.37 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.581 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -111.38 120.54 42.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.438 0.619 . . . . 0.0 110.379 179.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.08 45.14 1.3 Allowed 'Trans proline' 0 N--CA 1.47 0.12 0 C-N-CA 122.838 2.359 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.349 -179.862 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.022 0.439 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.57 -26.78 6.19 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.665 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -91.58 170.51 9.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.028 0.918 . . . . 0.0 113.182 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -116.87 177.21 4.79 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.173 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.43 58.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.497 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -56.74 -30.97 64.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.749 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -90.6 12.02 20.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.279 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.41 33.63 85.41 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.26 133.24 18.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.04 144.43 25.48 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.841 0.829 . . . . 0.0 111.584 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -88.98 -26.39 21.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.967 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.504 HG22 HH22 ' A' ' 25' ' ' ARG . 3.5 m -92.2 135.75 33.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.249 178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.6 156.83 38.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.01 26.69 73.91 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.954 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 78.1 m -136.03 153.63 51.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.294 0.568 . . . . 0.0 110.478 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.412 HG22 ' OD2' ' A' ' 18' ' ' ASP . 1.5 t -135.93 146.38 47.25 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.935 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -78.55 63.85 3.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.605 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.838 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 71.6 m-20 -73.8 -62.33 1.14 Allowed Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.251 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.838 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 60.7 Cg_endo -92.36 69.01 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.454 2.102 . . . . 0.0 111.728 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.449 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 54.5 t90 -48.11 140.3 9.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.454 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.449 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 47.7 Cg_endo -95.06 51.4 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.189 -1.588 . . . . 0.0 112.494 0.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.2 t -125.18 146.33 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.588 . . . . 0.0 112.327 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.581 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.8 m -89.62 151.65 21.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.956 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.04 125.59 25.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.504 HH22 HG22 ' A' ' 12' ' ' THR . 42.9 ttm-85 -96.53 108.52 21.11 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.507 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.96 42.7 25.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.916 0.865 . . . . 0.0 109.727 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.59 18.17 79.35 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.829 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 94.4 mt -128.58 131.88 24.02 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.083 0.442 . . . . 0.0 110.455 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.6 Cg_exo -71.83 47.55 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.179 2.586 . . . . 0.0 113.102 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.466 HG21 ' HB3' ' A' ' 25' ' ' ARG . 14.3 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.548 0.69 . . . . 0.0 111.152 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.403 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.6 m . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.31 -29.29 6.7 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.24 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.42 167.51 12.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.875 0.845 . . . . 0.0 111.946 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -118.03 174.7 6.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.773 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.3 p -150.39 66.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.87 -26.01 63.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.087 0.47 . . . . 0.0 110.782 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.91 3.77 50.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.21 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.505 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.05 32.75 69.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.417 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.35 132.9 15.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.02 141.2 29.71 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.78 0.8 . . . . 0.0 111.277 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.67 -27.42 20.14 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.858 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.39 131.46 35.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.257 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.692 HD21 ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -69.78 154.26 42.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.372 0.606 . . . . 0.0 109.943 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.692 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 67.85 25.12 74.28 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.243 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.2 m -133.41 154.99 50.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.301 0.572 . . . . 0.0 110.276 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.441 HG23 ' OD1' ' A' ' 18' ' ' ASP . 2.8 t -135.52 146.69 48.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.167 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.505 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.9 t -82.56 63.3 6.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.09 -60.79 0.47 Allowed Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.187 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.497 ' HD2' ' O ' ' A' ' 22' ' ' VAL . 88.3 Cg_endo -88.58 64.56 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.154 1.903 . . . . 0.0 111.727 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.477 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 62.3 t90 -47.81 139.85 8.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.51 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.477 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 49.1 Cg_endo -94.03 51.17 1.18 Allowed 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.859 0.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.497 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.5 t -126.52 148.91 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.948 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.7 m -89.45 153.99 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.099 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.03 129.53 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.976 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.415 ' HB3' HG11 ' A' ' 30' ' ' VAL . 49.2 ttm-85 -97.78 101.6 13.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.67 45.37 13.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.875 0.845 . . . . 0.0 109.988 -178.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.04 19.45 79.61 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.728 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.8 mt -129.55 130.23 23.25 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo -71.29 45.54 0.65 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.136 2.557 . . . . 0.0 112.971 -179.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.415 HG11 ' HB3' ' A' ' 25' ' ' ARG . 14.8 p . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 122.363 1.078 . . . . 0.0 110.64 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.671 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.78 -20.47 50.51 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.512 ' CD ' ' HG1' ' A' ' 12' ' ' THR . 10.1 mp0 -89.22 168.48 12.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.716 0.77 . . . . 0.0 111.933 -179.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -123.97 155.78 37.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.849 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 p -137.92 67.52 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.689 0.28 . . . . 0.0 111.733 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -59.54 -25.11 64.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.694 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -88.52 3.13 51.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.955 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.449 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.36 31.33 68.64 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.36 132.91 15.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.265 -0.468 . . . . 0.0 109.772 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -93.89 142.06 27.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.575 0.702 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.23 -23.7 22.29 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.829 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.512 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 6.7 m -94.64 139.25 31.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.741 179.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.55 158.03 36.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.763 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.95 75.52 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.903 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.772 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 89.2 m -130.4 149.89 51.88 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.732 0.777 . . . . 0.0 110.571 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.507 HG21 ' OD2' ' A' ' 18' ' ' ASP . 1.5 t -135.6 146.09 47.58 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.746 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.449 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.4 t -79.2 63.16 3.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.083 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.749 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 43.5 m-20 -76.36 -61.3 0.81 Allowed Pre-proline 0 C--N 1.318 -0.792 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.48 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.749 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.8 Cg_endo -90.29 66.85 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.347 2.031 . . . . 0.0 111.866 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.455 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.9 t90 -47.85 140.0 8.81 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.633 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.455 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.3 Cg_endo -94.6 50.78 1.27 Allowed 'Cis proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.101 -1.625 . . . . 0.0 112.589 0.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.535 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.0 t -125.2 147.52 29.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.273 0.559 . . . . 0.0 111.936 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.772 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 100.0 m -89.35 151.11 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.146 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.451 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -123.03 130.05 52.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.322 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.671 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 14.8 ttp180 -117.87 119.95 36.4 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.41 HD21 ' HA ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 58.76 40.41 23.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.928 0.871 . . . . 0.0 109.977 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.82 26.23 74.71 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.579 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.448 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 91.7 mt -144.6 134.21 11.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.0 Cg_exo -72.6 47.48 1.17 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 123.023 2.482 . . . . 0.0 112.594 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.788 0.804 . . . . 0.0 110.395 -179.646 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.688 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 39.3 m . . . . . 0 CA--C 1.518 -0.284 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.16 78.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.656 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.688 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 28.8 mp0 -88.06 159.34 18.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.911 0.863 . . . . 0.0 111.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -109.92 148.47 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.507 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.67 66.65 1.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.12 -30.0 65.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.953 0.406 . . . . 0.0 110.726 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -88.81 9.64 23.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.471 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.57 34.12 88.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.25 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.04 134.07 17.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -95.96 143.48 27.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.598 0.713 . . . . 0.0 110.18 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.13 -24.33 22.25 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.819 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -99.07 137.98 36.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.425 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.707 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.5 t-20 -71.61 156.54 39.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.988 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.707 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.36 12.38 84.29 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.972 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.0 m -129.76 152.26 49.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.519 HG21 ' OD1' ' A' ' 18' ' ' ASP . 2.7 t -132.07 145.72 51.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.421 -179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.471 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.77 62.17 4.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.468 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.625 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.51 -61.23 0.48 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.95 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.625 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 7.7 Cg_endo -87.64 66.07 3.81 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.439 2.093 . . . . 0.0 111.268 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.46 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 61.7 t90 -48.31 140.06 9.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.567 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 54.2 Cg_endo -95.03 53.89 1.04 Allowed 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.774 0.877 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 38.2 t -130.13 146.95 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.124 0.488 . . . . 0.0 111.986 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.655 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -88.89 152.14 21.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.916 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.92 132.56 40.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.947 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.56 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttt85 -94.22 103.93 15.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.39 44.78 14.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.811 0.815 . . . . 0.0 109.997 -178.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.48 73.76 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.249 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.28 143.98 45.91 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 50.05 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.32 -0.713 0 CA-C-O 121.464 0.65 . . . . 0.0 110.419 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.3 -30.4 7.76 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.392 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 167.89 12.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.895 0.855 . . . . 0.0 111.783 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -117.75 175.89 5.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.826 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.3 p -150.26 62.38 0.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.069 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.14 -29.64 65.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -91.15 10.45 26.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.302 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.5 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 66.19 35.33 90.28 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.81 133.63 19.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 t -100.93 144.18 30.18 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 111.694 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -89.7 -28.71 19.25 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.861 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.14 132.69 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.474 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.694 HD21 ' H ' ' A' ' 14' ' ' GLY . 1.1 t-20 -70.18 152.65 44.02 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.694 ' H ' HD21 ' A' ' 13' ' ' ASN . . . 67.08 22.65 72.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.157 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.574 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 80.9 m -123.02 155.64 36.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.593 0.711 . . . . 0.0 110.696 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -135.62 147.06 48.5 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.5 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.1 t -83.67 63.52 7.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.817 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.474 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.66 -60.79 0.44 Allowed Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.081 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.49 ' HD2' ' O ' ' A' ' 22' ' ' VAL . 93.8 Cg_endo -87.76 62.63 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.118 1.878 . . . . 0.0 111.771 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.464 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 57.3 t90 -46.91 139.58 6.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.638 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.464 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.5 Cg_endo -93.82 49.8 1.36 Allowed 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.104 -1.624 . . . . 0.0 112.698 0.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.49 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.0 t -124.47 149.59 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 111.854 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 84.8 m -89.57 154.97 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.346 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.74 134.97 43.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.197 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 35.7 ttp180 -132.46 124.98 29.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t30 58.75 36.11 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.984 0.897 . . . . 0.0 109.683 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.75 28.25 72.28 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.451 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.436 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 85.2 mt -148.63 137.5 11.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.15 50.85 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.215 2.61 . . . . 0.0 111.858 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 122.285 1.041 . . . . 0.0 110.713 -178.957 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.578 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 33.0 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.98 -16.64 60.62 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.403 ' CD ' ' HG1' ' A' ' 12' ' ' THR . 13.4 mp0 -88.09 166.81 14.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.843 0.83 . . . . 0.0 111.978 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -122.02 150.43 42.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.016 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.55 66.45 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.531 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.06 -26.57 62.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.94 4.02 49.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.546 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.94 32.24 69.86 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 133.83 16.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.814 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 143.32 28.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.654 0.74 . . . . 0.0 110.331 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.32 -25.35 21.68 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.317 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.403 ' HG1' ' CD ' ' A' ' 3' ' ' GLU . 3.4 m -89.72 136.17 33.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.343 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.696 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -70.26 156.14 39.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.263 0.554 . . . . 0.0 110.296 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.696 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.48 -5.36 45.28 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.176 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.1 m -113.48 150.79 32.35 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.619 0.723 . . . . 0.0 110.203 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -135.1 151.96 51.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.774 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.546 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.2 t -80.88 64.58 5.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.097 0.475 . . . . 0.0 111.708 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.768 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.2 m-20 -79.13 -61.95 0.47 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.748 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.768 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 85.0 Cg_endo -91.36 66.36 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.345 2.03 . . . . 0.0 111.738 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.451 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.4 139.6 7.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.666 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.451 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 50.3 Cg_endo -94.7 51.56 1.19 Allowed 'Cis proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.194 -1.586 . . . . 0.0 112.628 0.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.577 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.7 t -126.06 148.76 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.031 0.443 . . . . 0.0 111.688 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.784 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.2 m -90.72 148.06 22.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.761 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.488 HG22 ' HD3' ' A' ' 19' ' ' PRO . 0.9 OUTLIER -123.82 125.29 44.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.739 178.375 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.631 HH11 ' HB2' ' A' ' 26' ' ' ASN . 2.4 tmt_? -102.85 113.88 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.631 ' HB2' HH11 ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.97 41.26 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.897 0.748 . . . . 0.0 110.241 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.9 79.76 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.666 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.47 126.47 17.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.952 0.376 . . . . 0.0 110.355 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.9 50.55 2.15 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.915 2.41 . . . . 0.0 112.611 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.827 -179.369 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.473 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.1 m . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -24.3 8.08 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.653 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.89 173.03 8.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 112.307 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 p -125.31 172.39 9.63 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.071 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 p -150.96 59.03 0.92 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.551 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -57.25 -29.57 63.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.086 0.469 . . . . 0.0 110.589 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -89.89 11.01 21.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.285 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.62 33.14 80.1 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.15 131.2 14.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.102 -0.549 . . . . 0.0 109.574 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.528 ' SG ' HG21 ' A' ' 12' ' ' THR . 2.0 t -85.11 144.0 28.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.742 0.782 . . . . 0.0 111.155 -179.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -88.74 -26.22 21.89 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.528 HG21 ' SG ' ' A' ' 10' ' ' CYS . 13.1 t -103.05 144.67 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 178.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -74.88 162.95 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.562 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.88 29.19 74.3 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.913 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 97.2 m -142.5 157.28 44.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.511 0.672 . . . . 0.0 111.062 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.47 HG22 ' OD1' ' A' ' 18' ' ' ASP . 2.9 t -134.54 146.89 50.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.023 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.11 62.84 6.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.275 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.539 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.37 -60.4 0.47 Allowed Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 92.4 Cg_endo -88.71 63.98 2.9 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.228 1.952 . . . . 0.0 111.89 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.471 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 56.4 t90 -47.51 140.25 7.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.8 Cg_endo -94.03 49.18 1.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.562 0.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -125.05 149.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.256 0.551 . . . . 0.0 111.779 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.652 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.7 m -89.91 154.62 19.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.206 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.442 HG21 ' HG3' ' A' ' 19' ' ' PRO . 0.2 OUTLIER -128.86 129.83 46.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.429 178.714 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.509 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.9 ttm180 -116.86 118.15 31.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.61 42.08 27.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.897 0.855 . . . . 0.0 109.76 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.22 75.57 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.72 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.27 132.21 13.38 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.833 0.317 . . . . 0.0 110.356 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.26 47.89 1.67 Allowed 'Trans proline' 0 N--CA 1.471 0.2 0 C-N-CA 122.823 2.349 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 122.282 1.039 . . . . 0.0 110.464 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.628 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 61.5 m . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.68 54.22 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.531 ' HG2' ' HB ' ' A' ' 12' ' ' THR . 21.7 mp0 -88.68 178.53 6.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -134.44 163.76 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.78 63.46 1.3 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.686 0.279 . . . . 0.0 111.622 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -58.16 -25.75 61.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 p -88.69 4.88 45.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.98 30.69 67.56 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.5 131.56 14.36 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.557 ' SG ' HG23 ' A' ' 12' ' ' THR . 2.2 t -83.52 141.3 31.72 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.917 0.865 . . . . 0.0 110.896 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -89.28 -24.89 21.94 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.744 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.557 HG23 ' SG ' ' A' ' 10' ' ' CYS . 4.6 t -95.85 158.07 15.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.338 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -87.6 156.19 19.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.336 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.53 23.09 78.47 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.597 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 99.6 m -141.86 155.8 45.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.581 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -135.45 151.17 50.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.679 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.7 t -80.97 64.08 5.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 0.0 111.694 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.775 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-20 -78.6 -61.25 0.55 Allowed Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.735 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.775 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 95.4 Cg_endo -91.85 66.59 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.505 2.137 . . . . 0.0 112.116 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.46 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.6 t90 -47.46 139.88 7.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.775 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 49.9 Cg_endo -94.26 49.18 1.51 Allowed 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.191 -1.587 . . . . 0.0 112.559 0.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 21.7 t -123.95 151.49 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.647 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.776 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 90.1 m -93.47 150.14 20.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -118.08 121.16 39.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.795 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.628 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.2 ttm-85 -98.48 109.36 22.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.28 43.19 17.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 110.176 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.96 81.21 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.033 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.32 129.77 22.41 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 117.237 0.518 . . . . 0.0 110.29 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.34 48.71 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.903 2.402 . . . . 0.0 112.846 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 122.066 0.936 . . . . 0.0 110.314 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.593 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 38.1 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.561 0.696 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.3 -14.06 65.59 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.076 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.593 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 39.8 mp0 -87.9 162.66 16.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.0 111.949 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -118.35 150.13 40.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.995 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.33 67.07 1.54 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.661 0.267 . . . . 0.0 111.528 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.23 -26.32 62.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.043 0.449 . . . . 0.0 110.853 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 3.38 50.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.002 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.31 31.71 68.7 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.23 133.14 16.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.436 . . . . 0.0 109.901 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.81 144.78 25.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.698 0.761 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.77 -25.49 22.24 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.575 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -101.4 138.8 37.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.3 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.756 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.2 t-20 -71.52 160.3 32.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.756 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 83.55 -17.22 26.24 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.614 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 66.2 m -110.94 152.67 26.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.599 0.714 . . . . 0.0 110.464 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -134.45 151.67 51.31 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.652 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.6 t -79.6 64.51 4.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.803 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.759 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.4 m-20 -78.68 -61.74 0.51 Allowed Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.759 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.7 Cg_endo -91.29 67.19 1.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.506 2.137 . . . . 0.0 111.736 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.444 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.84 139.77 8.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.581 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.444 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 52.9 Cg_endo -95.11 53.29 1.08 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.115 -1.619 . . . . 0.0 112.71 0.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.573 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.3 t -128.76 148.2 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 111.777 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.742 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.5 m -89.94 150.36 22.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.671 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -129.1 122.43 29.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.807 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.79 HH11 ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -89.57 107.87 19.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.79 ' HB2' HH11 ' A' ' 25' ' ' ARG . 2.3 t-20 60.68 36.47 19.5 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.037 0.836 . . . . 0.0 109.342 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.59 8.03 85.32 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.795 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.412 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 mp -116.68 124.1 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 117.526 0.663 . . . . 0.0 110.655 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 6.5 Cg_exo -74.01 47.73 1.57 Allowed 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.281 2.654 . . . . 0.0 112.573 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.725 0.774 . . . . 0.0 110.491 -179.688 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.551 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 80.1 m . . . . . 0 CA--C 1.511 -0.548 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.16 -21.3 46.4 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.879 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.551 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.9 mp0 -88.86 169.38 11.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.65 . . . . 0.0 111.356 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -125.04 164.74 19.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.84 65.65 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.428 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.6 -24.61 61.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 0.0 110.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -88.26 2.08 53.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.983 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.423 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 72.96 29.27 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 131.76 14.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.476 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -84.83 140.8 30.92 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.876 0.846 . . . . 0.0 110.861 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.39 -24.58 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . 0.476 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.5 t -90.99 165.38 13.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -93.19 156.89 16.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.612 0.72 . . . . 0.0 111.109 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 19.51 72.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.111 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 81.3 m -136.28 155.74 49.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.528 0.68 . . . . 0.0 110.685 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -135.33 151.77 50.84 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.423 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.04 63.89 5.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.09 0.471 . . . . 0.0 111.738 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.771 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.4 m-20 -77.21 -61.44 0.67 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.771 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 91.3 Cg_endo -92.31 66.89 0.81 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 111.853 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 58.1 t90 -47.15 139.64 7.19 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.791 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.71 50.16 1.39 Allowed 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.145 -1.606 . . . . 0.0 112.51 0.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.588 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.14 151.1 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.8 m -94.46 150.65 20.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.804 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.495 HG23 ' HD3' ' A' ' 19' ' ' PRO . 1.1 p -124.47 124.84 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.158 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.664 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 2.7 ptp180 -104.37 117.56 34.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.55 36.04 22.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.847 0.832 . . . . 0.0 109.801 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.52 15.35 81.49 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.576 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -122.68 126.47 26.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 117.209 0.505 . . . . 0.0 110.378 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 43.25 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.975 2.45 . . . . 0.0 112.419 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.35 1.071 . . . . 0.0 109.966 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' CYS . . . . . 0.586 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 55.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.28 63.6 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.586 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 45.7 mp0 -87.93 162.76 16.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.816 0.817 . . . . 0.0 112.067 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.4 p -118.46 151.94 36.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.948 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -135.09 66.02 1.54 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.634 0.254 . . . . 0.0 111.543 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -58.07 -27.15 63.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.969 0.414 . . . . 0.0 110.765 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -88.98 5.15 45.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.165 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.91 31.81 69.9 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.18 133.04 16.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.038 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.77 145.28 24.92 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.62 0.724 . . . . 0.0 110.11 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -88.68 -24.74 22.66 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.694 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -103.62 139.56 38.74 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASN . . . . . 0.79 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -72.08 162.67 29.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.79 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 81.99 -13.14 39.43 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.607 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.731 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.2 m -115.15 153.79 30.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.466 0.651 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -134.68 151.27 50.89 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.828 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' CYS . . . . . 0.51 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -80.05 64.45 4.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.765 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.1 m-20 -79.43 -61.73 0.46 Allowed Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' PRO . . . . . 0.765 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 89.7 Cg_endo -90.79 67.03 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.45 2.1 . . . . 0.0 111.722 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TRP . . . . . 0.446 ' CG ' ' HA ' ' A' ' 21' ' ' PRO . 60.0 t90 -47.84 139.78 8.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.5 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.446 ' HA ' ' CG ' ' A' ' 20' ' ' TRP . 53.4 Cg_endo -95.15 52.65 1.13 Allowed 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.093 -1.628 . . . . 0.0 112.714 0.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.562 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.0 t -128.77 148.93 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.046 0.45 . . . . 0.0 111.683 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.731 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 79.9 m -89.95 149.25 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.709 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.433 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -127.05 128.55 46.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.523 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 76.6 ttt180 -106.04 115.44 30.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.38 42.28 21.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.98 0.895 . . . . 0.0 109.457 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.04 24.64 75.81 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.489 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.1 mt -135.62 128.67 18.13 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 122.678 -0.307 . . . . 0.0 110.493 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.33 49.37 2.02 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 123.229 2.619 . . . . 0.0 112.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.396 -179.445 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.746 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 79.7 m . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.375 0.607 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.16 -17.15 57.91 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.952 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.746 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 31.5 mp0 -89.05 163.76 15.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -121.18 150.48 41.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.349 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -132.37 64.9 1.59 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -57.75 -27.04 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 110.804 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -88.94 5.8 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.495 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.32 30.0 69.7 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 132.26 15.09 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.07 144.95 26.65 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.794 0.807 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.58 -25.23 22.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.735 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -105.09 142.27 35.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.155 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.0 166.63 21.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . 71.0 19.64 77.27 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.326 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.3 m -142.41 153.79 44.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.479 0.657 . . . . 0.0 110.394 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.07 149.54 50.1 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.398 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -81.0 64.44 5.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.532 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.794 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.9 m-20 -80.1 -61.64 0.43 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.752 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.794 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -90.71 65.57 1.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.443 2.096 . . . . 0.0 111.891 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.9 t90 -47.84 139.91 8.85 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.1 Cg_endo -94.36 50.76 1.25 Allowed 'Cis proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.091 -1.629 . . . . 0.0 112.675 0.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.558 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.2 t -126.54 149.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.52 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.0 m -90.8 148.69 22.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.771 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -115.74 121.72 43.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.571 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.738 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 26.3 ttm180 -95.93 108.84 21.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.06 36.19 21.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.941 0.877 . . . . 0.0 110.041 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.6 11.45 83.02 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.837 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.7 mp -125.95 133.32 24.81 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 117.27 0.535 . . . . 0.0 109.991 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.6 Cg_exo -70.86 45.39 0.57 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.857 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.3 m . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 121.393 0.615 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.93 -19.81 50.49 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.437 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.619 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.0 mp0 -89.26 170.29 10.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.38 0.609 . . . . 0.0 111.31 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.72 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 p -146.61 65.41 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.571 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.84 -24.63 62.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.957 0.408 . . . . 0.0 110.902 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -88.35 2.66 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.08 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 73.29 29.15 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.67 131.17 13.84 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.728 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -82.67 139.98 33.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.901 0.858 . . . . 0.0 110.444 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.45 -23.62 22.07 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.603 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.728 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.6 t -93.6 167.16 11.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.522 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -93.94 159.34 15.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.854 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 66.36 22.81 71.44 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.816 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 76.7 m -141.61 154.71 45.58 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.672 0.749 . . . . 0.0 110.954 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.37 151.71 50.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.27 64.49 6.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.085 0.469 . . . . 0.0 111.748 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.785 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.0 m-20 -78.97 -61.28 0.51 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -91.98 66.86 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.408 2.072 . . . . 0.0 112.04 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.8 t90 -47.74 139.97 8.53 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.854 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 57.4 Cg_endo -94.25 49.32 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.635 0.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -123.92 151.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.475 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -93.67 149.36 21.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.628 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -115.95 121.85 43.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.775 178.555 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.748 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 33.7 ttm180 -102.12 112.6 25.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.7 t30 60.17 39.59 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.001 0.905 . . . . 0.0 109.934 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.86 16.39 80.45 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.79 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.4 mt -133.79 131.77 21.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 117.055 0.428 . . . . 0.0 110.382 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.1 Cg_exo -71.39 50.1 1.21 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.112 2.541 . . . . 0.0 112.494 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 122.103 0.954 . . . . 0.0 110.231 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.733 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 92.4 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.72 -19.5 52.48 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.702 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.7 mp0 -88.44 166.64 14.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.465 0.65 . . . . 0.0 111.264 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 p -124.27 151.64 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.26 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 p -133.16 65.23 1.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.15 -31.2 67.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.917 0.389 . . . . 0.0 110.614 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -88.88 12.2 15.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.076 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.514 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.98 31.83 80.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.324 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.32 133.4 16.17 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -92.7 144.69 25.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.508 0.67 . . . . 0.0 109.843 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.79 -24.38 22.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.626 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -98.9 137.42 37.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.988 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -70.83 158.79 35.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.57 -19.28 20.47 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.431 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.6 m -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.826 0.822 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -132.94 150.47 52.16 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.411 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.0 t -80.54 64.62 5.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.691 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.798 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.2 m-20 -79.55 -62.26 0.43 Allowed Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 87.9 Cg_endo -91.37 67.03 1.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.416 2.077 . . . . 0.0 111.717 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.24 139.66 7.43 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.6 Cg_endo -94.92 51.2 1.24 Allowed 'Cis proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.592 0.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.3 t -125.81 149.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.2 m -90.74 151.06 21.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.681 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -130.34 135.57 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.99 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 1' ' ' CYS . 13.7 ptt180 -132.38 131.09 41.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 61.53 35.3 17.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.079 0.943 . . . . 0.0 109.236 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.88 84.64 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.053 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' HG23 ' A' ' 30' ' ' VAL . 94.1 mt -143.02 131.28 11.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.624 0.249 . . . . 0.0 110.581 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.18 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.99 2.46 . . . . 0.0 111.78 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.5 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.762 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 63.4 m . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.27 -24.94 8.52 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.264 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.6 172.84 8.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.834 0.826 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -122.61 174.17 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.039 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.06 59.06 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.533 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -56.66 -30.68 63.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.207 0.527 . . . . 0.0 110.662 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.06 11.49 20.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.372 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.31 34.32 87.61 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.43 132.02 16.8 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.37 146.1 23.96 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.824 0.821 . . . . 0.0 111.766 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -88.86 -26.46 21.62 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.78 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -91.87 135.35 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.122 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -72.72 157.4 37.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.62 2.43 50.2 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.858 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.7 m -109.86 157.4 19.25 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.408 0.623 . . . . 0.0 110.142 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.02 146.95 49.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -81.76 63.57 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.43 -60.64 0.52 Allowed Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.901 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.0 Cg_endo -89.24 63.14 2.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.249 1.966 . . . . 0.0 111.881 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 53.9 t90 -46.37 139.34 6.01 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.7 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 45.8 Cg_endo -94.18 50.24 1.33 Allowed 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.103 -1.624 . . . . 0.0 112.623 0.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.54 150.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.191 0.519 . . . . 0.0 111.77 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 98.3 m -92.75 153.09 19.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.674 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -133.57 117.35 16.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -89.36 100.61 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.617 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' HB2' ' NH1' ' A' ' 25' ' ' ARG . 3.5 t30 66.67 35.65 5.13 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.014 0.821 . . . . 0.0 109.196 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.51 85.59 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.31 121.95 38.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 117.154 0.477 . . . . 0.0 110.472 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 64.3 Cg_endo -73.78 44.62 0.96 Allowed 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.955 2.437 . . . . 0.0 113.075 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.308 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 37.4 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.0 79.81 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.918 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.6 mp0 -87.83 161.69 17.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.904 0.859 . . . . 0.0 112.301 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -110.97 150.47 29.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.302 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.5 p -137.29 67.65 1.43 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.441 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.09 -25.94 61.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.064 0.459 . . . . 0.0 110.987 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 p -88.6 2.44 53.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.178 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.29 34.13 79.57 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.12 136.83 19.18 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -105.08 142.49 34.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.739 0.78 . . . . 0.0 110.638 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.61 -25.25 21.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.55 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -88.57 141.5 28.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.051 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -64.64 151.7 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.643 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 65.1 2.46 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.999 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 57.6 m -111.58 143.5 42.35 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.82 0.819 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.0 151.31 50.7 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.776 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.447 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t -76.97 62.23 2.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.108 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.844 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 70.7 m-20 -72.66 -62.0 1.51 Allowed Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.753 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 Cg_endo -92.49 67.95 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.541 2.16 . . . . 0.0 111.414 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.6 t90 -47.9 140.07 8.88 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.495 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 43.8 Cg_endo -95.33 54.28 1.02 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.593 0.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.2 t -127.91 145.58 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.13 0.49 . . . . 0.0 111.993 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.6 m -89.46 150.08 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 128.36 28.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.958 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 6.2 tpt180 -89.42 110.21 21.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.36 40.91 23.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.999 0.904 . . . . 0.0 109.257 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 22.53 78.74 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.422 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.12 133.51 24.9 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 122.687 -0.302 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 48.54 1.85 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.842 2.361 . . . . 0.0 112.482 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.531 -179.541 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 69.4 m . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.36 26.79 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.36 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -89.74 179.69 5.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.974 0.893 . . . . 0.0 112.161 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -135.17 148.35 49.68 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.777 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 p -129.34 65.06 1.47 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.006 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.09 -30.08 65.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.087 0.47 . . . . 0.0 110.542 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -89.88 9.1 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.291 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 67.62 33.57 81.32 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.04 134.25 17.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.273 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -98.81 145.6 26.78 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 -28.22 19.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.162 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -92.07 143.5 26.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.517 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -74.26 160.79 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.54 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.62 24.76 75.28 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.511 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.5 m -137.16 153.86 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.584 0.707 . . . . 0.0 110.749 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.52 147.48 48.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.484 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.7 t -82.02 64.08 6.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.106 0.479 . . . . 0.0 111.355 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.569 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.79 -60.76 0.39 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.149 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.6 Cg_endo -88.13 63.12 3.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.238 1.959 . . . . 0.0 111.913 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.16 139.63 7.22 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.01 50.32 1.3 Allowed 'Cis proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.719 0.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.48 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -126.03 149.13 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.0 111.75 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 76.6 m -89.78 149.78 22.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.308 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -123.1 125.49 45.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 39.5 ttm180 -108.66 114.87 29.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 59.6 34.11 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.916 0.865 . . . . 0.0 109.798 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.2 82.47 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.692 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 mm? -128.91 131.99 24.09 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 117.131 0.465 . . . . 0.0 110.176 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.7 Cg_exo -72.25 49.06 1.3 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.165 2.577 . . . . 0.0 112.527 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.213 -179.495 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 -24.85 11.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.53 175.08 7.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.825 0.822 . . . . 0.0 112.193 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -129.1 147.28 50.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.139 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.5 p -120.88 63.78 0.86 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -57.31 -36.26 70.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -92.38 19.98 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.976 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.58 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 60.15 35.22 87.13 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.719 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 142.34 27.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.47 146.01 43.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.234 0.54 . . . . 0.0 109.798 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -89.56 -28.49 19.55 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.223 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 133.05 42.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.425 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.19 153.83 42.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.398 0.618 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.23 9.39 60.58 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.186 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.8 m -112.3 150.54 30.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.716 0.77 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 151.43 50.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.681 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.6 t -81.38 65.46 6.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.266 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.2 m-20 -78.27 -63.46 0.44 Allowed Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.846 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.2 Cg_endo -92.17 66.68 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.455 2.103 . . . . 0.0 111.748 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.1 t90 -46.8 139.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.752 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.0 Cg_endo -94.51 50.94 1.24 Allowed 'Cis proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.094 -1.627 . . . . 0.0 112.522 0.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 t -122.87 147.42 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.233 0.539 . . . . 0.0 111.879 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 72.1 m -90.97 148.09 22.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.368 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 18' ' ' ASP . 1.1 p -129.52 133.45 47.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.525 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 42.1 ptt85 -127.2 126.22 42.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 57.55 39.41 27.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.784 0.802 . . . . 0.0 109.683 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.26 74.39 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.211 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 30' ' ' VAL . 95.1 mt -142.15 126.63 10.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.628 0.252 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 77.6 Cg_endo -77.5 44.83 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.946 2.431 . . . . 0.0 112.322 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.1 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HG3' ' A' ' 25' ' ' ARG . 70.8 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.13 55.9 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.686 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.55 168.44 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.628 0.727 . . . . 0.0 112.077 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -123.38 151.71 42.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.223 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.1 p -132.87 66.38 1.56 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.672 0.272 . . . . 0.0 111.568 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.46 -26.57 63.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.976 0.417 . . . . 0.0 110.845 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -89.03 4.64 47.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.022 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.89 30.92 69.94 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.45 133.32 15.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.176 -0.512 . . . . 0.0 109.621 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -94.26 142.83 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.638 0.733 . . . . 0.0 110.103 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.04 -24.3 22.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.788 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -96.08 139.26 32.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.493 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -70.54 159.16 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 71.65 22.96 78.59 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.319 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 98.2 m -140.41 151.34 44.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.545 0.688 . . . . 0.0 110.616 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -135.53 148.24 49.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.253 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.3 t -80.46 65.13 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.092 0.472 . . . . 0.0 111.385 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.815 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.4 m-20 -77.82 -62.61 0.52 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 86.5 Cg_endo -92.4 67.85 0.76 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.46 2.107 . . . . 0.0 111.725 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.5 t90 -47.38 139.6 7.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.641 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.7 Cg_endo -94.85 51.75 1.19 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.575 0.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 t -125.37 148.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -91.4 151.61 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 p -131.84 131.49 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.924 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.653 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 81.3 mtt-85 -89.3 87.45 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.96 52.45 2.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.989 0.899 . . . . 0.0 109.66 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.9 7.97 87.38 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.846 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.02 118.87 41.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.32 0.56 . . . . 0.0 110.383 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.95 44.53 0.8 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.871 2.381 . . . . 0.0 112.828 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 25' ' ' ARG . 9.7 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 121.877 0.846 . . . . 0.0 110.671 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.611 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 85.4 m . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.507 0.67 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.85 -18.53 57.25 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.86 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 43.1 mp0 -88.01 162.27 16.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.892 0.853 . . . . 0.0 112.106 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -120.75 151.96 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.469 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -136.32 68.64 1.43 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.27 -25.2 63.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p -88.45 2.22 53.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.993 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 71.21 32.02 65.84 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 132.71 15.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.042 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.76 141.93 28.14 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.591 0.71 . . . . 0.0 109.93 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.2 -23.49 22.38 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.991 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -100.65 138.98 36.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.797 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -68.96 157.65 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 79.91 -4.02 67.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.399 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.3 m -121.91 151.56 40.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.465 0.65 . . . . 0.0 110.344 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -130.86 147.05 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.067 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.14 62.48 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.81 -60.08 0.46 Allowed Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 90.9 Cg_endo -88.29 65.4 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.199 1.932 . . . . 0.0 111.714 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.8 t90 -47.57 139.78 8.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.0 Cg_endo -94.99 52.59 1.13 Allowed 'Cis proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.686 0.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.478 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.9 t -128.82 148.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.123 0.487 . . . . 0.0 111.869 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.9 m -89.3 152.33 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.128 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -130.39 124.7 32.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.787 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.8 ttt85 -90.68 103.62 16.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.9 t30 59.43 37.35 23.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.011 0.91 . . . . 0.0 109.557 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.39 6.16 81.37 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.581 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 30' ' ' VAL . 3.5 mm? -111.38 120.54 42.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.438 0.619 . . . . 0.0 110.379 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.08 45.14 1.3 Allowed 'Trans proline' 0 N--CA 1.47 0.12 0 C-N-CA 122.838 2.359 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 28' ' ' LEU . 2.9 t . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.022 0.439 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.57 -26.78 6.19 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.665 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -91.58 170.51 9.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.028 0.918 . . . . 0.0 113.182 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -116.87 177.21 4.79 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.173 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.43 58.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.497 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -56.74 -30.97 64.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.749 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -90.6 12.02 20.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.279 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.41 33.63 85.41 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.26 133.24 18.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.04 144.43 25.48 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.841 0.829 . . . . 0.0 111.584 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -88.98 -26.39 21.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.967 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -92.2 135.75 33.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.249 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.6 156.83 38.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.01 26.69 73.91 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.954 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 78.1 m -136.03 153.63 51.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.294 0.568 . . . . 0.0 110.478 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.93 146.38 47.25 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.935 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -78.55 63.85 3.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.605 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.87 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 71.6 m-20 -73.8 -62.33 1.14 Allowed Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.251 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.87 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 60.7 Cg_endo -92.36 69.01 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.454 2.102 . . . . 0.0 111.728 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 54.5 t90 -48.11 140.3 9.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.454 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 47.7 Cg_endo -95.06 51.4 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.189 -1.588 . . . . 0.0 112.494 0.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.607 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.2 t -125.18 146.33 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.588 . . . . 0.0 112.327 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.8 m -89.62 151.65 21.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.956 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.04 125.59 25.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -96.53 108.52 21.11 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.96 42.7 25.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.916 0.865 . . . . 0.0 109.727 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.59 18.17 79.35 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.829 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 94.4 mt -128.58 131.88 24.02 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.083 0.442 . . . . 0.0 110.455 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.6 Cg_exo -71.83 47.55 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.179 2.586 . . . . 0.0 113.102 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.548 0.69 . . . . 0.0 111.152 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.6 m . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.31 -29.29 6.7 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.24 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.42 167.51 12.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.875 0.845 . . . . 0.0 111.946 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -118.03 174.7 6.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.773 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.3 p -150.39 66.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.87 -26.01 63.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.087 0.47 . . . . 0.0 110.782 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.91 3.77 50.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.21 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.05 32.75 69.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.417 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.35 132.9 15.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.02 141.2 29.71 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.78 0.8 . . . . 0.0 111.277 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.67 -27.42 20.14 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.858 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.39 131.46 35.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.257 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.78 154.26 42.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.372 0.606 . . . . 0.0 109.943 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.85 25.12 74.28 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.243 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.2 m -133.41 154.99 50.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.301 0.572 . . . . 0.0 110.276 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.52 146.69 48.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.167 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.9 t -82.56 63.3 6.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.09 -60.79 0.47 Allowed Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.187 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.3 Cg_endo -88.58 64.56 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.154 1.903 . . . . 0.0 111.727 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 62.3 t90 -47.81 139.85 8.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.51 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.1 Cg_endo -94.03 51.17 1.18 Allowed 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.859 0.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.5 t -126.52 148.91 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.948 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.7 m -89.45 153.99 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.099 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.03 129.53 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.976 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 49.2 ttm-85 -97.78 101.6 13.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 59.67 45.37 13.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.875 0.845 . . . . 0.0 109.988 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.04 19.45 79.61 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.728 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 89.8 mt -129.55 130.23 23.25 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.4 Cg_exo -71.29 45.54 0.65 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.136 2.557 . . . . 0.0 112.971 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 122.363 1.078 . . . . 0.0 110.64 -179.77 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.78 -20.47 50.51 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -89.22 168.48 12.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.716 0.77 . . . . 0.0 111.933 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -123.97 155.78 37.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.849 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 p -137.92 67.52 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.689 0.28 . . . . 0.0 111.733 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -59.54 -25.11 64.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.694 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -88.52 3.13 51.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.955 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.36 31.33 68.64 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.36 132.91 15.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.265 -0.468 . . . . 0.0 109.772 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -93.89 142.06 27.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.575 0.702 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.23 -23.7 22.29 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.829 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -94.64 139.25 31.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.741 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.55 158.03 36.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.763 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.95 75.52 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.903 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 89.2 m -130.4 149.89 51.88 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.732 0.777 . . . . 0.0 110.571 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.6 146.09 47.58 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.746 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.4 t -79.2 63.16 3.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.083 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.776 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 43.5 m-20 -76.36 -61.3 0.81 Allowed Pre-proline 0 C--N 1.318 -0.792 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.48 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.8 Cg_endo -90.29 66.85 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.347 2.031 . . . . 0.0 111.866 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.9 t90 -47.85 140.0 8.81 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.633 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.3 Cg_endo -94.6 50.78 1.27 Allowed 'Cis proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.101 -1.625 . . . . 0.0 112.589 0.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.0 t -125.2 147.52 29.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.273 0.559 . . . . 0.0 111.936 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 100.0 m -89.35 151.11 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.146 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -123.03 130.05 52.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.322 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 14.8 ttp180 -117.87 119.95 36.4 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 58.76 40.41 23.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.928 0.871 . . . . 0.0 109.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.82 26.23 74.71 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.579 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.494 ' HB3' HG23 ' A' ' 30' ' ' VAL . 91.7 mt -144.6 134.21 11.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.0 Cg_exo -72.6 47.48 1.17 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 123.023 2.482 . . . . 0.0 112.594 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.6 t . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.788 0.804 . . . . 0.0 110.395 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 39.3 m . . . . . 0 CA--C 1.518 -0.284 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.16 78.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.656 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.703 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 28.8 mp0 -88.06 159.34 18.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.911 0.863 . . . . 0.0 111.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -109.92 148.47 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.507 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.67 66.65 1.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.12 -30.0 65.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.953 0.406 . . . . 0.0 110.726 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -88.81 9.64 23.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.476 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.57 34.12 88.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.25 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.04 134.07 17.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -95.96 143.48 27.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.598 0.713 . . . . 0.0 110.18 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.13 -24.33 22.25 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.819 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -99.07 137.98 36.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.425 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -71.61 156.54 39.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.988 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . 76.36 12.38 84.29 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.972 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.0 m -129.76 152.26 49.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -132.07 145.72 51.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.476 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.77 62.17 4.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.468 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.645 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.51 -61.23 0.48 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.95 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 7.7 Cg_endo -87.64 66.07 3.81 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.439 2.093 . . . . 0.0 111.268 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 61.7 t90 -48.31 140.06 9.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.567 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 54.2 Cg_endo -95.03 53.89 1.04 Allowed 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.774 0.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 38.2 t -130.13 146.95 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.124 0.488 . . . . 0.0 111.986 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -88.89 152.14 21.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.916 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.92 132.56 40.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.947 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttt85 -94.22 103.93 15.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 59.39 44.78 14.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.811 0.815 . . . . 0.0 109.997 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.48 73.76 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.249 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.28 143.98 45.91 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 50.05 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.32 -0.713 0 CA-C-O 121.464 0.65 . . . . 0.0 110.419 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.3 -30.4 7.76 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.392 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 167.89 12.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.895 0.855 . . . . 0.0 111.783 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -117.75 175.89 5.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.826 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.3 p -150.26 62.38 0.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.069 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.14 -29.64 65.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -91.15 10.45 26.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.302 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 66.19 35.33 90.28 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.81 133.63 19.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 t -100.93 144.18 30.18 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 111.694 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -89.7 -28.71 19.25 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.861 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.14 132.69 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.474 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.18 152.65 44.02 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.08 22.65 72.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.157 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 80.9 m -123.02 155.64 36.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.593 0.711 . . . . 0.0 110.696 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -135.62 147.06 48.5 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.1 t -83.67 63.52 7.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.817 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.518 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.66 -60.79 0.44 Allowed Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.081 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 93.8 Cg_endo -87.76 62.63 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.118 1.878 . . . . 0.0 111.771 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.3 t90 -46.91 139.58 6.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.638 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.5 Cg_endo -93.82 49.8 1.36 Allowed 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.104 -1.624 . . . . 0.0 112.698 0.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.479 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.0 t -124.47 149.59 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 111.854 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 84.8 m -89.57 154.97 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.346 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.74 134.97 43.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.197 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 35.7 ttp180 -132.46 124.98 29.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t30 58.75 36.11 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.984 0.897 . . . . 0.0 109.683 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.75 28.25 72.28 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.451 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 85.2 mt -148.63 137.5 11.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.15 50.85 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.215 2.61 . . . . 0.0 111.858 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 122.285 1.041 . . . . 0.0 110.713 -178.957 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 33.0 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.98 -16.64 60.62 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -88.09 166.81 14.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.843 0.83 . . . . 0.0 111.978 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -122.02 150.43 42.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.016 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.55 66.45 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.531 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.06 -26.57 62.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.94 4.02 49.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.549 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.94 32.24 69.86 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 133.83 16.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.814 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 143.32 28.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.654 0.74 . . . . 0.0 110.331 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.32 -25.35 21.68 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.317 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -89.72 136.17 33.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.343 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -70.26 156.14 39.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.263 0.554 . . . . 0.0 110.296 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.48 -5.36 45.28 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.176 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.1 m -113.48 150.79 32.35 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.619 0.723 . . . . 0.0 110.203 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -135.1 151.96 51.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.774 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.2 t -80.88 64.58 5.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.097 0.475 . . . . 0.0 111.708 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.796 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.2 m-20 -79.13 -61.95 0.47 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.748 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 85.0 Cg_endo -91.36 66.36 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.345 2.03 . . . . 0.0 111.738 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.4 139.6 7.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.666 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.3 Cg_endo -94.7 51.56 1.19 Allowed 'Cis proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.194 -1.586 . . . . 0.0 112.628 0.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.7 t -126.06 148.76 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.031 0.443 . . . . 0.0 111.688 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.2 m -90.72 148.06 22.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.761 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.82 125.29 44.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.739 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.653 HH11 ' HB2' ' A' ' 26' ' ' ASN . 2.4 tmt_? -102.85 113.88 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.653 ' HB2' HH11 ' A' ' 25' ' ' ARG . 10.0 t-20 59.97 41.26 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.897 0.748 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.9 79.76 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.666 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.47 126.47 17.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.952 0.376 . . . . 0.0 110.355 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.9 50.55 2.15 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.915 2.41 . . . . 0.0 112.611 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.827 -179.369 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.1 m . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -24.3 8.08 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.653 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.89 173.03 8.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 112.307 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 p -125.31 172.39 9.63 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.071 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 p -150.96 59.03 0.92 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.551 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -57.25 -29.57 63.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.086 0.469 . . . . 0.0 110.589 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -89.89 11.01 21.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.285 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.62 33.14 80.1 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.15 131.2 14.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.102 -0.549 . . . . 0.0 109.574 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.11 144.0 28.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.742 0.782 . . . . 0.0 111.155 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -88.74 -26.22 21.89 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.1 t -103.05 144.67 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -74.88 162.95 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.562 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.88 29.19 74.3 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.913 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 97.2 m -142.5 157.28 44.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.511 0.672 . . . . 0.0 111.062 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 t -134.54 146.89 50.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.023 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.11 62.84 6.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.275 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.37 -60.4 0.47 Allowed Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 92.4 Cg_endo -88.71 63.98 2.9 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.228 1.952 . . . . 0.0 111.89 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 56.4 t90 -47.51 140.25 7.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.8 Cg_endo -94.03 49.18 1.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.562 0.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -125.05 149.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.256 0.551 . . . . 0.0 111.779 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.7 m -89.91 154.62 19.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.206 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.86 129.83 46.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.9 ttm180 -116.86 118.15 31.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.61 42.08 27.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.897 0.855 . . . . 0.0 109.76 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.22 75.57 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.72 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.27 132.21 13.38 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.833 0.317 . . . . 0.0 110.356 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.26 47.89 1.67 Allowed 'Trans proline' 0 N--CA 1.471 0.2 0 C-N-CA 122.823 2.349 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 122.282 1.039 . . . . 0.0 110.464 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 61.5 m . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.68 54.22 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.546 ' HG2' ' HB ' ' A' ' 12' ' ' THR . 21.7 mp0 -88.68 178.53 6.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -134.44 163.76 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.78 63.46 1.3 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.686 0.279 . . . . 0.0 111.622 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -58.16 -25.75 61.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 p -88.69 4.88 45.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.98 30.69 67.56 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.5 131.56 14.36 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' A' ' 12' ' ' THR . 2.2 t -83.52 141.3 31.72 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.917 0.865 . . . . 0.0 110.896 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -89.28 -24.89 21.94 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.744 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.684 HG22 ' SG ' ' A' ' 10' ' ' CYS . 4.6 t -95.85 158.07 15.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.338 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -87.6 156.19 19.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.336 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.53 23.09 78.47 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.597 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 99.6 m -141.86 155.8 45.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.581 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -135.45 151.17 50.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.679 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.7 t -80.97 64.08 5.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 0.0 111.694 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.79 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-20 -78.6 -61.25 0.55 Allowed Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.735 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 95.4 Cg_endo -91.85 66.59 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.505 2.137 . . . . 0.0 112.116 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.6 t90 -47.46 139.88 7.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.775 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.9 Cg_endo -94.26 49.18 1.51 Allowed 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.191 -1.587 . . . . 0.0 112.559 0.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 21.7 t -123.95 151.49 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.647 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 90.1 m -93.47 150.14 20.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -118.08 121.16 39.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.795 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.64 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.2 ttm-85 -98.48 109.36 22.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 59.28 43.19 17.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 110.176 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.96 81.21 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.033 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.32 129.77 22.41 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 117.237 0.518 . . . . 0.0 110.29 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.34 48.71 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.903 2.402 . . . . 0.0 112.846 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 122.066 0.936 . . . . 0.0 110.314 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 38.1 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.561 0.696 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.3 -14.06 65.59 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.076 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.615 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 39.8 mp0 -87.9 162.66 16.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.0 111.949 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -118.35 150.13 40.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.995 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.33 67.07 1.54 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.661 0.267 . . . . 0.0 111.528 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.23 -26.32 62.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.043 0.449 . . . . 0.0 110.853 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 3.38 50.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.002 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.31 31.71 68.7 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.23 133.14 16.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.436 . . . . 0.0 109.901 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.81 144.78 25.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.698 0.761 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.77 -25.49 22.24 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.575 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -101.4 138.8 37.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.3 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -71.52 160.3 32.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.55 -17.22 26.24 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.614 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 66.2 m -110.94 152.67 26.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.599 0.714 . . . . 0.0 110.464 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -134.45 151.67 51.31 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.652 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.6 t -79.6 64.51 4.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.803 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.786 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.4 m-20 -78.68 -61.74 0.51 Allowed Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.7 Cg_endo -91.29 67.19 1.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.506 2.137 . . . . 0.0 111.736 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.84 139.77 8.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.581 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.9 Cg_endo -95.11 53.29 1.08 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.115 -1.619 . . . . 0.0 112.71 0.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.3 t -128.76 148.2 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 111.777 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.5 m -89.94 150.36 22.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.671 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -129.1 122.43 29.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.807 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.81 HH11 ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -89.57 107.87 19.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.81 ' HB2' HH11 ' A' ' 25' ' ' ARG . 0.1 OUTLIER 60.68 36.47 19.5 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.037 0.836 . . . . 0.0 109.342 -179.112 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.59 8.03 85.32 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.795 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 mp -116.68 124.1 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 117.526 0.663 . . . . 0.0 110.655 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 6.5 Cg_exo -74.01 47.73 1.57 Allowed 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.281 2.654 . . . . 0.0 112.573 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.725 0.774 . . . . 0.0 110.491 -179.688 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 80.1 m . . . . . 0 CA--C 1.511 -0.548 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.16 -21.3 46.4 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.879 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.9 mp0 -88.86 169.38 11.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.65 . . . . 0.0 111.356 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -125.04 164.74 19.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.84 65.65 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.428 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.6 -24.61 61.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 0.0 110.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -88.26 2.08 53.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.983 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 72.96 29.27 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 131.76 14.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -84.83 140.8 30.92 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.876 0.846 . . . . 0.0 110.861 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.39 -24.58 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.5 t -90.99 165.38 13.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -93.19 156.89 16.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.612 0.72 . . . . 0.0 111.109 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 19.51 72.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.111 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 81.3 m -136.28 155.74 49.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.528 0.68 . . . . 0.0 110.685 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -135.33 151.77 50.84 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.04 63.89 5.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.09 0.471 . . . . 0.0 111.738 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.787 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.4 m-20 -77.21 -61.44 0.67 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.787 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 91.3 Cg_endo -92.31 66.89 0.81 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 111.853 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.1 t90 -47.15 139.64 7.19 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.791 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.71 50.16 1.39 Allowed 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.145 -1.606 . . . . 0.0 112.51 0.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.58 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.14 151.1 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.8 m -94.46 150.65 20.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.804 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -124.47 124.84 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.158 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.67 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 2.7 ptp180 -104.37 117.56 34.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 59.55 36.04 22.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.847 0.832 . . . . 0.0 109.801 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.52 15.35 81.49 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.576 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 28' ' ' LEU . 3.3 mm? -122.68 126.47 26.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 117.209 0.505 . . . . 0.0 110.378 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 43.25 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.975 2.45 . . . . 0.0 112.419 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.35 1.071 . . . . 0.0 109.966 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' CYS . . . . . 0.608 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 55.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.28 63.6 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 45.7 mp0 -87.93 162.76 16.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.816 0.817 . . . . 0.0 112.067 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.4 p -118.46 151.94 36.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.948 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -135.09 66.02 1.54 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.634 0.254 . . . . 0.0 111.543 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -58.07 -27.15 63.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.969 0.414 . . . . 0.0 110.765 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -88.98 5.15 45.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.165 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.91 31.81 69.9 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.18 133.04 16.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.038 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.77 145.28 24.92 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.62 0.724 . . . . 0.0 110.11 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -88.68 -24.74 22.66 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.694 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -103.62 139.56 38.74 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -72.08 162.67 29.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.99 -13.14 39.43 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.607 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.2 m -115.15 153.79 30.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.466 0.651 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -134.68 151.27 50.89 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.828 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -80.05 64.45 4.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.791 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.1 m-20 -79.43 -61.73 0.46 Allowed Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 89.7 Cg_endo -90.79 67.03 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.45 2.1 . . . . 0.0 111.722 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.0 t90 -47.84 139.78 8.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.5 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 53.4 Cg_endo -95.15 52.65 1.13 Allowed 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.093 -1.628 . . . . 0.0 112.714 0.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.0 t -128.77 148.93 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.046 0.45 . . . . 0.0 111.683 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 79.9 m -89.95 149.25 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.709 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -127.05 128.55 46.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.523 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 76.6 ttt180 -106.04 115.44 30.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.38 42.28 21.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.98 0.895 . . . . 0.0 109.457 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.04 24.64 75.81 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.489 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.1 mt -135.62 128.67 18.13 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 122.678 -0.307 . . . . 0.0 110.493 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.33 49.37 2.02 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 123.229 2.619 . . . . 0.0 112.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.396 -179.445 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.746 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 79.7 m . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.375 0.607 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.16 -17.15 57.91 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.952 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.746 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 31.5 mp0 -89.05 163.76 15.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -121.18 150.48 41.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.349 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -132.37 64.9 1.59 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -57.75 -27.04 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 110.804 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -88.94 5.8 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.495 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.32 30.0 69.7 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 132.26 15.09 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.07 144.95 26.65 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.794 0.807 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.58 -25.23 22.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.735 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -105.09 142.27 35.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.155 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -72.0 166.63 21.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.249 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.416 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . 71.0 19.64 77.27 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.326 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.3 m -142.41 153.79 44.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.479 0.657 . . . . 0.0 110.394 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.07 149.54 50.1 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.398 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -81.0 64.44 5.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.532 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.794 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.9 m-20 -80.1 -61.64 0.43 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.752 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.794 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -90.71 65.57 1.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.443 2.096 . . . . 0.0 111.891 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.9 t90 -47.84 139.91 8.85 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.1 Cg_endo -94.36 50.76 1.25 Allowed 'Cis proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.091 -1.629 . . . . 0.0 112.675 0.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.558 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.2 t -126.54 149.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.52 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.0 m -90.8 148.69 22.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.771 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -115.74 121.72 43.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.571 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.738 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 26.3 ttm180 -95.93 108.84 21.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.06 36.19 21.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.941 0.877 . . . . 0.0 110.041 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.6 11.45 83.02 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.837 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.7 mp -125.95 133.32 24.81 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 117.27 0.535 . . . . 0.0 109.991 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.6 Cg_exo -70.86 45.39 0.57 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.857 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.3 m . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 121.393 0.615 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.93 -19.81 50.49 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.437 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.619 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.0 mp0 -89.26 170.29 10.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.38 0.609 . . . . 0.0 111.31 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.72 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 p -146.61 65.41 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.571 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.84 -24.63 62.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.957 0.408 . . . . 0.0 110.902 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -88.35 2.66 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.08 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 73.29 29.15 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.67 131.17 13.84 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.728 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -82.67 139.98 33.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.901 0.858 . . . . 0.0 110.444 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.45 -23.62 22.07 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.603 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.728 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.6 t -93.6 167.16 11.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.522 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -93.94 159.34 15.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.854 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 66.36 22.81 71.44 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.816 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 76.7 m -141.61 154.71 45.58 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.672 0.749 . . . . 0.0 110.954 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.37 151.71 50.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.27 64.49 6.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.085 0.469 . . . . 0.0 111.748 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.785 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.0 m-20 -78.97 -61.28 0.51 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -91.98 66.86 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.408 2.072 . . . . 0.0 112.04 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.8 t90 -47.74 139.97 8.53 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.854 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 57.4 Cg_endo -94.25 49.32 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.635 0.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -123.92 151.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.475 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -93.67 149.36 21.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.628 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -115.95 121.85 43.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.775 178.555 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.748 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 33.7 ttm180 -102.12 112.6 25.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.7 t30 60.17 39.59 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.001 0.905 . . . . 0.0 109.934 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.86 16.39 80.45 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.79 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.4 mt -133.79 131.77 21.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 117.055 0.428 . . . . 0.0 110.382 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.1 Cg_exo -71.39 50.1 1.21 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.112 2.541 . . . . 0.0 112.494 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 122.103 0.954 . . . . 0.0 110.231 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.733 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 92.4 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.72 -19.5 52.48 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.702 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.7 mp0 -88.44 166.64 14.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.465 0.65 . . . . 0.0 111.264 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 p -124.27 151.64 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.26 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 p -133.16 65.23 1.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.15 -31.2 67.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.917 0.389 . . . . 0.0 110.614 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -88.88 12.2 15.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.076 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.514 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.98 31.83 80.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.324 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.32 133.4 16.17 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -92.7 144.69 25.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.508 0.67 . . . . 0.0 109.843 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.79 -24.38 22.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.626 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -98.9 137.42 37.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.988 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -70.83 158.79 35.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.57 -19.28 20.47 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.431 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.6 m -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.826 0.822 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -132.94 150.47 52.16 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.411 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.0 t -80.54 64.62 5.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.691 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.798 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.2 m-20 -79.55 -62.26 0.43 Allowed Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 87.9 Cg_endo -91.37 67.03 1.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.416 2.077 . . . . 0.0 111.717 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.24 139.66 7.43 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.6 Cg_endo -94.92 51.2 1.24 Allowed 'Cis proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.592 0.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.3 t -125.81 149.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.2 m -90.74 151.06 21.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.681 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -130.34 135.57 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.99 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 1' ' ' CYS . 13.7 ptt180 -132.38 131.09 41.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 61.53 35.3 17.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.079 0.943 . . . . 0.0 109.236 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.88 84.64 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.053 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' HG23 ' A' ' 30' ' ' VAL . 94.1 mt -143.02 131.28 11.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.624 0.249 . . . . 0.0 110.581 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.18 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.99 2.46 . . . . 0.0 111.78 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.5 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.762 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 63.4 m . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.27 -24.94 8.52 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.264 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.6 172.84 8.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.834 0.826 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -122.61 174.17 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.039 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.06 59.06 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.533 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -56.66 -30.68 63.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.207 0.527 . . . . 0.0 110.662 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.06 11.49 20.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.372 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.31 34.32 87.61 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.43 132.02 16.8 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.37 146.1 23.96 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.824 0.821 . . . . 0.0 111.766 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -88.86 -26.46 21.62 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.78 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -91.87 135.35 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.122 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -72.72 157.4 37.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.62 2.43 50.2 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.858 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.7 m -109.86 157.4 19.25 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.408 0.623 . . . . 0.0 110.142 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.02 146.95 49.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -81.76 63.57 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.43 -60.64 0.52 Allowed Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.901 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.0 Cg_endo -89.24 63.14 2.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.249 1.966 . . . . 0.0 111.881 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 53.9 t90 -46.37 139.34 6.01 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.7 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 45.8 Cg_endo -94.18 50.24 1.33 Allowed 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.103 -1.624 . . . . 0.0 112.623 0.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.54 150.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.191 0.519 . . . . 0.0 111.77 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 98.3 m -92.75 153.09 19.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.674 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -133.57 117.35 16.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -89.36 100.61 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.617 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' HB2' ' NH1' ' A' ' 25' ' ' ARG . 3.5 t30 66.67 35.65 5.13 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.014 0.821 . . . . 0.0 109.196 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.51 85.59 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.31 121.95 38.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 117.154 0.477 . . . . 0.0 110.472 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 64.3 Cg_endo -73.78 44.62 0.96 Allowed 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.955 2.437 . . . . 0.0 113.075 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.308 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 37.4 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.0 79.81 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.918 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.6 mp0 -87.83 161.69 17.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.904 0.859 . . . . 0.0 112.301 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -110.97 150.47 29.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.302 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.5 p -137.29 67.65 1.43 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.441 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.09 -25.94 61.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.064 0.459 . . . . 0.0 110.987 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 p -88.6 2.44 53.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.178 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.29 34.13 79.57 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.12 136.83 19.18 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -105.08 142.49 34.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.739 0.78 . . . . 0.0 110.638 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.61 -25.25 21.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.55 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -88.57 141.5 28.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.051 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -64.64 151.7 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.643 -179.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 65.1 2.46 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.999 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 57.6 m -111.58 143.5 42.35 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.82 0.819 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.0 151.31 50.7 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.776 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.447 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t -76.97 62.23 2.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.108 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.844 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 70.7 m-20 -72.66 -62.0 1.51 Allowed Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.753 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 Cg_endo -92.49 67.95 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.541 2.16 . . . . 0.0 111.414 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.6 t90 -47.9 140.07 8.88 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.495 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 43.8 Cg_endo -95.33 54.28 1.02 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.593 0.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.2 t -127.91 145.58 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.13 0.49 . . . . 0.0 111.993 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.6 m -89.46 150.08 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 128.36 28.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.958 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.613 ' HA ' ' O ' ' A' ' 14' ' ' GLY . 6.2 tpt180 -89.42 110.21 21.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.36 40.91 23.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.999 0.904 . . . . 0.0 109.257 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 22.53 78.74 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.422 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.12 133.51 24.9 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 122.687 -0.302 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 48.54 1.85 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.842 2.361 . . . . 0.0 112.482 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.531 -179.541 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 69.4 m . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.36 26.79 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.36 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -89.74 179.69 5.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.974 0.893 . . . . 0.0 112.161 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -135.17 148.35 49.68 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.777 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 p -129.34 65.06 1.47 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.006 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.09 -30.08 65.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.087 0.47 . . . . 0.0 110.542 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -89.88 9.1 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.291 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 67.62 33.57 81.32 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.04 134.25 17.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.273 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -98.81 145.6 26.78 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 -28.22 19.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.162 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -92.07 143.5 26.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.517 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -74.26 160.79 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.54 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.62 24.76 75.28 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.511 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.5 m -137.16 153.86 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.584 0.707 . . . . 0.0 110.749 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.52 147.48 48.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.484 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.7 t -82.02 64.08 6.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.106 0.479 . . . . 0.0 111.355 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.569 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.79 -60.76 0.39 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.149 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.6 Cg_endo -88.13 63.12 3.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.238 1.959 . . . . 0.0 111.913 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.16 139.63 7.22 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.01 50.32 1.3 Allowed 'Cis proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.719 0.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.48 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -126.03 149.13 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.0 111.75 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 76.6 m -89.78 149.78 22.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.308 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -123.1 125.49 45.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 39.5 ttm180 -108.66 114.87 29.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 59.6 34.11 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.916 0.865 . . . . 0.0 109.798 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.2 82.47 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.692 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 mm? -128.91 131.99 24.09 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 117.131 0.465 . . . . 0.0 110.176 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.7 Cg_exo -72.25 49.06 1.3 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.165 2.577 . . . . 0.0 112.527 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.213 -179.495 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 -24.85 11.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.53 175.08 7.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.825 0.822 . . . . 0.0 112.193 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -129.1 147.28 50.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.139 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.5 p -120.88 63.78 0.86 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -57.31 -36.26 70.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -92.38 19.98 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.976 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.58 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 60.15 35.22 87.13 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.719 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 142.34 27.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.47 146.01 43.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.234 0.54 . . . . 0.0 109.798 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -89.56 -28.49 19.55 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.223 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 133.05 42.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.425 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.19 153.83 42.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.398 0.618 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.23 9.39 60.58 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.186 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.8 m -112.3 150.54 30.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.716 0.77 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 151.43 50.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.681 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.6 t -81.38 65.46 6.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.266 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.2 m-20 -78.27 -63.46 0.44 Allowed Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.846 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.2 Cg_endo -92.17 66.68 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.455 2.103 . . . . 0.0 111.748 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.1 t90 -46.8 139.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.752 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.0 Cg_endo -94.51 50.94 1.24 Allowed 'Cis proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.094 -1.627 . . . . 0.0 112.522 0.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 t -122.87 147.42 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.233 0.539 . . . . 0.0 111.879 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 72.1 m -90.97 148.09 22.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.368 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 18' ' ' ASP . 1.1 p -129.52 133.45 47.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.525 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 42.1 ptt85 -127.2 126.22 42.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 57.55 39.41 27.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.784 0.802 . . . . 0.0 109.683 -178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.26 74.39 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.211 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 30' ' ' VAL . 95.1 mt -142.15 126.63 10.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.628 0.252 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 77.6 Cg_endo -77.5 44.83 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.946 2.431 . . . . 0.0 112.322 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.1 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HG3' ' A' ' 25' ' ' ARG . 70.8 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.13 55.9 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.686 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.55 168.44 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.628 0.727 . . . . 0.0 112.077 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -123.38 151.71 42.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.223 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.1 p -132.87 66.38 1.56 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.672 0.272 . . . . 0.0 111.568 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.46 -26.57 63.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.976 0.417 . . . . 0.0 110.845 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -89.03 4.64 47.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.022 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.89 30.92 69.94 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.45 133.32 15.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.176 -0.512 . . . . 0.0 109.621 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -94.26 142.83 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.638 0.733 . . . . 0.0 110.103 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.04 -24.3 22.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.788 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -96.08 139.26 32.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.493 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -70.54 159.16 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 71.65 22.96 78.59 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.319 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 98.2 m -140.41 151.34 44.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.545 0.688 . . . . 0.0 110.616 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -135.53 148.24 49.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.253 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.3 t -80.46 65.13 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.092 0.472 . . . . 0.0 111.385 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.815 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.4 m-20 -77.82 -62.61 0.52 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 86.5 Cg_endo -92.4 67.85 0.76 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.46 2.107 . . . . 0.0 111.725 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.5 t90 -47.38 139.6 7.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.641 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.7 Cg_endo -94.85 51.75 1.19 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.575 0.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 t -125.37 148.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -91.4 151.61 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 p -131.84 131.49 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.924 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.653 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 81.3 mtt-85 -89.3 87.45 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.96 52.45 2.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.989 0.899 . . . . 0.0 109.66 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.9 7.97 87.38 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.846 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.02 118.87 41.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.32 0.56 . . . . 0.0 110.383 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.95 44.53 0.8 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.871 2.381 . . . . 0.0 112.828 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 25' ' ' ARG . 9.7 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 121.877 0.846 . . . . 0.0 110.671 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.611 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 85.4 m . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.507 0.67 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.85 -18.53 57.25 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.86 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 43.1 mp0 -88.01 162.27 16.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.892 0.853 . . . . 0.0 112.106 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -120.75 151.96 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.469 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -136.32 68.64 1.43 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.27 -25.2 63.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p -88.45 2.22 53.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.993 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 71.21 32.02 65.84 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 132.71 15.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.042 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.76 141.93 28.14 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.591 0.71 . . . . 0.0 109.93 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.2 -23.49 22.38 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.991 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -100.65 138.98 36.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.797 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -68.96 157.65 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 79.91 -4.02 67.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.399 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.3 m -121.91 151.56 40.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.465 0.65 . . . . 0.0 110.344 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -130.86 147.05 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.067 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.14 62.48 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.81 -60.08 0.46 Allowed Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 90.9 Cg_endo -88.29 65.4 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.199 1.932 . . . . 0.0 111.714 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.8 t90 -47.57 139.78 8.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.0 Cg_endo -94.99 52.59 1.13 Allowed 'Cis proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.686 0.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.478 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.9 t -128.82 148.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.123 0.487 . . . . 0.0 111.869 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.9 m -89.3 152.33 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.128 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -130.39 124.7 32.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.787 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.8 ttt85 -90.68 103.62 16.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.9 t30 59.43 37.35 23.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.011 0.91 . . . . 0.0 109.557 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.39 6.16 81.37 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.581 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 30' ' ' VAL . 3.5 mm? -111.38 120.54 42.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.438 0.619 . . . . 0.0 110.379 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.08 45.14 1.3 Allowed 'Trans proline' 0 N--CA 1.47 0.12 0 C-N-CA 122.838 2.359 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 28' ' ' LEU . 2.9 t . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.022 0.439 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.57 -26.78 6.19 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.665 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -91.58 170.51 9.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.028 0.918 . . . . 0.0 113.182 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -116.87 177.21 4.79 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.173 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.43 58.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.497 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -56.74 -30.97 64.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.749 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -90.6 12.02 20.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.279 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.41 33.63 85.41 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.26 133.24 18.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.04 144.43 25.48 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.841 0.829 . . . . 0.0 111.584 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -88.98 -26.39 21.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.967 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -92.2 135.75 33.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.249 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.6 156.83 38.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.01 26.69 73.91 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.954 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 78.1 m -136.03 153.63 51.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.294 0.568 . . . . 0.0 110.478 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.93 146.38 47.25 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.935 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -78.55 63.85 3.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.605 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.87 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 71.6 m-20 -73.8 -62.33 1.14 Allowed Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.251 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.87 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 60.7 Cg_endo -92.36 69.01 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.454 2.102 . . . . 0.0 111.728 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 54.5 t90 -48.11 140.3 9.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.454 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 47.7 Cg_endo -95.06 51.4 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.189 -1.588 . . . . 0.0 112.494 0.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.607 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.2 t -125.18 146.33 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.588 . . . . 0.0 112.327 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.8 m -89.62 151.65 21.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.956 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.04 125.59 25.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -96.53 108.52 21.11 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.96 42.7 25.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.916 0.865 . . . . 0.0 109.727 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.59 18.17 79.35 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.829 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 94.4 mt -128.58 131.88 24.02 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.083 0.442 . . . . 0.0 110.455 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.6 Cg_exo -71.83 47.55 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.179 2.586 . . . . 0.0 113.102 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.548 0.69 . . . . 0.0 111.152 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.6 m . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.31 -29.29 6.7 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.24 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.42 167.51 12.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.875 0.845 . . . . 0.0 111.946 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -118.03 174.7 6.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.773 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.3 p -150.39 66.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.87 -26.01 63.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.087 0.47 . . . . 0.0 110.782 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.91 3.77 50.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.21 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.05 32.75 69.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.417 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.35 132.9 15.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.02 141.2 29.71 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.78 0.8 . . . . 0.0 111.277 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.67 -27.42 20.14 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.858 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.39 131.46 35.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.257 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.1 t30 -69.78 154.26 42.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.372 0.606 . . . . 0.0 109.943 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.85 25.12 74.28 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.243 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.2 m -133.41 154.99 50.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.301 0.572 . . . . 0.0 110.276 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.52 146.69 48.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.167 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.9 t -82.56 63.3 6.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.09 -60.79 0.47 Allowed Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.187 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.3 Cg_endo -88.58 64.56 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.154 1.903 . . . . 0.0 111.727 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 62.3 t90 -47.81 139.85 8.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.51 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.1 Cg_endo -94.03 51.17 1.18 Allowed 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.859 0.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.5 t -126.52 148.91 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.948 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.7 m -89.45 153.99 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.099 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.03 129.53 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.976 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 49.2 ttm-85 -97.78 101.6 13.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.0 t-20 59.67 45.37 13.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.875 0.845 . . . . 0.0 109.988 -178.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.04 19.45 79.61 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.728 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 89.8 mt -129.55 130.23 23.25 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.4 Cg_exo -71.29 45.54 0.65 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.136 2.557 . . . . 0.0 112.971 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 122.363 1.078 . . . . 0.0 110.64 -179.77 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.78 -20.47 50.51 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -89.22 168.48 12.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.716 0.77 . . . . 0.0 111.933 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -123.97 155.78 37.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.849 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 p -137.92 67.52 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.689 0.28 . . . . 0.0 111.733 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -59.54 -25.11 64.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.694 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -88.52 3.13 51.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.955 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.36 31.33 68.64 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.36 132.91 15.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.265 -0.468 . . . . 0.0 109.772 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -93.89 142.06 27.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.575 0.702 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.23 -23.7 22.29 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.829 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -94.64 139.25 31.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.741 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.55 158.03 36.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.763 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.95 75.52 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.903 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 89.2 m -130.4 149.89 51.88 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.732 0.777 . . . . 0.0 110.571 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.6 146.09 47.58 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.746 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.4 t -79.2 63.16 3.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.083 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.776 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 43.5 m-20 -76.36 -61.3 0.81 Allowed Pre-proline 0 C--N 1.318 -0.792 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.48 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.8 Cg_endo -90.29 66.85 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.347 2.031 . . . . 0.0 111.866 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.9 t90 -47.85 140.0 8.81 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.633 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.3 Cg_endo -94.6 50.78 1.27 Allowed 'Cis proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.101 -1.625 . . . . 0.0 112.589 0.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.0 t -125.2 147.52 29.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.273 0.559 . . . . 0.0 111.936 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 100.0 m -89.35 151.11 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.146 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -123.03 130.05 52.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.322 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 14.8 ttp180 -117.87 119.95 36.4 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 58.76 40.41 23.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.928 0.871 . . . . 0.0 109.977 -178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.82 26.23 74.71 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.579 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.494 ' HB3' HG23 ' A' ' 30' ' ' VAL . 91.7 mt -144.6 134.21 11.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.0 Cg_exo -72.6 47.48 1.17 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 123.023 2.482 . . . . 0.0 112.594 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.6 t . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.788 0.804 . . . . 0.0 110.395 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 39.3 m . . . . . 0 CA--C 1.518 -0.284 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.16 78.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.656 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.703 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 28.8 mp0 -88.06 159.34 18.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.911 0.863 . . . . 0.0 111.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -109.92 148.47 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.507 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.67 66.65 1.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.12 -30.0 65.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.953 0.406 . . . . 0.0 110.726 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -88.81 9.64 23.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.476 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.57 34.12 88.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.25 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.04 134.07 17.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -95.96 143.48 27.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.598 0.713 . . . . 0.0 110.18 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.13 -24.33 22.25 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.819 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -99.07 137.98 36.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.425 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -71.61 156.54 39.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.988 -179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.54 ' O ' ' HG3' ' A' ' 25' ' ' ARG . . . 76.36 12.38 84.29 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.972 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.0 m -129.76 152.26 49.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -132.07 145.72 51.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.476 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.77 62.17 4.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.468 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.645 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.51 -61.23 0.48 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.95 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 7.7 Cg_endo -87.64 66.07 3.81 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.439 2.093 . . . . 0.0 111.268 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 61.7 t90 -48.31 140.06 9.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.567 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 54.2 Cg_endo -95.03 53.89 1.04 Allowed 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.774 0.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 38.2 t -130.13 146.95 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.124 0.488 . . . . 0.0 111.986 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -88.89 152.14 21.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.916 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.92 132.56 40.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.947 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttt85 -94.22 103.93 15.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 59.39 44.78 14.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.811 0.815 . . . . 0.0 109.997 -178.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.48 73.76 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.249 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.28 143.98 45.91 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 50.05 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.32 -0.713 0 CA-C-O 121.464 0.65 . . . . 0.0 110.419 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.3 -30.4 7.76 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.392 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 167.89 12.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.895 0.855 . . . . 0.0 111.783 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -117.75 175.89 5.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.826 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.3 p -150.26 62.38 0.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.069 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.14 -29.64 65.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -91.15 10.45 26.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.302 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 66.19 35.33 90.28 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.81 133.63 19.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 t -100.93 144.18 30.18 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 111.694 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -89.7 -28.71 19.25 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.861 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.14 132.69 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.474 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.5 t30 -70.18 152.65 44.02 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 67.08 22.65 72.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.157 -179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 80.9 m -123.02 155.64 36.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.593 0.711 . . . . 0.0 110.696 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -135.62 147.06 48.5 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.1 t -83.67 63.52 7.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.817 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.66 -60.79 0.44 Allowed Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.081 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 93.8 Cg_endo -87.76 62.63 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.118 1.878 . . . . 0.0 111.771 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.3 t90 -46.91 139.58 6.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.638 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.5 Cg_endo -93.82 49.8 1.36 Allowed 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.104 -1.624 . . . . 0.0 112.698 0.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.479 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.0 t -124.47 149.59 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 111.854 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 84.8 m -89.57 154.97 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.346 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.74 134.97 43.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.197 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 35.7 ttp180 -132.46 124.98 29.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t30 58.75 36.11 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.984 0.897 . . . . 0.0 109.683 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.75 28.25 72.28 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.451 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 85.2 mt -148.63 137.5 11.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.15 50.85 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.215 2.61 . . . . 0.0 111.858 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 122.285 1.041 . . . . 0.0 110.713 -178.957 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 33.0 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.98 -16.64 60.62 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -88.09 166.81 14.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.843 0.83 . . . . 0.0 111.978 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -122.02 150.43 42.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.016 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.55 66.45 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.531 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.06 -26.57 62.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.94 4.02 49.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.549 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.94 32.24 69.86 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 133.83 16.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.814 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 143.32 28.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.654 0.74 . . . . 0.0 110.331 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.32 -25.35 21.68 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.317 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -89.72 136.17 33.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.343 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -70.26 156.14 39.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.263 0.554 . . . . 0.0 110.296 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 76.48 -5.36 45.28 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.176 179.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.1 m -113.48 150.79 32.35 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.619 0.723 . . . . 0.0 110.203 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -135.1 151.96 51.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.774 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.2 t -80.88 64.58 5.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.097 0.475 . . . . 0.0 111.708 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.796 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.2 m-20 -79.13 -61.95 0.47 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.748 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 85.0 Cg_endo -91.36 66.36 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.345 2.03 . . . . 0.0 111.738 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.4 139.6 7.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.666 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.3 Cg_endo -94.7 51.56 1.19 Allowed 'Cis proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.194 -1.586 . . . . 0.0 112.628 0.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.7 t -126.06 148.76 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.031 0.443 . . . . 0.0 111.688 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.2 m -90.72 148.06 22.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.761 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.82 125.29 44.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.739 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.653 HH11 ' HB2' ' A' ' 26' ' ' ASN . 2.4 tmt_? -102.85 113.88 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.653 ' HB2' HH11 ' A' ' 25' ' ' ARG . 10.0 t-20 59.97 41.26 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.897 0.748 . . . . 0.0 110.241 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.9 79.76 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.666 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.47 126.47 17.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.952 0.376 . . . . 0.0 110.355 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.9 50.55 2.15 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.915 2.41 . . . . 0.0 112.611 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.827 -179.369 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.1 m . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -24.3 8.08 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.653 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.89 173.03 8.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 112.307 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 p -125.31 172.39 9.63 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.071 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 p -150.96 59.03 0.92 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.551 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -57.25 -29.57 63.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.086 0.469 . . . . 0.0 110.589 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -89.89 11.01 21.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.285 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.62 33.14 80.1 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.15 131.2 14.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.102 -0.549 . . . . 0.0 109.574 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.11 144.0 28.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.742 0.782 . . . . 0.0 111.155 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -88.74 -26.22 21.89 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.1 t -103.05 144.67 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -74.88 162.95 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.562 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.88 29.19 74.3 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.913 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 97.2 m -142.5 157.28 44.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.511 0.672 . . . . 0.0 111.062 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 t -134.54 146.89 50.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.023 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.11 62.84 6.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.275 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.37 -60.4 0.47 Allowed Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 92.4 Cg_endo -88.71 63.98 2.9 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.228 1.952 . . . . 0.0 111.89 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 56.4 t90 -47.51 140.25 7.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.8 Cg_endo -94.03 49.18 1.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.562 0.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -125.05 149.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.256 0.551 . . . . 0.0 111.779 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.7 m -89.91 154.62 19.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.206 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.86 129.83 46.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.9 ttm180 -116.86 118.15 31.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.61 42.08 27.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.897 0.855 . . . . 0.0 109.76 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.22 75.57 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.72 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.27 132.21 13.38 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.833 0.317 . . . . 0.0 110.356 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.26 47.89 1.67 Allowed 'Trans proline' 0 N--CA 1.471 0.2 0 C-N-CA 122.823 2.349 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 122.282 1.039 . . . . 0.0 110.464 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 61.5 m . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.68 54.22 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.546 ' HG2' ' HB ' ' A' ' 12' ' ' THR . 21.7 mp0 -88.68 178.53 6.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -134.44 163.76 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.78 63.46 1.3 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.686 0.279 . . . . 0.0 111.622 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -58.16 -25.75 61.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 p -88.69 4.88 45.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.98 30.69 67.56 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.5 131.56 14.36 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' A' ' 12' ' ' THR . 2.2 t -83.52 141.3 31.72 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.917 0.865 . . . . 0.0 110.896 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -89.28 -24.89 21.94 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.744 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.684 HG22 ' SG ' ' A' ' 10' ' ' CYS . 4.6 t -95.85 158.07 15.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.338 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -87.6 156.19 19.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.336 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.53 23.09 78.47 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.597 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 99.6 m -141.86 155.8 45.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.581 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -135.45 151.17 50.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.679 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.7 t -80.97 64.08 5.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 0.0 111.694 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.79 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-20 -78.6 -61.25 0.55 Allowed Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.735 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 95.4 Cg_endo -91.85 66.59 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.505 2.137 . . . . 0.0 112.116 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.6 t90 -47.46 139.88 7.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.775 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.9 Cg_endo -94.26 49.18 1.51 Allowed 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.191 -1.587 . . . . 0.0 112.559 0.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 21.7 t -123.95 151.49 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.647 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 90.1 m -93.47 150.14 20.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -118.08 121.16 39.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.795 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.64 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.2 ttm-85 -98.48 109.36 22.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 59.28 43.19 17.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 110.176 -178.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.96 81.21 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.033 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.32 129.77 22.41 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 117.237 0.518 . . . . 0.0 110.29 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.34 48.71 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.903 2.402 . . . . 0.0 112.846 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 122.066 0.936 . . . . 0.0 110.314 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 38.1 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.561 0.696 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.3 -14.06 65.59 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.076 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.615 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 39.8 mp0 -87.9 162.66 16.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.0 111.949 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -118.35 150.13 40.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.995 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.33 67.07 1.54 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.661 0.267 . . . . 0.0 111.528 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.23 -26.32 62.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.043 0.449 . . . . 0.0 110.853 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 3.38 50.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.002 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.31 31.71 68.7 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.23 133.14 16.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.436 . . . . 0.0 109.901 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.81 144.78 25.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.698 0.761 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.77 -25.49 22.24 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.575 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -101.4 138.8 37.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.3 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 51.6 t30 -71.52 160.3 32.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.55 -17.22 26.24 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.614 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 66.2 m -110.94 152.67 26.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.599 0.714 . . . . 0.0 110.464 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -134.45 151.67 51.31 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.652 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.6 t -79.6 64.51 4.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.803 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.786 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.4 m-20 -78.68 -61.74 0.51 Allowed Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.7 Cg_endo -91.29 67.19 1.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.506 2.137 . . . . 0.0 111.736 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.84 139.77 8.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.581 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.9 Cg_endo -95.11 53.29 1.08 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.115 -1.619 . . . . 0.0 112.71 0.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.3 t -128.76 148.2 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 111.777 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.5 m -89.94 150.36 22.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.671 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -129.1 122.43 29.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.807 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.81 HH11 ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -89.57 107.87 19.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.81 ' HB2' HH11 ' A' ' 25' ' ' ARG . 0.1 OUTLIER 60.68 36.47 19.5 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.037 0.836 . . . . 0.0 109.342 -179.112 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.59 8.03 85.32 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.795 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 mp -116.68 124.1 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 117.526 0.663 . . . . 0.0 110.655 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 6.5 Cg_exo -74.01 47.73 1.57 Allowed 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.281 2.654 . . . . 0.0 112.573 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.725 0.774 . . . . 0.0 110.491 -179.688 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 80.1 m . . . . . 0 CA--C 1.511 -0.548 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.16 -21.3 46.4 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.879 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.9 mp0 -88.86 169.38 11.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.65 . . . . 0.0 111.356 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -125.04 164.74 19.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.84 65.65 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.428 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.6 -24.61 61.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 0.0 110.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -88.26 2.08 53.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.983 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 72.96 29.27 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 131.76 14.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -84.83 140.8 30.92 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.876 0.846 . . . . 0.0 110.861 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.39 -24.58 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.5 t -90.99 165.38 13.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -93.19 156.89 16.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.612 0.72 . . . . 0.0 111.109 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 19.51 72.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.111 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 81.3 m -136.28 155.74 49.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.528 0.68 . . . . 0.0 110.685 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -135.33 151.77 50.84 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.04 63.89 5.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.09 0.471 . . . . 0.0 111.738 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.787 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.4 m-20 -77.21 -61.44 0.67 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.787 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 91.3 Cg_endo -92.31 66.89 0.81 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 111.853 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.1 t90 -47.15 139.64 7.19 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.791 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.71 50.16 1.39 Allowed 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.145 -1.606 . . . . 0.0 112.51 0.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.58 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.14 151.1 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.8 m -94.46 150.65 20.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.804 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -124.47 124.84 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.158 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.67 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 2.7 ptp180 -104.37 117.56 34.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 59.55 36.04 22.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.847 0.832 . . . . 0.0 109.801 -177.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.52 15.35 81.49 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.576 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 28' ' ' LEU . 3.3 mm? -122.68 126.47 26.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 117.209 0.505 . . . . 0.0 110.378 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 43.25 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.975 2.45 . . . . 0.0 112.419 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.35 1.071 . . . . 0.0 109.966 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' CYS . . . . . 0.608 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 55.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.28 63.6 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 45.7 mp0 -87.93 162.76 16.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.816 0.817 . . . . 0.0 112.067 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.4 p -118.46 151.94 36.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.948 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -135.09 66.02 1.54 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.634 0.254 . . . . 0.0 111.543 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -58.07 -27.15 63.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.969 0.414 . . . . 0.0 110.765 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -88.98 5.15 45.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.165 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.91 31.81 69.9 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.18 133.04 16.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.038 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.77 145.28 24.92 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.62 0.724 . . . . 0.0 110.11 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -88.68 -24.74 22.66 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.694 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -103.62 139.56 38.74 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -72.08 162.67 29.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 -179.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.99 -13.14 39.43 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.607 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.2 m -115.15 153.79 30.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.466 0.651 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -134.68 151.27 50.89 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.828 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -80.05 64.45 4.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.791 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.1 m-20 -79.43 -61.73 0.46 Allowed Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 89.7 Cg_endo -90.79 67.03 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.45 2.1 . . . . 0.0 111.722 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.0 t90 -47.84 139.78 8.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.5 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 53.4 Cg_endo -95.15 52.65 1.13 Allowed 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.093 -1.628 . . . . 0.0 112.714 0.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.0 t -128.77 148.93 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.046 0.45 . . . . 0.0 111.683 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 79.9 m -89.95 149.25 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.709 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -127.05 128.55 46.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.523 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 76.6 ttt180 -106.04 115.44 30.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.38 42.28 21.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.98 0.895 . . . . 0.0 109.457 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.04 24.64 75.81 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.489 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.1 mt -135.62 128.67 18.13 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 122.678 -0.307 . . . . 0.0 110.493 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.33 49.37 2.02 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 123.229 2.619 . . . . 0.0 112.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.396 -179.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.746 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 79.7 m . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.375 0.607 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.16 -17.15 57.91 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.952 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.746 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 31.5 mp0 -89.05 163.76 15.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -121.18 150.48 41.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.349 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -132.37 64.9 1.59 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -57.75 -27.04 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 110.804 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -88.94 5.8 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.495 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.32 30.0 69.7 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 132.26 15.09 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.07 144.95 26.65 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.794 0.807 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.58 -25.23 22.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.735 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -105.09 142.27 35.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.155 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.778 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -72.0 166.63 21.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.778 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 71.0 19.64 77.27 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.326 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.3 m -142.41 153.79 44.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.479 0.657 . . . . 0.0 110.394 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.07 149.54 50.1 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.398 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -81.0 64.44 5.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.532 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.794 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.9 m-20 -80.1 -61.64 0.43 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.752 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.794 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -90.71 65.57 1.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.443 2.096 . . . . 0.0 111.891 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.9 t90 -47.84 139.91 8.85 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.1 Cg_endo -94.36 50.76 1.25 Allowed 'Cis proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.091 -1.629 . . . . 0.0 112.675 0.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.558 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.2 t -126.54 149.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.52 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.0 m -90.8 148.69 22.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.771 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -115.74 121.72 43.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.571 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.738 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 26.3 ttm180 -95.93 108.84 21.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.06 36.19 21.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.941 0.877 . . . . 0.0 110.041 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.6 11.45 83.02 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.837 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.7 mp -125.95 133.32 24.81 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 117.27 0.535 . . . . 0.0 109.991 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.6 Cg_exo -70.86 45.39 0.57 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.857 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.3 m . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 121.393 0.615 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.93 -19.81 50.49 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.437 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.619 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.0 mp0 -89.26 170.29 10.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.38 0.609 . . . . 0.0 111.31 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.72 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 p -146.61 65.41 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.571 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.84 -24.63 62.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.957 0.408 . . . . 0.0 110.902 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -88.35 2.66 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.08 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 73.29 29.15 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.67 131.17 13.84 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.728 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -82.67 139.98 33.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.901 0.858 . . . . 0.0 110.444 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.45 -23.62 22.07 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.603 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.728 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.6 t -93.6 167.16 11.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.522 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -93.94 159.34 15.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.854 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 66.36 22.81 71.44 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.816 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 76.7 m -141.61 154.71 45.58 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.672 0.749 . . . . 0.0 110.954 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.37 151.71 50.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.27 64.49 6.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.085 0.469 . . . . 0.0 111.748 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.785 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.0 m-20 -78.97 -61.28 0.51 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -91.98 66.86 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.408 2.072 . . . . 0.0 112.04 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.8 t90 -47.74 139.97 8.53 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.854 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 57.4 Cg_endo -94.25 49.32 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.635 0.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -123.92 151.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.475 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -93.67 149.36 21.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.628 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -115.95 121.85 43.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.775 178.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.748 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 33.7 ttm180 -102.12 112.6 25.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.7 t30 60.17 39.59 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.001 0.905 . . . . 0.0 109.934 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.86 16.39 80.45 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.79 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.4 mt -133.79 131.77 21.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 117.055 0.428 . . . . 0.0 110.382 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.1 Cg_exo -71.39 50.1 1.21 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.112 2.541 . . . . 0.0 112.494 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 122.103 0.954 . . . . 0.0 110.231 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.733 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 92.4 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.72 -19.5 52.48 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.702 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.7 mp0 -88.44 166.64 14.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.465 0.65 . . . . 0.0 111.264 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 p -124.27 151.64 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.26 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 p -133.16 65.23 1.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.15 -31.2 67.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.917 0.389 . . . . 0.0 110.614 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -88.88 12.2 15.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.076 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.514 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.98 31.83 80.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.324 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.32 133.4 16.17 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -92.7 144.69 25.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.508 0.67 . . . . 0.0 109.843 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.79 -24.38 22.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.626 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -98.9 137.42 37.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.988 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -70.83 158.79 35.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.57 -19.28 20.47 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.431 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.6 m -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.826 0.822 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -132.94 150.47 52.16 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.411 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.0 t -80.54 64.62 5.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.691 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.798 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.2 m-20 -79.55 -62.26 0.43 Allowed Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 87.9 Cg_endo -91.37 67.03 1.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.416 2.077 . . . . 0.0 111.717 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.24 139.66 7.43 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.6 Cg_endo -94.92 51.2 1.24 Allowed 'Cis proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.592 0.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.3 t -125.81 149.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.2 m -90.74 151.06 21.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.681 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -130.34 135.57 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.99 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 1' ' ' CYS . 13.7 ptt180 -132.38 131.09 41.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 61.53 35.3 17.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.079 0.943 . . . . 0.0 109.236 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.88 84.64 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.053 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' HG23 ' A' ' 30' ' ' VAL . 94.1 mt -143.02 131.28 11.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.624 0.249 . . . . 0.0 110.581 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.18 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.99 2.46 . . . . 0.0 111.78 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.5 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.762 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 63.4 m . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.27 -24.94 8.52 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.264 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.6 172.84 8.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.834 0.826 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -122.61 174.17 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.039 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.06 59.06 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.533 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -56.66 -30.68 63.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.207 0.527 . . . . 0.0 110.662 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.06 11.49 20.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.372 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.31 34.32 87.61 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.43 132.02 16.8 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.37 146.1 23.96 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.824 0.821 . . . . 0.0 111.766 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -88.86 -26.46 21.62 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.78 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -91.87 135.35 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.122 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -72.72 157.4 37.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.62 2.43 50.2 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.858 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.7 m -109.86 157.4 19.25 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.408 0.623 . . . . 0.0 110.142 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.02 146.95 49.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -81.76 63.57 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.43 -60.64 0.52 Allowed Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.901 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.0 Cg_endo -89.24 63.14 2.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.249 1.966 . . . . 0.0 111.881 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 53.9 t90 -46.37 139.34 6.01 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.7 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 45.8 Cg_endo -94.18 50.24 1.33 Allowed 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.103 -1.624 . . . . 0.0 112.623 0.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.54 150.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.191 0.519 . . . . 0.0 111.77 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 98.3 m -92.75 153.09 19.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.674 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -133.57 117.35 16.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -89.36 100.61 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' HB2' ' NH1' ' A' ' 25' ' ' ARG . 3.5 t30 66.67 35.65 5.13 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.014 0.821 . . . . 0.0 109.196 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.51 85.59 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.31 121.95 38.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 117.154 0.477 . . . . 0.0 110.472 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 64.3 Cg_endo -73.78 44.62 0.96 Allowed 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.955 2.437 . . . . 0.0 113.075 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.308 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 37.4 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.0 79.81 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.918 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.6 mp0 -87.83 161.69 17.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.904 0.859 . . . . 0.0 112.301 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -110.97 150.47 29.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.302 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.5 p -137.29 67.65 1.43 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.441 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.09 -25.94 61.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.064 0.459 . . . . 0.0 110.987 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 p -88.6 2.44 53.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.178 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.447 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.29 34.13 79.57 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.12 136.83 19.18 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -105.08 142.49 34.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.739 0.78 . . . . 0.0 110.638 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.61 -25.25 21.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.55 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -88.57 141.5 28.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.051 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.839 ' ND2' HH12 ' A' ' 25' ' ' ARG . 13.0 t30 -64.64 151.7 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.643 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 65.1 2.46 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.999 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 57.6 m -111.58 143.5 42.35 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.82 0.819 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.0 151.31 50.7 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.776 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.447 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t -76.97 62.23 2.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.108 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.844 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 70.7 m-20 -72.66 -62.0 1.51 Allowed Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.753 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 Cg_endo -92.49 67.95 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.541 2.16 . . . . 0.0 111.414 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.6 t90 -47.9 140.07 8.88 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.495 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 43.8 Cg_endo -95.33 54.28 1.02 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.593 0.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.2 t -127.91 145.58 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.13 0.49 . . . . 0.0 111.993 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.6 m -89.46 150.08 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 128.36 28.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.958 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.839 HH12 ' ND2' ' A' ' 13' ' ' ASN . 6.2 tpt180 -89.42 110.21 21.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.36 40.91 23.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.999 0.904 . . . . 0.0 109.257 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 22.53 78.74 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.422 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.12 133.51 24.9 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 122.687 -0.302 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 48.54 1.85 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.842 2.361 . . . . 0.0 112.482 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.531 -179.541 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 69.4 m . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.36 26.79 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.36 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -89.74 179.69 5.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.974 0.893 . . . . 0.0 112.161 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -135.17 148.35 49.68 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.777 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 p -129.34 65.06 1.47 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.006 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.09 -30.08 65.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.087 0.47 . . . . 0.0 110.542 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -89.88 9.1 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.291 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 67.62 33.57 81.32 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.04 134.25 17.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.273 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -98.81 145.6 26.78 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 -28.22 19.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.162 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -92.07 143.5 26.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.517 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -74.26 160.79 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.54 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.62 24.76 75.28 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.511 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.5 m -137.16 153.86 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.584 0.707 . . . . 0.0 110.749 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.52 147.48 48.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.484 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.7 t -82.02 64.08 6.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.106 0.479 . . . . 0.0 111.355 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.569 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.79 -60.76 0.39 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.149 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.6 Cg_endo -88.13 63.12 3.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.238 1.959 . . . . 0.0 111.913 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.16 139.63 7.22 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.01 50.32 1.3 Allowed 'Cis proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.719 0.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.48 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -126.03 149.13 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.0 111.75 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 76.6 m -89.78 149.78 22.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.308 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -123.1 125.49 45.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.511 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 39.5 ttm180 -108.66 114.87 29.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 59.6 34.11 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.916 0.865 . . . . 0.0 109.798 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.2 82.47 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.692 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 mm? -128.91 131.99 24.09 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 117.131 0.465 . . . . 0.0 110.176 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.7 Cg_exo -72.25 49.06 1.3 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.165 2.577 . . . . 0.0 112.527 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.213 -179.495 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 -24.85 11.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.53 175.08 7.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.825 0.822 . . . . 0.0 112.193 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -129.1 147.28 50.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.139 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.5 p -120.88 63.78 0.86 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -57.31 -36.26 70.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -92.38 19.98 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.976 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.58 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 60.15 35.22 87.13 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.719 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 142.34 27.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.47 146.01 43.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.234 0.54 . . . . 0.0 109.798 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -89.56 -28.49 19.55 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.223 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 133.05 42.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.425 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.19 153.83 42.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.398 0.618 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.23 9.39 60.58 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.186 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.8 m -112.3 150.54 30.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.716 0.77 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 151.43 50.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.681 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.6 t -81.38 65.46 6.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.266 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.2 m-20 -78.27 -63.46 0.44 Allowed Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.846 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.2 Cg_endo -92.17 66.68 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.455 2.103 . . . . 0.0 111.748 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.1 t90 -46.8 139.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.752 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.0 Cg_endo -94.51 50.94 1.24 Allowed 'Cis proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.094 -1.627 . . . . 0.0 112.522 0.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 t -122.87 147.42 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.233 0.539 . . . . 0.0 111.879 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 72.1 m -90.97 148.09 22.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.368 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 18' ' ' ASP . 1.1 p -129.52 133.45 47.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.525 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 42.1 ptt85 -127.2 126.22 42.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.55 39.41 27.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.784 0.802 . . . . 0.0 109.683 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.26 74.39 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.211 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 30' ' ' VAL . 95.1 mt -142.15 126.63 10.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.628 0.252 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 77.6 Cg_endo -77.5 44.83 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.946 2.431 . . . . 0.0 112.322 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.1 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HG3' ' A' ' 25' ' ' ARG . 70.8 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.13 55.9 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.686 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.55 168.44 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.628 0.727 . . . . 0.0 112.077 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -123.38 151.71 42.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.223 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.1 p -132.87 66.38 1.56 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.672 0.272 . . . . 0.0 111.568 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.46 -26.57 63.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.976 0.417 . . . . 0.0 110.845 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -89.03 4.64 47.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.022 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.89 30.92 69.94 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.45 133.32 15.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.176 -0.512 . . . . 0.0 109.621 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -94.26 142.83 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.638 0.733 . . . . 0.0 110.103 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.04 -24.3 22.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.788 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -96.08 139.26 32.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.493 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -70.54 159.16 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 71.65 22.96 78.59 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.319 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 98.2 m -140.41 151.34 44.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.545 0.688 . . . . 0.0 110.616 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -135.53 148.24 49.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.253 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.3 t -80.46 65.13 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.092 0.472 . . . . 0.0 111.385 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.815 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.4 m-20 -77.82 -62.61 0.52 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 86.5 Cg_endo -92.4 67.85 0.76 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.46 2.107 . . . . 0.0 111.725 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.5 t90 -47.38 139.6 7.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.641 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.7 Cg_endo -94.85 51.75 1.19 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.575 0.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 t -125.37 148.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -91.4 151.61 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 p -131.84 131.49 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.924 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.653 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 81.3 mtt-85 -89.3 87.45 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.96 52.45 2.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.989 0.899 . . . . 0.0 109.66 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.9 7.97 87.38 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.846 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.02 118.87 41.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.32 0.56 . . . . 0.0 110.383 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.95 44.53 0.8 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.871 2.381 . . . . 0.0 112.828 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 25' ' ' ARG . 9.7 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 121.877 0.846 . . . . 0.0 110.671 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.611 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 85.4 m . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.507 0.67 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.85 -18.53 57.25 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.86 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 43.1 mp0 -88.01 162.27 16.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.892 0.853 . . . . 0.0 112.106 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -120.75 151.96 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.469 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -136.32 68.64 1.43 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.27 -25.2 63.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p -88.45 2.22 53.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.993 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 71.21 32.02 65.84 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 132.71 15.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.042 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.76 141.93 28.14 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.591 0.71 . . . . 0.0 109.93 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.2 -23.49 22.38 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.991 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -100.65 138.98 36.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.797 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -68.96 157.65 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 79.91 -4.02 67.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.399 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.3 m -121.91 151.56 40.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.465 0.65 . . . . 0.0 110.344 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -130.86 147.05 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.067 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.14 62.48 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.81 -60.08 0.46 Allowed Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 90.9 Cg_endo -88.29 65.4 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.199 1.932 . . . . 0.0 111.714 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.8 t90 -47.57 139.78 8.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.0 Cg_endo -94.99 52.59 1.13 Allowed 'Cis proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.686 0.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.478 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.9 t -128.82 148.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.123 0.487 . . . . 0.0 111.869 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.9 m -89.3 152.33 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.128 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -130.39 124.7 32.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.787 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.8 ttt85 -90.68 103.62 16.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.9 t30 59.43 37.35 23.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.011 0.91 . . . . 0.0 109.557 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.39 6.16 81.37 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.581 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 30' ' ' VAL . 3.5 mm? -111.38 120.54 42.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.438 0.619 . . . . 0.0 110.379 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.08 45.14 1.3 Allowed 'Trans proline' 0 N--CA 1.47 0.12 0 C-N-CA 122.838 2.359 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 28' ' ' LEU . 2.9 t . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.022 0.439 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.57 -26.78 6.19 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.665 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -91.58 170.51 9.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.028 0.918 . . . . 0.0 113.182 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -116.87 177.21 4.79 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.173 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.43 58.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.497 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -56.74 -30.97 64.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.749 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -90.6 12.02 20.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.279 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.41 33.63 85.41 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.26 133.24 18.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.04 144.43 25.48 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.841 0.829 . . . . 0.0 111.584 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -88.98 -26.39 21.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.967 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -92.2 135.75 33.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.249 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.6 156.83 38.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.01 26.69 73.91 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.954 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 78.1 m -136.03 153.63 51.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.294 0.568 . . . . 0.0 110.478 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.93 146.38 47.25 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.935 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -78.55 63.85 3.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.605 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.87 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 71.6 m-20 -73.8 -62.33 1.14 Allowed Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.251 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.87 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 60.7 Cg_endo -92.36 69.01 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.454 2.102 . . . . 0.0 111.728 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 54.5 t90 -48.11 140.3 9.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.454 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 47.7 Cg_endo -95.06 51.4 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.189 -1.588 . . . . 0.0 112.494 0.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.607 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.2 t -125.18 146.33 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.588 . . . . 0.0 112.327 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.8 m -89.62 151.65 21.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.956 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.04 125.59 25.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -96.53 108.52 21.11 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.96 42.7 25.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.916 0.865 . . . . 0.0 109.727 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.59 18.17 79.35 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.829 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 94.4 mt -128.58 131.88 24.02 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.083 0.442 . . . . 0.0 110.455 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.6 Cg_exo -71.83 47.55 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.179 2.586 . . . . 0.0 113.102 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.548 0.69 . . . . 0.0 111.152 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.6 m . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.31 -29.29 6.7 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.24 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.42 167.51 12.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.875 0.845 . . . . 0.0 111.946 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -118.03 174.7 6.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.773 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.3 p -150.39 66.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.87 -26.01 63.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.087 0.47 . . . . 0.0 110.782 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.91 3.77 50.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.21 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.05 32.75 69.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.417 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.35 132.9 15.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.02 141.2 29.71 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.78 0.8 . . . . 0.0 111.277 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.67 -27.42 20.14 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.858 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.39 131.46 35.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.257 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.667 HD22 ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -69.78 154.26 42.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.372 0.606 . . . . 0.0 109.943 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.667 ' H ' HD22 ' A' ' 13' ' ' ASN . . . 67.85 25.12 74.28 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.243 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.2 m -133.41 154.99 50.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.301 0.572 . . . . 0.0 110.276 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.52 146.69 48.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.167 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.9 t -82.56 63.3 6.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.09 -60.79 0.47 Allowed Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.187 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.3 Cg_endo -88.58 64.56 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.154 1.903 . . . . 0.0 111.727 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 62.3 t90 -47.81 139.85 8.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.51 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.1 Cg_endo -94.03 51.17 1.18 Allowed 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.859 0.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.5 t -126.52 148.91 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.948 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.7 m -89.45 153.99 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.099 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.03 129.53 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.976 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 49.2 ttm-85 -97.78 101.6 13.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.423 ' HA ' HD22 ' A' ' 26' ' ' ASN . 0.5 OUTLIER 59.67 45.37 13.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.875 0.845 . . . . 0.0 109.988 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.04 19.45 79.61 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.728 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 89.8 mt -129.55 130.23 23.25 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.4 Cg_exo -71.29 45.54 0.65 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.136 2.557 . . . . 0.0 112.971 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 122.363 1.078 . . . . 0.0 110.64 -179.77 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.78 -20.47 50.51 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -89.22 168.48 12.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.716 0.77 . . . . 0.0 111.933 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -123.97 155.78 37.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.849 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 p -137.92 67.52 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.689 0.28 . . . . 0.0 111.733 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -59.54 -25.11 64.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.694 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -88.52 3.13 51.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.955 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.36 31.33 68.64 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.36 132.91 15.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.265 -0.468 . . . . 0.0 109.772 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -93.89 142.06 27.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.575 0.702 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.23 -23.7 22.29 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.829 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -94.64 139.25 31.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.741 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.55 158.03 36.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.763 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.95 75.52 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.903 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 89.2 m -130.4 149.89 51.88 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.732 0.777 . . . . 0.0 110.571 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.6 146.09 47.58 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.746 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.4 t -79.2 63.16 3.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.083 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.776 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 43.5 m-20 -76.36 -61.3 0.81 Allowed Pre-proline 0 C--N 1.318 -0.792 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.48 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.8 Cg_endo -90.29 66.85 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.347 2.031 . . . . 0.0 111.866 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.9 t90 -47.85 140.0 8.81 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.633 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.3 Cg_endo -94.6 50.78 1.27 Allowed 'Cis proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.101 -1.625 . . . . 0.0 112.589 0.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.0 t -125.2 147.52 29.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.273 0.559 . . . . 0.0 111.936 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 100.0 m -89.35 151.11 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.146 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -123.03 130.05 52.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.322 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 14.8 ttp180 -117.87 119.95 36.4 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 58.76 40.41 23.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.928 0.871 . . . . 0.0 109.977 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.82 26.23 74.71 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.579 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.494 ' HB3' HG23 ' A' ' 30' ' ' VAL . 91.7 mt -144.6 134.21 11.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.0 Cg_exo -72.6 47.48 1.17 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 123.023 2.482 . . . . 0.0 112.594 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.6 t . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.788 0.804 . . . . 0.0 110.395 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 39.3 m . . . . . 0 CA--C 1.518 -0.284 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.16 78.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.656 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.703 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 28.8 mp0 -88.06 159.34 18.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.911 0.863 . . . . 0.0 111.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -109.92 148.47 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.507 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.67 66.65 1.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.12 -30.0 65.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.953 0.406 . . . . 0.0 110.726 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -88.81 9.64 23.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.476 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.57 34.12 88.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.25 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.04 134.07 17.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -95.96 143.48 27.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.598 0.713 . . . . 0.0 110.18 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.13 -24.33 22.25 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.819 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -99.07 137.98 36.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.425 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.668 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.5 t-20 -71.61 156.54 39.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.988 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.36 12.38 84.29 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.972 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.0 m -129.76 152.26 49.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -132.07 145.72 51.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.476 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.77 62.17 4.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.468 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.645 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.51 -61.23 0.48 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.95 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 7.7 Cg_endo -87.64 66.07 3.81 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.439 2.093 . . . . 0.0 111.268 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 61.7 t90 -48.31 140.06 9.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.567 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 54.2 Cg_endo -95.03 53.89 1.04 Allowed 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.774 0.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 38.2 t -130.13 146.95 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.124 0.488 . . . . 0.0 111.986 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -88.89 152.14 21.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.916 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.92 132.56 40.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.947 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttt85 -94.22 103.93 15.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 59.39 44.78 14.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.811 0.815 . . . . 0.0 109.997 -178.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.48 73.76 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.249 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.28 143.98 45.91 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 50.05 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.32 -0.713 0 CA-C-O 121.464 0.65 . . . . 0.0 110.419 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.3 -30.4 7.76 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.392 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 167.89 12.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.895 0.855 . . . . 0.0 111.783 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -117.75 175.89 5.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.826 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.3 p -150.26 62.38 0.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.069 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.14 -29.64 65.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -91.15 10.45 26.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.302 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 66.19 35.33 90.28 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.81 133.63 19.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 t -100.93 144.18 30.18 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 111.694 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -89.7 -28.71 19.25 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.861 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.14 132.69 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.474 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.638 HD22 ' H ' ' A' ' 14' ' ' GLY . 1.1 t-20 -70.18 152.65 44.02 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.638 ' H ' HD22 ' A' ' 13' ' ' ASN . . . 67.08 22.65 72.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.157 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 80.9 m -123.02 155.64 36.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.593 0.711 . . . . 0.0 110.696 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -135.62 147.06 48.5 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.1 t -83.67 63.52 7.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.817 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.518 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.66 -60.79 0.44 Allowed Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.081 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 93.8 Cg_endo -87.76 62.63 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.118 1.878 . . . . 0.0 111.771 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.3 t90 -46.91 139.58 6.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.638 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.5 Cg_endo -93.82 49.8 1.36 Allowed 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.104 -1.624 . . . . 0.0 112.698 0.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.479 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.0 t -124.47 149.59 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 111.854 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 84.8 m -89.57 154.97 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.346 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.74 134.97 43.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.197 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 35.7 ttp180 -132.46 124.98 29.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t30 58.75 36.11 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.984 0.897 . . . . 0.0 109.683 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.75 28.25 72.28 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.451 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 85.2 mt -148.63 137.5 11.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.15 50.85 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.215 2.61 . . . . 0.0 111.858 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 122.285 1.041 . . . . 0.0 110.713 -178.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 33.0 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.98 -16.64 60.62 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -88.09 166.81 14.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.843 0.83 . . . . 0.0 111.978 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -122.02 150.43 42.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.016 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.55 66.45 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.531 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.06 -26.57 62.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.94 4.02 49.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.549 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.94 32.24 69.86 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 133.83 16.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.814 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 143.32 28.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.654 0.74 . . . . 0.0 110.331 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.32 -25.35 21.68 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.317 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -89.72 136.17 33.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.343 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -70.26 156.14 39.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.263 0.554 . . . . 0.0 110.296 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.659 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.48 -5.36 45.28 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.176 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.1 m -113.48 150.79 32.35 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.619 0.723 . . . . 0.0 110.203 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -135.1 151.96 51.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.774 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.2 t -80.88 64.58 5.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.097 0.475 . . . . 0.0 111.708 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.796 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.2 m-20 -79.13 -61.95 0.47 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.748 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 85.0 Cg_endo -91.36 66.36 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.345 2.03 . . . . 0.0 111.738 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.4 139.6 7.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.666 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.3 Cg_endo -94.7 51.56 1.19 Allowed 'Cis proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.194 -1.586 . . . . 0.0 112.628 0.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.7 t -126.06 148.76 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.031 0.443 . . . . 0.0 111.688 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.2 m -90.72 148.06 22.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.761 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.82 125.29 44.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.739 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.653 HH11 ' HB2' ' A' ' 26' ' ' ASN . 2.4 tmt_? -102.85 113.88 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.653 ' HB2' HH11 ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.97 41.26 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.897 0.748 . . . . 0.0 110.241 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.9 79.76 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.666 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.47 126.47 17.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.952 0.376 . . . . 0.0 110.355 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.9 50.55 2.15 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.915 2.41 . . . . 0.0 112.611 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.827 -179.369 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.1 m . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -24.3 8.08 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.653 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.89 173.03 8.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 112.307 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 p -125.31 172.39 9.63 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.071 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 p -150.96 59.03 0.92 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.551 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -57.25 -29.57 63.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.086 0.469 . . . . 0.0 110.589 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -89.89 11.01 21.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.285 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.62 33.14 80.1 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.15 131.2 14.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.102 -0.549 . . . . 0.0 109.574 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.11 144.0 28.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.742 0.782 . . . . 0.0 111.155 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -88.74 -26.22 21.89 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.1 t -103.05 144.67 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -74.88 162.95 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.562 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.88 29.19 74.3 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.913 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 97.2 m -142.5 157.28 44.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.511 0.672 . . . . 0.0 111.062 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 t -134.54 146.89 50.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.023 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.11 62.84 6.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.275 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.37 -60.4 0.47 Allowed Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 92.4 Cg_endo -88.71 63.98 2.9 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.228 1.952 . . . . 0.0 111.89 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 56.4 t90 -47.51 140.25 7.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.8 Cg_endo -94.03 49.18 1.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.562 0.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -125.05 149.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.256 0.551 . . . . 0.0 111.779 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.7 m -89.91 154.62 19.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.206 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.86 129.83 46.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.9 ttm180 -116.86 118.15 31.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.61 42.08 27.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.897 0.855 . . . . 0.0 109.76 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.22 75.57 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.72 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.27 132.21 13.38 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.833 0.317 . . . . 0.0 110.356 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.26 47.89 1.67 Allowed 'Trans proline' 0 N--CA 1.471 0.2 0 C-N-CA 122.823 2.349 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 122.282 1.039 . . . . 0.0 110.464 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 61.5 m . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.68 54.22 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.546 ' HG2' ' HB ' ' A' ' 12' ' ' THR . 21.7 mp0 -88.68 178.53 6.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -134.44 163.76 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.78 63.46 1.3 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.686 0.279 . . . . 0.0 111.622 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -58.16 -25.75 61.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 p -88.69 4.88 45.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.98 30.69 67.56 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.5 131.56 14.36 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' A' ' 12' ' ' THR . 2.2 t -83.52 141.3 31.72 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.917 0.865 . . . . 0.0 110.896 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -89.28 -24.89 21.94 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.744 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.684 HG22 ' SG ' ' A' ' 10' ' ' CYS . 4.6 t -95.85 158.07 15.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.338 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -87.6 156.19 19.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.336 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.53 23.09 78.47 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.597 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 99.6 m -141.86 155.8 45.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.581 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -135.45 151.17 50.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.679 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.7 t -80.97 64.08 5.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 0.0 111.694 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.79 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-20 -78.6 -61.25 0.55 Allowed Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.735 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 95.4 Cg_endo -91.85 66.59 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.505 2.137 . . . . 0.0 112.116 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.6 t90 -47.46 139.88 7.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.775 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.9 Cg_endo -94.26 49.18 1.51 Allowed 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.191 -1.587 . . . . 0.0 112.559 0.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 21.7 t -123.95 151.49 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.647 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 90.1 m -93.47 150.14 20.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -118.08 121.16 39.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.795 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.64 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.2 ttm-85 -98.48 109.36 22.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.28 43.19 17.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 110.176 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.96 81.21 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.033 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.32 129.77 22.41 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 117.237 0.518 . . . . 0.0 110.29 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.34 48.71 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.903 2.402 . . . . 0.0 112.846 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 122.066 0.936 . . . . 0.0 110.314 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 38.1 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.561 0.696 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.3 -14.06 65.59 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.076 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.615 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 39.8 mp0 -87.9 162.66 16.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.0 111.949 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -118.35 150.13 40.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.995 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.33 67.07 1.54 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.661 0.267 . . . . 0.0 111.528 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.23 -26.32 62.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.043 0.449 . . . . 0.0 110.853 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 3.38 50.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.002 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.31 31.71 68.7 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.23 133.14 16.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.436 . . . . 0.0 109.901 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.81 144.78 25.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.698 0.761 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.77 -25.49 22.24 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.575 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -101.4 138.8 37.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.3 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.2 t-20 -71.52 160.3 32.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.706 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 83.55 -17.22 26.24 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.614 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 66.2 m -110.94 152.67 26.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.599 0.714 . . . . 0.0 110.464 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -134.45 151.67 51.31 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.652 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.6 t -79.6 64.51 4.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.803 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.786 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.4 m-20 -78.68 -61.74 0.51 Allowed Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.7 Cg_endo -91.29 67.19 1.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.506 2.137 . . . . 0.0 111.736 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.84 139.77 8.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.581 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.9 Cg_endo -95.11 53.29 1.08 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.115 -1.619 . . . . 0.0 112.71 0.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.3 t -128.76 148.2 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 111.777 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.5 m -89.94 150.36 22.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.671 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -129.1 122.43 29.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.807 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.81 HH11 ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -89.57 107.87 19.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.81 ' HB2' HH11 ' A' ' 25' ' ' ARG . 2.3 t-20 60.68 36.47 19.5 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.037 0.836 . . . . 0.0 109.342 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.59 8.03 85.32 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.795 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 mp -116.68 124.1 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 117.526 0.663 . . . . 0.0 110.655 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 6.5 Cg_exo -74.01 47.73 1.57 Allowed 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.281 2.654 . . . . 0.0 112.573 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.725 0.774 . . . . 0.0 110.491 -179.688 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 80.1 m . . . . . 0 CA--C 1.511 -0.548 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.16 -21.3 46.4 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.879 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.9 mp0 -88.86 169.38 11.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.65 . . . . 0.0 111.356 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -125.04 164.74 19.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.84 65.65 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.428 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.6 -24.61 61.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 0.0 110.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -88.26 2.08 53.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.983 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 72.96 29.27 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 131.76 14.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -84.83 140.8 30.92 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.876 0.846 . . . . 0.0 110.861 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.39 -24.58 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.5 t -90.99 165.38 13.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -93.19 156.89 16.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.612 0.72 . . . . 0.0 111.109 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 19.51 72.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.111 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 81.3 m -136.28 155.74 49.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.528 0.68 . . . . 0.0 110.685 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -135.33 151.77 50.84 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.421 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.04 63.89 5.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.09 0.471 . . . . 0.0 111.738 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.787 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.4 m-20 -77.21 -61.44 0.67 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.787 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 91.3 Cg_endo -92.31 66.89 0.81 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 111.853 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.1 t90 -47.15 139.64 7.19 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.791 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.71 50.16 1.39 Allowed 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.145 -1.606 . . . . 0.0 112.51 0.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.58 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.14 151.1 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.8 m -94.46 150.65 20.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.804 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -124.47 124.84 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.158 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.67 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 2.7 ptp180 -104.37 117.56 34.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.55 36.04 22.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.847 0.832 . . . . 0.0 109.801 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.52 15.35 81.49 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.576 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 28' ' ' LEU . 3.3 mm? -122.68 126.47 26.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 117.209 0.505 . . . . 0.0 110.378 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 43.25 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.975 2.45 . . . . 0.0 112.419 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.35 1.071 . . . . 0.0 109.966 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' CYS . . . . . 0.608 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 55.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.28 63.6 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 45.7 mp0 -87.93 162.76 16.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.816 0.817 . . . . 0.0 112.067 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.4 p -118.46 151.94 36.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.948 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -135.09 66.02 1.54 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.634 0.254 . . . . 0.0 111.543 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -58.07 -27.15 63.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.969 0.414 . . . . 0.0 110.765 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -88.98 5.15 45.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.165 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.91 31.81 69.9 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.18 133.04 16.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.038 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.77 145.28 24.92 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.62 0.724 . . . . 0.0 110.11 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -88.68 -24.74 22.66 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.694 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -103.62 139.56 38.74 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASN . . . . . 0.744 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -72.08 162.67 29.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.744 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 81.99 -13.14 39.43 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.607 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.2 m -115.15 153.79 30.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.466 0.651 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -134.68 151.27 50.89 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.828 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -80.05 64.45 4.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.791 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.1 m-20 -79.43 -61.73 0.46 Allowed Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 89.7 Cg_endo -90.79 67.03 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.45 2.1 . . . . 0.0 111.722 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.0 t90 -47.84 139.78 8.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.5 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 53.4 Cg_endo -95.15 52.65 1.13 Allowed 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.093 -1.628 . . . . 0.0 112.714 0.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.0 t -128.77 148.93 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.046 0.45 . . . . 0.0 111.683 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 79.9 m -89.95 149.25 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.709 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -127.05 128.55 46.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.523 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 76.6 ttt180 -106.04 115.44 30.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.38 42.28 21.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.98 0.895 . . . . 0.0 109.457 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.04 24.64 75.81 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.489 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.1 mt -135.62 128.67 18.13 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 122.678 -0.307 . . . . 0.0 110.493 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.33 49.37 2.02 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 123.229 2.619 . . . . 0.0 112.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.396 -179.445 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.746 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 79.7 m . . . . . 0 CA--C 1.514 -0.413 0 CA-C-O 121.375 0.607 . . . . 0.0 109.722 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.16 -17.15 57.91 Favored Glycine 0 N--CA 1.445 -0.731 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.952 -179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.746 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 31.5 mp0 -89.05 163.76 15.36 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.604 0.716 . . . . 0.0 111.52 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -121.18 150.48 41.23 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.776 -1.102 . . . . 0.0 110.349 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -132.37 64.9 1.59 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.433 -178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -57.75 -27.04 62.66 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.073 0.463 . . . . 0.0 110.804 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.5 p -88.94 5.8 42.37 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.182 179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.495 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.32 30.0 69.7 Favored Glycine 0 N--CA 1.451 -0.354 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -179.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.41 132.26 15.09 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 -179.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -87.07 144.95 26.65 Favored 'General case' 0 CA--C 1.504 -0.824 0 CA-C-O 121.794 0.807 . . . . 0.0 110.163 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -88.58 -25.23 22.58 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 113.941 -1.481 . . . . 0.0 109.735 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 27.5 m -105.09 142.27 35.17 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.155 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.778 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.7 OUTLIER -72.0 166.63 21.82 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.249 179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.778 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 71.0 19.64 77.27 Favored Glycine 0 N--CA 1.448 -0.556 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.326 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.3 m -142.41 153.79 44.04 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.479 0.657 . . . . 0.0 110.394 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.07 149.54 50.1 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.398 179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.495 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -81.0 64.44 5.75 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-O 121.166 0.508 . . . . 0.0 111.532 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.794 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.9 m-20 -80.1 -61.64 0.43 Allowed Pre-proline 0 C--N 1.317 -0.831 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.752 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.794 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -90.71 65.57 1.54 Allowed 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.443 2.096 . . . . 0.0 111.891 179.265 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.9 t90 -47.84 139.91 8.85 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.533 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.1 Cg_endo -94.36 50.76 1.25 Allowed 'Cis proline' 0 N--CA 1.455 -0.741 0 C-N-CA 123.091 -1.629 . . . . 0.0 112.675 0.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.558 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.2 t -126.54 149.2 31.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.52 -178.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.87 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.0 m -90.8 148.69 22.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.771 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.431 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -115.74 121.72 43.31 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.571 178.286 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.738 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 26.3 ttm180 -95.93 108.84 21.26 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.7 t30 60.06 36.19 21.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.941 0.877 . . . . 0.0 110.041 -178.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 81.6 11.45 83.02 Favored Glycine 0 CA--C 1.521 0.436 0 CA-C-N 115.325 -0.852 . . . . 0.0 113.837 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.426 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 7.7 mp -125.95 133.32 24.81 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 117.27 0.535 . . . . 0.0 109.991 179.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.6 Cg_exo -70.86 45.39 0.57 Allowed 'Trans proline' 0 CA--C 1.529 0.261 0 C-N-CA 122.959 2.439 . . . . 0.0 112.857 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 22.5 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.31 -179.882 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.748 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.3 m . . . . . 0 CA--C 1.513 -0.476 0 CA-C-O 121.393 0.615 . . . . 0.0 109.525 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 100.93 -19.81 50.49 Favored Glycine 0 N--CA 1.443 -0.879 0 CA-C-N 114.742 -1.117 . . . . 0.0 110.437 -178.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.619 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.0 mp0 -89.26 170.29 10.71 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.38 0.609 . . . . 0.0 111.31 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.2 p -126.33 165.61 18.69 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.219 -0.901 . . . . 0.0 110.72 179.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.8 p -146.61 65.41 1.18 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.571 -179.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.84 -24.63 62.32 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.957 0.408 . . . . 0.0 110.902 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.0 p -88.35 2.66 52.09 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.146 -0.479 . . . . 0.0 112.08 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 73.29 29.15 64.68 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.388 -0.685 . . . . 0.0 111.388 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.67 131.17 13.84 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 -179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.728 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -82.67 139.98 33.4 Favored 'General case' 0 CA--C 1.504 -0.805 0 CA-C-O 121.901 0.858 . . . . 0.0 110.444 -179.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -89.45 -23.62 22.07 Favored 'General case' 0 C--N 1.306 -1.299 0 CA-C-N 113.636 -1.62 . . . . 0.0 109.603 -179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.728 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.6 t -93.6 167.16 11.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.522 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -93.94 159.34 15.22 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.854 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 66.36 22.81 71.44 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.816 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 76.7 m -141.61 154.71 45.58 Favored 'General case' 0 CA--C 1.513 -0.473 0 CA-C-O 121.672 0.749 . . . . 0.0 110.954 179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.5 t -135.37 151.71 50.74 Favored 'General case' 0 C--N 1.311 -1.09 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.37 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.27 64.49 6.02 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.085 0.469 . . . . 0.0 111.748 -178.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.785 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.0 m-20 -78.97 -61.28 0.51 Allowed Pre-proline 0 C--N 1.317 -0.811 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.768 179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.785 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.0 Cg_endo -91.98 66.86 0.94 Allowed 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.408 2.072 . . . . 0.0 112.04 179.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.8 t90 -47.74 139.97 8.53 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.854 -179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 57.4 Cg_endo -94.25 49.32 1.49 Allowed 'Cis proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.111 -1.621 . . . . 0.0 112.635 0.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -123.92 151.25 28.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.475 -178.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.84 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 88.3 m -93.67 149.36 21.3 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.628 179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -115.95 121.85 43.52 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.775 178.555 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.748 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 33.7 ttm180 -102.12 112.6 25.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 179.142 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.7 t30 60.17 39.59 19.2 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.001 0.905 . . . . 0.0 109.934 -178.23 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.86 16.39 80.45 Favored Glycine 0 CA--C 1.52 0.374 0 CA-C-N 115.237 -0.892 . . . . 0.0 113.79 179.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.4 mt -133.79 131.77 21.26 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 117.055 0.428 . . . . 0.0 110.382 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.1 Cg_exo -71.39 50.1 1.21 Allowed 'Trans proline' 0 CA--C 1.528 0.218 0 C-N-CA 123.112 2.541 . . . . 0.0 112.494 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 10.6 p . . . . . 0 C--N 1.32 -0.676 0 CA-C-O 122.103 0.954 . . . . 0.0 110.231 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.733 ' HA ' ' CZ ' ' A' ' 25' ' ' ARG . 92.4 m . . . . . 0 N--CA 1.448 -0.556 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 93.72 -19.5 52.48 Favored Glycine 0 N--CA 1.445 -0.757 0 CA-C-N 115.021 -0.99 . . . . 0.0 111.317 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.702 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.7 mp0 -88.44 166.64 14.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.465 0.65 . . . . 0.0 111.264 179.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.3 p -124.27 151.64 43.96 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.26 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.6 p -133.16 65.23 1.59 Allowed 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.472 -178.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.15 -31.2 67.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.917 0.389 . . . . 0.0 110.614 179.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.7 m -88.88 12.2 15.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.064 0.459 . . . . 0.0 111.076 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.514 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.98 31.83 80.72 Favored Glycine 0 C--N 1.331 0.265 0 C-N-CA 121.15 -0.548 . . . . 0.0 112.324 179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.32 133.4 16.17 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 110.1 -0.333 . . . . 0.0 110.1 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -92.7 144.69 25.06 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.508 0.67 . . . . 0.0 109.843 -179.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -88.79 -24.38 22.64 Favored 'General case' 0 C--N 1.306 -1.294 0 CA-C-N 114.361 -1.29 . . . . 0.0 109.626 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.3 m -98.9 137.42 37.48 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.988 178.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 40.2 t30 -70.83 158.79 35.76 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.946 -179.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.57 -19.28 20.47 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.397 -0.82 . . . . 0.0 112.431 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 71.6 m -104.53 151.79 23.17 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 121.826 0.822 . . . . 0.0 110.828 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 t -132.94 150.47 52.16 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.411 179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.514 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.0 t -80.54 64.62 5.4 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.691 -178.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.798 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.2 m-20 -79.55 -62.26 0.43 Allowed Pre-proline 0 C--N 1.316 -0.872 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.798 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.798 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 87.9 Cg_endo -91.37 67.03 1.18 Allowed 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 122.416 2.077 . . . . 0.0 111.717 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.42 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.24 139.66 7.43 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.821 -179.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.6 Cg_endo -94.92 51.2 1.24 Allowed 'Cis proline' 0 N--CA 1.455 -0.789 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.592 0.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.3 t -125.81 149.0 30.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.02 0.438 . . . . 0.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.94 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 73.2 m -90.74 151.06 21.37 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.681 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -130.34 135.57 48.2 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.99 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.733 ' CZ ' ' HA ' ' A' ' 1' ' ' CYS . 13.7 ptt180 -132.38 131.09 41.49 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 108.291 -1.004 . . . . 0.0 108.291 177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 41.3 t30 61.53 35.3 17.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 122.079 0.943 . . . . 0.0 109.236 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.58 32.88 84.64 Favored Glycine 0 C--N 1.334 0.431 0 CA-C-N 114.847 -1.07 . . . . 0.0 113.053 179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.596 ' HB3' HG23 ' A' ' 30' ' ' VAL . 94.1 mt -143.02 131.28 11.29 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-O 120.624 0.249 . . . . 0.0 110.581 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -79.18 42.84 1.36 Allowed 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.99 2.46 . . . . 0.0 111.78 179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.596 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.5 t . . . . . 0 C--N 1.318 -0.799 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.762 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.444 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 63.4 m . . . . . 0 CA--C 1.518 -0.265 0 CA-C-O 121.179 0.514 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 87.27 -24.94 8.52 Favored Glycine 0 N--CA 1.448 -0.518 0 CA-C-N 115.57 -0.741 . . . . 0.0 112.264 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.0 mm-40 -89.6 172.84 8.67 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.834 0.826 . . . . 0.0 112.521 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.2 p -122.61 174.17 7.25 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 114.08 -1.418 . . . . 0.0 110.039 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 13.0 p -151.06 59.06 0.91 Allowed 'General case' 0 C--N 1.321 -0.631 0 C-N-CA 120.926 -0.31 . . . . 0.0 111.533 -179.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -56.66 -30.68 63.64 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.207 0.527 . . . . 0.0 110.662 179.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.7 p -90.06 11.49 20.59 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.372 179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.31 34.32 87.61 Favored Glycine 0 N--CA 1.451 -0.364 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -148.43 132.02 16.8 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.9 t -92.37 146.1 23.96 Favored 'General case' 0 CA--C 1.506 -0.735 0 CA-C-O 121.824 0.821 . . . . 0.0 111.766 -178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -88.86 -26.46 21.62 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-N 113.671 -1.604 . . . . 0.0 108.78 178.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 2.8 m -91.87 135.35 33.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.176 -0.92 . . . . 0.0 110.122 178.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.6 t30 -72.72 157.4 37.59 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.122 0.487 . . . . 0.0 110.508 179.333 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.62 2.43 50.2 Favored Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 115.441 -0.8 . . . . 0.0 112.858 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.7 m -109.86 157.4 19.25 Favored 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 121.408 0.623 . . . . 0.0 110.142 179.611 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.02 146.95 49.5 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.792 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.6 t -81.76 63.57 6.08 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.127 -178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.574 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.43 -60.64 0.52 Allowed Pre-proline 0 C--N 1.314 -0.955 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.901 179.682 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.574 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.0 Cg_endo -89.24 63.14 2.48 Favored 'Trans proline' 0 N--CA 1.452 -0.952 0 C-N-CA 122.249 1.966 . . . . 0.0 111.881 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.433 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 53.9 t90 -46.37 139.34 6.01 Favored Pre-proline 0 C--N 1.327 -0.413 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.7 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 45.8 Cg_endo -94.18 50.24 1.33 Allowed 'Cis proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.103 -1.624 . . . . 0.0 112.623 0.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.508 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.54 150.54 29.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.191 0.519 . . . . 0.0 111.77 -178.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.621 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 98.3 m -92.75 153.09 19.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.674 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -133.57 117.35 16.99 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.791 178.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.609 ' NH1' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -89.36 100.61 13.36 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.617 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' HB2' ' NH1' ' A' ' 25' ' ' ARG . 3.5 t30 66.67 35.65 5.13 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.014 0.821 . . . . 0.0 109.196 -178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.21 2.51 85.59 Favored Glycine 0 CA--C 1.521 0.449 0 CA-C-N 115.364 -0.834 . . . . 0.0 113.275 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 89.4 mt -111.31 121.95 38.97 Favored Pre-proline 0 C--N 1.327 -0.372 0 CA-C-N 117.154 0.477 . . . . 0.0 110.472 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.445 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 64.3 Cg_endo -73.78 44.62 0.96 Allowed 'Trans proline' 0 N--CA 1.471 0.196 0 C-N-CA 122.955 2.437 . . . . 0.0 113.075 -179.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.5 m . . . . . 0 C--N 1.318 -0.789 0 CA-C-N 115.665 -0.698 . . . . 0.0 111.308 -179.865 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.662 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 37.4 m . . . . . 0 N--CA 1.451 -0.389 0 N-CA-C 108.659 -0.867 . . . . 0.0 108.659 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.21 -8.0 79.81 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.141 -0.936 . . . . 0.0 112.918 178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.662 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 42.6 mp0 -87.83 161.69 17.39 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.904 0.859 . . . . 0.0 112.301 -179.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -110.97 150.47 29.21 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.02 -1.445 . . . . 0.0 110.302 179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 3.5 p -137.29 67.65 1.43 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.441 -178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -58.09 -25.94 61.94 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.064 0.459 . . . . 0.0 110.987 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.3 p -88.6 2.44 53.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.178 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.447 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 68.29 34.13 79.57 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 111.402 -0.679 . . . . 0.0 111.402 -179.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.12 136.83 19.18 Favored 'General case' 0 C--N 1.319 -0.725 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 -179.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -105.08 142.49 34.77 Favored 'General case' 0 CA--C 1.505 -0.779 0 CA-C-O 121.739 0.78 . . . . 0.0 110.638 -179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.61 -25.25 21.4 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 113.935 -1.484 . . . . 0.0 109.55 179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.9 m -88.57 141.5 28.48 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.051 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.839 ' ND2' HH12 ' A' ' 25' ' ' ARG . 13.0 t30 -64.64 151.7 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.058 -0.974 . . . . 0.0 112.643 -179.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.613 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 65.1 2.46 8.83 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 113.806 -1.543 . . . . 0.0 113.999 178.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 57.6 m -111.58 143.5 42.35 Favored 'General case' 0 N--CA 1.441 -0.911 0 CA-C-O 121.82 0.819 . . . . 0.0 110.264 179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.0 151.31 50.7 Favored 'General case' 0 C--N 1.304 -1.375 0 CA-C-N 114.534 -1.212 . . . . 0.0 109.776 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.447 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 1.8 t -76.97 62.23 2.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.108 -178.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.844 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 70.7 m-20 -72.66 -62.0 1.51 Allowed Pre-proline 0 C--N 1.319 -0.739 0 C-N-CA 120.232 -0.587 . . . . 0.0 109.753 178.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.844 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 73.9 Cg_endo -92.49 67.95 0.73 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 122.541 2.16 . . . . 0.0 111.414 178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.6 t90 -47.9 140.07 8.88 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.495 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 43.8 Cg_endo -95.33 54.28 1.02 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.155 -1.602 . . . . 0.0 112.593 0.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.616 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 40.2 t -127.91 145.58 34.92 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 CA-C-O 121.13 0.49 . . . . 0.0 111.993 -178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.768 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.6 m -89.46 150.08 22.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.389 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.4 p -136.74 128.36 28.75 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.958 178.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.839 HH12 ' ND2' ' A' ' 13' ' ' ASN . 6.2 tpt180 -89.42 110.21 21.05 Favored 'General case' 0 CA--C 1.513 -0.449 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.36 40.91 23.87 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.999 0.904 . . . . 0.0 109.257 -178.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.93 22.53 78.74 Favored Glycine 0 CA--C 1.519 0.287 0 CA-C-N 114.999 -1.001 . . . . 0.0 113.422 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.1 mt -125.12 133.51 24.9 Favored Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 122.687 -0.302 . . . . 0.0 110.304 179.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -74.41 48.54 1.85 Allowed 'Trans proline' 0 CA--C 1.527 0.133 0 C-N-CA 122.842 2.361 . . . . 0.0 112.482 -179.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--N 1.319 -0.746 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.531 -179.541 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.511 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 69.4 m . . . . . 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 110.078 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.09 -19.36 26.79 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.36 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 65.1 mt-10 -89.74 179.69 5.95 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.974 0.893 . . . . 0.0 112.161 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.2 p -135.17 148.35 49.68 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 113.813 -1.54 . . . . 0.0 108.777 178.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 10.7 p -129.34 65.06 1.47 Allowed 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 120.761 -0.376 . . . . 0.0 112.006 -178.084 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -58.09 -30.08 65.95 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.087 0.47 . . . . 0.0 110.542 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -89.88 9.1 28.88 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.291 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.57 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 67.62 33.57 81.32 Favored Glycine 0 C--N 1.32 -0.348 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -150.04 134.25 17.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.546 -0.327 . . . . 0.0 110.273 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -98.81 145.6 26.78 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 -179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.62 -28.22 19.66 Favored 'General case' 0 C--N 1.304 -1.406 0 CA-C-N 114.605 -1.179 . . . . 0.0 109.162 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.8 t -92.07 143.5 26.4 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.517 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -74.26 160.79 30.64 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 114.944 -1.025 . . . . 0.0 111.54 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.62 24.76 75.28 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.02 -0.991 . . . . 0.0 112.511 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.5 m -137.16 153.86 50.37 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-O 121.584 0.707 . . . . 0.0 110.749 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.9 t -135.52 147.48 48.82 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.484 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.57 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.7 t -82.02 64.08 6.54 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.106 0.479 . . . . 0.0 111.355 -178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.569 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -81.79 -60.76 0.39 Allowed Pre-proline 0 C--N 1.315 -0.897 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.149 179.605 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.569 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 83.6 Cg_endo -88.13 63.12 3.36 Favored 'Trans proline' 0 N--CA 1.453 -0.854 0 C-N-CA 122.238 1.959 . . . . 0.0 111.913 179.128 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.437 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.8 t90 -47.16 139.63 7.22 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.657 -179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.437 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.01 50.32 1.3 Allowed 'Cis proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.719 0.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.48 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -126.03 149.13 30.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.2 0.524 . . . . 0.0 111.75 -178.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.714 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 76.6 m -89.78 149.78 22.56 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.308 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.514 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.5 OUTLIER -123.1 125.49 45.27 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.802 178.735 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.511 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 39.5 ttm180 -108.66 114.87 29.04 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 40.8 t30 59.6 34.11 22.21 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.916 0.865 . . . . 0.0 109.798 -178.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 79.99 13.2 82.47 Favored Glycine 0 CA--C 1.521 0.441 0 CA-C-N 115.202 -0.908 . . . . 0.0 113.692 179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 3.0 mm? -128.91 131.99 24.09 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-N 117.131 0.465 . . . . 0.0 110.176 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.7 Cg_exo -72.25 49.06 1.3 Allowed 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.165 2.577 . . . . 0.0 112.527 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 20.6 m . . . . . 0 C--N 1.32 -0.687 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.213 -179.495 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 80.9 m . . . . . 0 CA--C 1.516 -0.331 0 CA-C-O 121.362 0.601 . . . . 0.0 109.699 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 88.93 -24.85 11.17 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.494 -0.775 . . . . 0.0 112.34 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -89.53 175.08 7.43 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.825 0.822 . . . . 0.0 112.193 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.7 p -129.1 147.28 50.94 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.138 -1.392 . . . . 0.0 109.139 178.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.5 p -120.88 63.78 0.86 Allowed 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 112.124 0.416 . . . . 0.0 112.124 -178.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -57.31 -36.26 70.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.084 0.468 . . . . 0.0 110.414 179.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -92.38 19.98 6.6 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.976 179.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.58 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 60.15 35.22 87.13 Favored Glycine 0 C--N 1.332 0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.719 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -147.28 142.34 27.07 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 110.107 -0.331 . . . . 0.0 110.107 -179.611 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.47 146.01 43.79 Favored 'General case' 0 CA--C 1.505 -0.757 0 CA-C-O 121.234 0.54 . . . . 0.0 109.798 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -89.56 -28.49 19.55 Favored 'General case' 0 C--N 1.307 -1.239 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.223 179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.4 m -74.05 133.05 42.88 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 115.009 -0.996 . . . . 0.0 109.425 178.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 42.0 t30 -71.19 153.83 42.17 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.398 0.618 . . . . 0.0 110.817 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 69.23 9.39 60.58 Favored Glycine 0 C--N 1.315 -0.638 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.186 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 72.8 m -112.3 150.54 30.84 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.716 0.77 . . . . 0.0 110.348 179.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 151.43 50.26 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.681 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.58 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.6 t -81.38 65.46 6.52 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.266 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.816 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 94.2 m-20 -78.27 -63.46 0.44 Allowed Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.846 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.816 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.2 Cg_endo -92.17 66.68 0.87 Allowed 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.455 2.103 . . . . 0.0 111.748 179.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.1 t90 -46.8 139.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.407 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.752 -179.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.0 Cg_endo -94.51 50.94 1.24 Allowed 'Cis proline' 0 N--CA 1.456 -0.706 0 C-N-CA 123.094 -1.627 . . . . 0.0 112.522 0.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.9 t -122.87 147.42 27.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.233 0.539 . . . . 0.0 111.879 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.701 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 72.1 m -90.97 148.09 22.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.368 179.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.411 ' OG1' ' HB2' ' A' ' 18' ' ' ASP . 1.1 p -129.52 133.45 47.25 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.525 178.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.574 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 42.1 ptt85 -127.2 126.22 42.42 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 178.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 57.55 39.41 27.78 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.784 0.802 . . . . 0.0 109.683 -178.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.9 29.26 74.39 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.198 -0.91 . . . . 0.0 113.211 -179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.576 ' HB3' HG23 ' A' ' 30' ' ' VAL . 95.1 mt -142.15 126.63 10.12 Favored Pre-proline 0 C--N 1.326 -0.441 0 CA-C-O 120.628 0.252 . . . . 0.0 110.568 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.478 ' HA ' ' O ' ' A' ' 23' ' ' CYS . 77.6 Cg_endo -77.5 44.83 1.6 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.946 2.431 . . . . 0.0 112.322 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.576 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.1 t . . . . . 0 C--N 1.318 -0.772 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.664 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.653 ' SG ' ' HG3' ' A' ' 25' ' ' ARG . 70.8 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.13 55.9 Favored Glycine 0 N--CA 1.447 -0.624 0 CA-C-N 114.885 -1.052 . . . . 0.0 110.686 -179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.0 mp0 -89.55 168.44 12.17 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.628 0.727 . . . . 0.0 112.077 -179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.6 p -123.38 151.71 42.29 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.618 -1.174 . . . . 0.0 110.223 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.1 p -132.87 66.38 1.56 Allowed 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.672 0.272 . . . . 0.0 111.568 -178.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -58.46 -26.57 63.5 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.976 0.417 . . . . 0.0 110.845 179.408 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 p -89.03 4.64 47.61 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.089 -0.505 . . . . 0.0 112.022 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.516 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.89 30.92 69.94 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.362 -0.695 . . . . 0.0 111.362 -179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.45 133.32 15.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.176 -0.512 . . . . 0.0 109.621 -179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.4 t -94.26 142.83 26.96 Favored 'General case' 0 CA--C 1.506 -0.726 0 CA-C-O 121.638 0.733 . . . . 0.0 110.103 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.04 -24.3 22.36 Favored 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.132 -1.394 . . . . 0.0 109.788 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.2 m -96.08 139.26 32.51 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.493 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.4 t30 -70.54 159.16 34.82 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.686 179.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 71.65 22.96 78.59 Favored Glycine 0 N--CA 1.443 -0.852 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.319 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 98.2 m -140.41 151.34 44.85 Favored 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 121.545 0.688 . . . . 0.0 110.616 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.6 t -135.53 148.24 49.08 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-N 114.774 -1.103 . . . . 0.0 109.253 179.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.516 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.3 t -80.46 65.13 5.5 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.092 0.472 . . . . 0.0 111.385 -178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.815 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.4 m-20 -77.82 -62.61 0.52 Allowed Pre-proline 0 C--N 1.317 -0.823 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.737 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.815 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 86.5 Cg_endo -92.4 67.85 0.76 Allowed 'Trans proline' 0 N--CA 1.45 -1.077 0 C-N-CA 122.46 2.107 . . . . 0.0 111.725 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.426 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.5 t90 -47.38 139.6 7.84 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.641 -179.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 51.7 Cg_endo -94.85 51.75 1.19 Allowed 'Cis proline' 0 N--CA 1.456 -0.712 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.575 0.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.596 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.1 t -125.37 148.39 29.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 121.035 0.445 . . . . 0.0 111.878 -178.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.849 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -91.4 151.61 20.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.253 179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.5 p -131.84 131.49 42.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.924 179.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.653 ' HG3' ' SG ' ' A' ' 1' ' ' CYS . 81.3 mtt-85 -89.3 87.45 7.13 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 63.96 52.45 2.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.989 0.899 . . . . 0.0 109.66 -177.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.9 7.97 87.38 Favored Glycine 0 CA--C 1.522 0.478 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.846 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 91.4 mt -114.02 118.87 41.83 Favored Pre-proline 0 C--N 1.325 -0.461 0 CA-C-N 117.32 0.56 . . . . 0.0 110.383 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.95 44.53 0.8 Allowed 'Trans proline' 0 N--CA 1.472 0.211 0 C-N-CA 122.871 2.381 . . . . 0.0 112.828 -179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.543 HG13 ' HD2' ' A' ' 25' ' ' ARG . 9.7 p . . . . . 0 C--N 1.317 -0.831 0 CA-C-O 121.877 0.846 . . . . 0.0 110.671 -179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.611 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 85.4 m . . . . . 0 CA--C 1.517 -0.312 0 CA-C-O 121.507 0.67 . . . . 0.0 109.402 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.85 -18.53 57.25 Favored Glycine 0 N--CA 1.444 -0.767 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.86 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.611 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 43.1 mp0 -88.01 162.27 16.92 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.892 0.853 . . . . 0.0 112.106 -179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -120.75 151.96 38.9 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.135 -1.393 . . . . 0.0 109.469 179.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.0 p -136.32 68.64 1.43 Allowed 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.779 0.323 . . . . 0.0 111.703 -178.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -59.27 -25.2 63.88 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.992 0.425 . . . . 0.0 110.768 179.197 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.9 p -88.45 2.22 53.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.993 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 71.21 32.02 65.84 Favored Glycine 0 N--CA 1.45 -0.376 0 N-CA-C 111.511 -0.635 . . . . 0.0 111.511 -179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.39 132.71 15.52 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.364 -0.418 . . . . 0.0 110.042 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -91.76 141.93 28.14 Favored 'General case' 0 CA--C 1.504 -0.802 0 CA-C-O 121.591 0.71 . . . . 0.0 109.93 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.2 -23.49 22.38 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.263 -1.335 . . . . 0.0 109.991 -179.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 25.4 m -100.65 138.98 36.98 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.797 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 26.4 t30 -68.96 157.65 36.27 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.252 -0.885 . . . . 0.0 110.902 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 25' ' ' ARG . . . 79.91 -4.02 67.72 Favored Glycine 0 N--CA 1.448 -0.554 0 CA-C-N 115.221 -0.9 . . . . 0.0 113.399 178.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.3 m -121.91 151.56 40.57 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-O 121.465 0.65 . . . . 0.0 110.344 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.2 t -130.86 147.05 52.46 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.053 -0.976 . . . . 0.0 110.067 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.532 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.14 62.48 4.33 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.692 -178.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.555 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.81 -60.08 0.46 Allowed Pre-proline 0 C--N 1.315 -0.934 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.924 179.386 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.555 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 90.9 Cg_endo -88.29 65.4 3.28 Favored 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.199 1.932 . . . . 0.0 111.714 178.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.439 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.8 t90 -47.57 139.78 8.22 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.0 Cg_endo -94.99 52.59 1.13 Allowed 'Cis proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.186 -1.589 . . . . 0.0 112.686 0.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.478 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 25.9 t -128.82 148.89 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-O 121.123 0.487 . . . . 0.0 111.869 -178.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.78 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.9 m -89.3 152.33 21.61 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.128 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.436 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -130.39 124.7 32.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.787 179.314 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.8 ttt85 -90.68 103.62 16.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 178.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 44.9 t30 59.43 37.35 23.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 122.011 0.91 . . . . 0.0 109.557 -178.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.39 6.16 81.37 Favored Glycine 0 CA--C 1.522 0.485 0 CA-C-N 115.214 -0.903 . . . . 0.0 113.581 179.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.467 ' HB3' HG23 ' A' ' 30' ' ' VAL . 3.5 mm? -111.38 120.54 42.57 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 117.438 0.619 . . . . 0.0 110.379 179.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -75.08 45.14 1.3 Allowed 'Trans proline' 0 N--CA 1.47 0.12 0 C-N-CA 122.838 2.359 . . . . 0.0 112.579 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.467 HG23 ' HB3' ' A' ' 28' ' ' LEU . 2.9 t . . . . . 0 C--N 1.318 -0.769 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.349 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 64.6 m . . . . . 0 N--CA 1.451 -0.406 0 CA-C-O 121.022 0.439 . . . . 0.0 109.897 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.57 -26.78 6.19 Favored Glycine 0 N--CA 1.448 -0.548 0 CA-C-N 115.672 -0.695 . . . . 0.0 112.665 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -91.58 170.51 9.87 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 122.028 0.918 . . . . 0.0 113.182 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 34.8 p -116.87 177.21 4.79 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 113.604 -1.634 . . . . 0.0 110.173 179.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.7 p -151.43 58.83 0.89 Allowed 'General case' 0 C--N 1.322 -0.616 0 C-N-CA 120.985 -0.286 . . . . 0.0 111.497 -179.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.4 m-85 -56.74 -30.97 64.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.06 0.457 . . . . 0.0 110.749 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.1 p -90.6 12.02 20.18 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.279 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 66.41 33.63 85.41 Favored Glycine 0 N--CA 1.452 -0.295 0 N-CA-C 111.316 -0.714 . . . . 0.0 111.316 -179.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -148.26 133.24 18.15 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.1 t -94.04 144.43 25.48 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-O 121.841 0.829 . . . . 0.0 111.584 -178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -88.98 -26.39 21.52 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 113.748 -1.569 . . . . 0.0 108.967 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.5 m -92.2 135.75 33.74 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.249 178.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 35.2 t30 -72.6 156.83 38.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.149 0.5 . . . . 0.0 110.866 179.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.01 26.69 73.91 Favored Glycine 0 N--CA 1.446 -0.688 0 CA-C-N 114.958 -1.019 . . . . 0.0 111.954 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 78.1 m -136.03 153.63 51.3 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.294 0.568 . . . . 0.0 110.478 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.93 146.38 47.25 Favored 'General case' 0 C--N 1.311 -1.08 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.935 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 5.5 t -78.55 63.85 3.46 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.65 -0.704 . . . . 0.0 111.605 -178.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.87 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 71.6 m-20 -73.8 -62.33 1.14 Allowed Pre-proline 0 C--N 1.318 -0.767 0 C-N-CA 120.304 -0.559 . . . . 0.0 110.251 179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.87 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 60.7 Cg_endo -92.36 69.01 0.76 Allowed 'Trans proline' 0 N--CA 1.448 -1.174 0 C-N-CA 122.454 2.102 . . . . 0.0 111.728 178.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.401 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 54.5 t90 -48.11 140.3 9.28 Favored Pre-proline 0 C--N 1.326 -0.446 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.454 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 47.7 Cg_endo -95.06 51.4 1.23 Allowed 'Cis proline' 0 N--CA 1.456 -0.689 0 C-N-CA 123.189 -1.588 . . . . 0.0 112.494 0.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.607 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 29.2 t -125.18 146.33 31.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 CA-C-O 121.336 0.588 . . . . 0.0 112.327 -178.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.8 m -89.62 151.65 21.8 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.956 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -136.04 125.59 25.23 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.032 178.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 42.9 ttm-85 -96.53 108.52 21.11 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 178.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.96 42.7 25.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.916 0.865 . . . . 0.0 109.727 -178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.59 18.17 79.35 Favored Glycine 0 CA--C 1.521 0.442 0 CA-C-N 115.244 -0.889 . . . . 0.0 113.829 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 94.4 mt -128.58 131.88 24.02 Favored Pre-proline 0 C--N 1.325 -0.478 0 CA-C-N 117.083 0.442 . . . . 0.0 110.455 179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 10.6 Cg_exo -71.83 47.55 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.265 0 C-N-CA 123.179 2.586 . . . . 0.0 113.102 -179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.3 m . . . . . 0 C--N 1.321 -0.667 0 CA-C-O 121.548 0.69 . . . . 0.0 111.152 -179.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.414 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.6 m . . . . . 0 CA--C 1.513 -0.466 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 90.31 -29.29 6.7 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.363 -0.835 . . . . 0.0 112.24 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -89.42 167.51 12.95 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-O 121.875 0.845 . . . . 0.0 111.946 -179.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.9 p -118.03 174.7 6.05 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 114.286 -1.325 . . . . 0.0 109.773 179.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.3 p -150.39 66.3 0.95 Allowed 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 111.805 0.298 . . . . 0.0 111.805 -179.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.87 -26.01 63.84 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.087 0.47 . . . . 0.0 110.782 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.91 3.77 50.25 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.997 -0.547 . . . . 0.0 112.21 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.506 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.05 32.75 69.45 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.884 -0.674 . . . . 0.0 111.417 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.35 132.9 15.73 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 t -96.02 141.2 29.71 Favored 'General case' 0 CA--C 1.505 -0.764 0 CA-C-O 121.78 0.8 . . . . 0.0 111.277 -179.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -89.67 -27.42 20.14 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 113.766 -1.561 . . . . 0.0 108.858 178.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -82.39 131.46 35.22 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.257 179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.667 HD22 ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -69.78 154.26 42.22 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.372 0.606 . . . . 0.0 109.943 179.385 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.667 ' H ' HD22 ' A' ' 13' ' ' ASN . . . 67.85 25.12 74.28 Favored Glycine 0 C--N 1.311 -0.824 0 CA-C-N 114.757 -1.111 . . . . 0.0 112.243 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 75.2 m -133.41 154.99 50.31 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-O 121.301 0.572 . . . . 0.0 110.276 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.8 t -135.52 146.69 48.34 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.167 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.506 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.9 t -82.56 63.3 6.64 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.135 -179.133 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.54 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.09 -60.79 0.47 Allowed Pre-proline 0 C--N 1.316 -0.876 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.187 179.838 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.54 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.3 Cg_endo -88.58 64.56 3.04 Favored 'Trans proline' 0 N--CA 1.452 -0.93 0 C-N-CA 122.154 1.903 . . . . 0.0 111.727 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.447 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 62.3 t90 -47.81 139.85 8.82 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.51 -179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.447 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.1 Cg_endo -94.03 51.17 1.18 Allowed 'Cis proline' 0 N--CA 1.455 -0.76 0 C-N-CA 123.044 -1.648 . . . . 0.0 112.859 0.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.487 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 23.5 t -126.52 148.91 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 CA-C-O 121.184 0.516 . . . . 0.0 111.948 -178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.574 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 91.7 m -89.45 153.99 20.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.099 179.39 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.03 129.53 34.23 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.976 179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.414 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 49.2 ttm-85 -97.78 101.6 13.15 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.423 ' HA ' HD22 ' A' ' 26' ' ' ASN . 0.5 OUTLIER 59.67 45.37 13.12 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-O 121.875 0.845 . . . . 0.0 109.988 -178.341 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.04 19.45 79.61 Favored Glycine 0 C--N 1.332 0.348 0 CA-C-N 115.274 -0.876 . . . . 0.0 113.728 179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 89.8 mt -129.55 130.23 23.25 Favored Pre-proline 0 C--N 1.324 -0.522 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 11.4 Cg_exo -71.29 45.54 0.65 Allowed 'Trans proline' 0 N--CA 1.473 0.272 0 C-N-CA 123.136 2.557 . . . . 0.0 112.971 -179.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 14.8 p . . . . . 0 C--N 1.32 -0.706 0 CA-C-O 122.363 1.078 . . . . 0.0 110.64 -179.77 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.687 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 75.2 m . . . . . 0 CA--C 1.511 -0.544 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.78 -20.47 50.51 Favored Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.97 -179.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.1 mp0 -89.22 168.48 12.25 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.716 0.77 . . . . 0.0 111.933 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.2 p -123.97 155.78 37.58 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.849 179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.1 p -137.92 67.52 1.42 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.689 0.28 . . . . 0.0 111.733 -178.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -59.54 -25.11 64.24 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.11 0.481 . . . . 0.0 110.694 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.6 p -88.52 3.13 51.37 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.955 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.45 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.36 31.33 68.64 Favored Glycine 0 N--CA 1.451 -0.335 0 N-CA-C 111.479 -0.648 . . . . 0.0 111.479 -179.216 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.36 132.91 15.73 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.265 -0.468 . . . . 0.0 109.772 -179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 t -93.89 142.06 27.81 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-O 121.575 0.702 . . . . 0.0 110.008 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -89.23 -23.7 22.29 Favored 'General case' 0 C--N 1.306 -1.288 0 CA-C-N 114.187 -1.37 . . . . 0.0 109.829 -179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 6.7 m -94.64 139.25 31.45 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.741 179.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 37.9 t30 -69.55 158.03 36.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.763 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 72.15 11.95 75.52 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.103 -0.953 . . . . 0.0 112.903 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 89.2 m -130.4 149.89 51.88 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.732 0.777 . . . . 0.0 110.571 179.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.5 t -135.6 146.09 47.58 Favored 'General case' 0 C--N 1.308 -1.236 0 CA-C-N 114.647 -1.16 . . . . 0.0 109.746 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.45 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.4 t -79.2 63.16 3.77 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.972 -0.558 . . . . 0.0 112.083 -178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.776 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 43.5 m-20 -76.36 -61.3 0.81 Allowed Pre-proline 0 C--N 1.318 -0.792 0 C-N-CA 120.498 -0.481 . . . . 0.0 110.48 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.776 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 96.8 Cg_endo -90.29 66.85 1.79 Allowed 'Trans proline' 0 N--CA 1.451 -1.002 0 C-N-CA 122.347 2.031 . . . . 0.0 111.866 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.413 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.9 t90 -47.85 140.0 8.81 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.633 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.3 Cg_endo -94.6 50.78 1.27 Allowed 'Cis proline' 0 N--CA 1.455 -0.737 0 C-N-CA 123.101 -1.625 . . . . 0.0 112.589 0.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.531 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.0 t -125.2 147.52 29.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.273 0.559 . . . . 0.0 111.936 -178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.798 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 100.0 m -89.35 151.11 22.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.146 179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.448 ' O ' ' HA ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -123.03 130.05 52.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.322 178.585 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.687 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 14.8 ttp180 -117.87 119.95 36.4 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 108.368 -0.975 . . . . 0.0 108.368 179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.431 HD22 ' HA ' ' A' ' 26' ' ' ASN . 0.4 OUTLIER 58.76 40.41 23.12 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.928 0.871 . . . . 0.0 109.977 -178.493 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.82 26.23 74.71 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 115.108 -0.951 . . . . 0.0 113.579 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.494 ' HB3' HG23 ' A' ' 30' ' ' VAL . 91.7 mt -144.6 134.21 11.54 Favored Pre-proline 0 C--N 1.324 -0.517 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 8.0 Cg_exo -72.6 47.48 1.17 Allowed 'Trans proline' 0 CA--C 1.528 0.178 0 C-N-CA 123.023 2.482 . . . . 0.0 112.594 -179.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG23 ' HB3' ' A' ' 28' ' ' LEU . 3.6 t . . . . . 0 C--N 1.321 -0.659 0 CA-C-O 121.788 0.804 . . . . 0.0 110.395 -179.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.703 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 39.3 m . . . . . 0 CA--C 1.518 -0.284 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.16 78.15 Favored Glycine 0 N--CA 1.448 -0.526 0 CA-C-N 115.214 -0.903 . . . . 0.0 112.656 178.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.703 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 28.8 mp0 -88.06 159.34 18.29 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.911 0.863 . . . . 0.0 111.979 -179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 29.9 p -109.92 148.47 31.52 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 114.131 -1.395 . . . . 0.0 110.507 179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -135.67 66.65 1.5 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.12 -30.0 65.95 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.953 0.406 . . . . 0.0 110.726 179.553 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.6 m -88.81 9.64 23.9 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.252 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.476 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 65.57 34.12 88.18 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.97 -0.634 . . . . 0.0 112.25 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.04 134.07 17.03 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 t -95.96 143.48 27.1 Favored 'General case' 0 CA--C 1.505 -0.771 0 CA-C-O 121.598 0.713 . . . . 0.0 110.18 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -89.13 -24.33 22.25 Favored 'General case' 0 C--N 1.306 -1.297 0 CA-C-N 114.255 -1.339 . . . . 0.0 109.819 -179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 22.3 m -99.07 137.98 36.82 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.425 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.668 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.5 t-20 -71.61 156.54 39.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.988 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.668 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.36 12.38 84.29 Favored Glycine 0 C--N 1.315 -0.613 0 CA-C-N 114.948 -1.024 . . . . 0.0 112.972 179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.0 m -129.76 152.26 49.45 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.192 0.52 . . . . 0.0 109.951 179.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.7 t -132.07 145.72 51.6 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.476 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 6.3 t -80.77 62.17 4.7 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.468 -178.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.645 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -79.51 -61.23 0.48 Allowed Pre-proline 0 C--N 1.316 -0.879 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.95 179.708 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.645 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 7.7 Cg_endo -87.64 66.07 3.81 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.439 2.093 . . . . 0.0 111.268 178.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.44 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 61.7 t90 -48.31 140.06 9.98 Favored Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.567 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 54.2 Cg_endo -95.03 53.89 1.04 Allowed 'Cis proline' 0 N--CA 1.453 -0.9 0 C-N-CA 123.179 -1.592 . . . . 0.0 112.774 0.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.608 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 38.2 t -130.13 146.95 33.31 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-O 121.124 0.488 . . . . 0.0 111.986 -178.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.693 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 77.6 m -88.89 152.14 21.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.916 179.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -133.92 132.56 40.39 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.947 179.097 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.565 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 22.3 ttt85 -94.22 103.93 15.95 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.411 HD22 ' HA ' ' A' ' 26' ' ' ASN . 0.5 OUTLIER 59.39 44.78 14.67 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-O 121.811 0.815 . . . . 0.0 109.997 -178.471 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.46 27.48 73.76 Favored Glycine 0 C--N 1.332 0.358 0 CA-C-N 115.272 -0.876 . . . . 0.0 113.249 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.3 mt -136.28 143.98 45.91 Favored Pre-proline 0 C--N 1.322 -0.605 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -72.25 50.05 1.48 Allowed 'Trans proline' 0 CA--C 1.53 0.295 0 C-N-CA 122.814 2.343 . . . . 0.0 112.873 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 4.9 t . . . . . 0 C--N 1.32 -0.713 0 CA-C-O 121.464 0.65 . . . . 0.0 110.419 -179.853 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . . . . . . . . . 75.8 m . . . . . 0 CA--C 1.511 -0.522 0 N-CA-C 109.654 -0.498 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 94.3 -30.4 7.76 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.392 -179.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.6 167.89 12.58 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.895 0.855 . . . . 0.0 111.783 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.5 p -117.75 175.89 5.44 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 114.214 -1.357 . . . . 0.0 108.826 178.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 14.3 p -150.26 62.38 0.96 Allowed 'General case' 0 C--N 1.32 -0.706 0 C-N-CA 120.38 -0.528 . . . . 0.0 112.069 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.8 m-85 -58.14 -29.64 65.71 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.074 0.464 . . . . 0.0 110.499 179.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 p -91.15 10.45 26.94 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.302 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.502 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 66.19 35.33 90.28 Favored Glycine 0 C--N 1.32 -0.347 0 N-CA-C 111.763 -0.535 . . . . 0.0 111.763 -179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -147.81 133.63 19.03 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.1 t -100.93 144.18 30.18 Favored 'General case' 0 CA--C 1.505 -0.775 0 CA-C-O 121.866 0.841 . . . . 0.0 111.694 -179.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 m-85 -89.7 -28.71 19.25 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 113.697 -1.592 . . . . 0.0 108.861 178.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.14 132.69 35.37 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.474 179.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.638 HD22 ' H ' ' A' ' 14' ' ' GLY . 1.1 t-20 -70.18 152.65 44.02 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.465 0.65 . . . . 0.0 110.437 179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.638 ' H ' HD22 ' A' ' 13' ' ' ASN . . . 67.08 22.65 72.6 Favored Glycine 0 N--CA 1.445 -0.707 0 CA-C-N 114.524 -1.216 . . . . 0.0 112.157 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 80.9 m -123.02 155.64 36.44 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-O 121.593 0.711 . . . . 0.0 110.696 179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 3.1 t -135.62 147.06 48.5 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.119 -179.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.502 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 8.1 t -83.67 63.52 7.47 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.817 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.6 OUTLIER -80.66 -60.79 0.44 Allowed Pre-proline 0 C--N 1.315 -0.911 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.081 179.997 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.518 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 93.8 Cg_endo -87.76 62.63 3.62 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.118 1.878 . . . . 0.0 111.771 178.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 57.3 t90 -46.91 139.58 6.69 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.638 -179.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.5 Cg_endo -93.82 49.8 1.36 Allowed 'Cis proline' 0 N--CA 1.456 -0.725 0 C-N-CA 123.104 -1.624 . . . . 0.0 112.698 0.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.479 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.0 t -124.47 149.59 28.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 121.265 0.555 . . . . 0.0 111.854 -178.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.516 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 84.8 m -89.57 154.97 19.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.346 179.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -133.74 134.97 43.63 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.197 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.586 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 35.7 ttp180 -132.46 124.98 29.65 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.5 t30 58.75 36.11 24.68 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.984 0.897 . . . . 0.0 109.683 -178.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.75 28.25 72.28 Favored Glycine 0 C--N 1.333 0.365 0 CA-C-N 115.042 -0.981 . . . . 0.0 113.451 179.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 85.2 mt -148.63 137.5 11.97 Favored Pre-proline 0 C--N 1.327 -0.409 0 N-CA-C 110.366 -0.235 . . . . 0.0 110.366 179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.15 50.85 2.31 Favored 'Trans proline' 0 CA--C 1.53 0.303 0 C-N-CA 123.215 2.61 . . . . 0.0 111.858 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 13.2 p . . . . . 0 C--N 1.319 -0.724 0 CA-C-O 122.285 1.041 . . . . 0.0 110.713 -178.957 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.59 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 33.0 m . . . . . 0 CA--C 1.516 -0.364 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 96.98 -16.64 60.62 Favored Glycine 0 N--CA 1.445 -0.742 0 CA-C-N 115.253 -0.885 . . . . 0.0 111.588 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -88.09 166.81 14.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.843 0.83 . . . . 0.0 111.978 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.8 p -122.02 150.43 42.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.016 179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.4 p -131.55 66.45 1.54 Allowed 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.611 -0.268 . . . . 0.0 111.531 -178.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -58.06 -26.57 62.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.928 0.394 . . . . 0.0 110.801 179.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.9 p -88.94 4.02 49.46 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.137 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.549 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.94 32.24 69.86 Favored Glycine 0 N--CA 1.451 -0.353 0 N-CA-C 111.58 -0.608 . . . . 0.0 111.58 -179.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.42 133.83 16.42 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.28 -0.46 . . . . 0.0 109.814 -179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -97.35 143.32 28.22 Favored 'General case' 0 CA--C 1.505 -0.783 0 CA-C-O 121.654 0.74 . . . . 0.0 110.331 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -89.32 -25.35 21.68 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.104 -1.407 . . . . 0.0 109.317 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.4 m -89.72 136.17 33.19 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.343 179.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.659 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.3 t-20 -70.26 156.14 39.68 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.263 0.554 . . . . 0.0 110.296 179.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.659 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 76.48 -5.36 45.28 Favored Glycine 0 C--N 1.314 -0.69 0 CA-C-N 115.232 -0.895 . . . . 0.0 113.176 179.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 82.1 m -113.48 150.79 32.35 Favored 'General case' 0 N--CA 1.444 -0.729 0 CA-C-O 121.619 0.723 . . . . 0.0 110.203 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -135.1 151.96 51.21 Favored 'General case' 0 C--N 1.307 -1.244 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.774 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.549 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.2 t -80.88 64.58 5.7 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.097 0.475 . . . . 0.0 111.708 -178.381 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.796 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.2 m-20 -79.13 -61.95 0.47 Allowed Pre-proline 0 C--N 1.316 -0.862 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.748 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.796 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 85.0 Cg_endo -91.36 66.36 1.19 Allowed 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.345 2.03 . . . . 0.0 111.738 179.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.4 139.6 7.87 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.666 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 50.3 Cg_endo -94.7 51.56 1.19 Allowed 'Cis proline' 0 N--CA 1.454 -0.835 0 C-N-CA 123.194 -1.586 . . . . 0.0 112.628 0.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 26.7 t -126.06 148.76 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-O 121.031 0.443 . . . . 0.0 111.688 -178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.2 m -90.72 148.06 22.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.916 -0.584 . . . . 0.0 111.761 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -123.82 125.29 44.43 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.739 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.653 HH11 ' HB2' ' A' ' 26' ' ' ASN . 2.4 tmt_? -102.85 113.88 27.68 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 178.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.653 ' HB2' HH11 ' A' ' 25' ' ' ARG . 0.3 OUTLIER 59.97 41.26 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 O-C-N 123.897 0.748 . . . . 0.0 110.241 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.4 19.9 79.76 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-N 115.262 -0.881 . . . . 0.0 113.666 179.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.8 mt -135.47 126.47 17.21 Favored Pre-proline 0 C--N 1.326 -0.437 0 CA-C-N 116.952 0.376 . . . . 0.0 110.355 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -73.9 50.55 2.15 Favored 'Trans proline' 0 C--N 1.34 0.116 0 C-N-CA 122.915 2.41 . . . . 0.0 112.611 -179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 24.8 m . . . . . 0 C--N 1.319 -0.739 0 CA-C-N 115.681 -0.691 . . . . 0.0 111.827 -179.369 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.493 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 72.1 m . . . . . 0 CA--C 1.516 -0.357 0 CA-C-O 121.008 0.432 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 85.95 -24.3 8.08 Favored Glycine 0 N--CA 1.447 -0.593 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.653 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 7.9 mm-40 -89.89 173.03 8.46 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.7 0.762 . . . . 0.0 112.307 179.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 35.2 p -125.31 172.39 9.63 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-N 114.205 -1.361 . . . . 0.0 110.071 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 15.2 p -150.96 59.03 0.92 Allowed 'General case' 0 C--N 1.322 -0.614 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.551 -179.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -57.25 -29.57 63.91 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.086 0.469 . . . . 0.0 110.589 179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.0 p -89.89 11.01 21.59 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.285 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 67.62 33.14 80.1 Favored Glycine 0 N--CA 1.452 -0.298 0 N-CA-C 111.4 -0.68 . . . . 0.0 111.4 -179.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.15 131.2 14.37 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.102 -0.549 . . . . 0.0 109.574 -179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 2.0 t -85.11 144.0 28.49 Favored 'General case' 0 CA--C 1.504 -0.804 0 CA-C-O 121.742 0.782 . . . . 0.0 111.155 -179.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -88.74 -26.22 21.89 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.382 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 13.1 t -103.05 144.67 30.99 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.274 178.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 38.3 t30 -74.88 162.95 28.17 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.245 -0.888 . . . . 0.0 111.562 -179.05 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 66.88 29.19 74.3 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.913 -179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 97.2 m -142.5 157.28 44.91 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.511 0.672 . . . . 0.0 111.062 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 t -134.54 146.89 50.11 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.911 -1.04 . . . . 0.0 110.023 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . . . . . . . . . 8.8 t -83.11 62.84 6.82 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.881 -0.6 . . . . 0.0 111.275 -178.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.58 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -80.37 -60.4 0.47 Allowed Pre-proline 0 C--N 1.313 -0.986 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.923 179.655 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.58 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 92.4 Cg_endo -88.71 63.98 2.9 Favored 'Trans proline' 0 N--CA 1.452 -0.929 0 C-N-CA 122.228 1.952 . . . . 0.0 111.89 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 56.4 t90 -47.51 140.25 7.77 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.611 -179.592 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.8 Cg_endo -94.03 49.18 1.48 Allowed 'Cis proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.038 -1.651 . . . . 0.0 112.562 0.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.498 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.8 t -125.05 149.03 29.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.256 0.551 . . . . 0.0 111.779 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.675 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.7 m -89.91 154.62 19.72 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.206 179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.86 129.83 46.08 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.429 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 42.9 ttm180 -116.86 118.15 31.69 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 56.61 42.08 27.59 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.897 0.855 . . . . 0.0 109.76 -178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.05 25.22 75.57 Favored Glycine 0 CA--C 1.52 0.347 0 CA-C-N 115.228 -0.896 . . . . 0.0 113.72 179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 96.7 mt -141.27 132.21 13.38 Favored Pre-proline 0 C--N 1.325 -0.46 0 CA-C-N 116.833 0.317 . . . . 0.0 110.356 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -74.26 47.89 1.67 Allowed 'Trans proline' 0 N--CA 1.471 0.2 0 C-N-CA 122.823 2.349 . . . . 0.0 112.382 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.319 -0.737 0 CA-C-O 122.282 1.039 . . . . 0.0 110.464 -179.479 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.64 ' SG ' ' HB2' ' A' ' 25' ' ' ARG . 61.5 m . . . . . 0 CA--C 1.512 -0.513 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 101.05 -18.68 54.22 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 114.83 -1.077 . . . . 0.0 110.682 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.546 ' HG2' ' HB ' ' A' ' 12' ' ' THR . 21.7 mp0 -88.68 178.53 6.46 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.405 0.622 . . . . 0.0 111.239 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 6.0 p -134.44 163.76 28.98 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.101 -0.954 . . . . 0.0 110.105 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.9 p -144.78 63.46 1.3 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.686 0.279 . . . . 0.0 111.622 -178.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -58.16 -25.75 61.88 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.061 0.458 . . . . 0.0 110.756 179.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.7 p -88.69 4.88 45.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.075 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.427 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.98 30.69 67.56 Favored Glycine 0 N--CA 1.452 -0.274 0 N-CA-C 111.277 -0.729 . . . . 0.0 111.277 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.5 131.56 14.36 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 -179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.684 ' SG ' HG22 ' A' ' 12' ' ' THR . 2.2 t -83.52 141.3 31.72 Favored 'General case' 0 CA--C 1.505 -0.776 0 CA-C-O 121.917 0.865 . . . . 0.0 110.896 -179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -89.28 -24.89 21.94 Favored 'General case' 0 C--N 1.307 -1.271 0 CA-C-N 113.589 -1.642 . . . . 0.0 109.744 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.684 HG22 ' SG ' ' A' ' 10' ' ' CYS . 4.6 t -95.85 158.07 15.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.338 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 -87.6 156.19 19.61 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.635 -0.712 . . . . 0.0 110.336 179.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 71.53 23.09 78.47 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 114.976 -1.011 . . . . 0.0 112.597 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 99.6 m -141.86 155.8 45.53 Favored 'General case' 0 CA--C 1.513 -0.468 0 CA-C-O 121.427 0.632 . . . . 0.0 110.581 179.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 4.9 t -135.45 151.17 50.15 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.679 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.427 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.7 t -80.97 64.08 5.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.12 0.486 . . . . 0.0 111.694 -178.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.79 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 97.6 m-20 -78.6 -61.25 0.55 Allowed Pre-proline 0 C--N 1.316 -0.869 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.735 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.79 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 95.4 Cg_endo -91.85 66.59 0.99 Allowed 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 122.505 2.137 . . . . 0.0 112.116 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.6 t90 -47.46 139.88 7.86 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.775 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.411 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 49.9 Cg_endo -94.26 49.18 1.51 Allowed 'Cis proline' 0 N--CA 1.455 -0.756 0 C-N-CA 123.191 -1.587 . . . . 0.0 112.559 0.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.568 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 21.7 t -123.95 151.49 28.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.647 -178.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.794 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 90.1 m -93.47 150.14 20.68 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.438 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.409 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.7 OUTLIER -118.08 121.16 39.87 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.795 178.671 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.64 ' HB2' ' SG ' ' A' ' 1' ' ' CYS . 50.2 ttm-85 -98.48 109.36 22.13 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.28 43.19 17.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.876 0.846 . . . . 0.0 110.176 -178.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 74.38 13.96 81.21 Favored Glycine 0 CA--C 1.521 0.468 0 CA-C-N 115.188 -0.914 . . . . 0.0 114.033 179.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 95.9 mt -131.32 129.77 22.41 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 117.237 0.518 . . . . 0.0 110.29 179.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.34 48.71 0.98 Allowed 'Trans proline' 0 CA--C 1.529 0.273 0 C-N-CA 122.903 2.402 . . . . 0.0 112.846 -179.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 11.1 p . . . . . 0 C--N 1.318 -0.773 0 CA-C-O 122.066 0.936 . . . . 0.0 110.314 -179.674 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.615 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 38.1 m . . . . . 0 N--CA 1.453 -0.309 0 CA-C-O 121.561 0.696 . . . . 0.0 109.648 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 92.3 -14.06 65.59 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.321 -0.854 . . . . 0.0 112.076 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.615 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 39.8 mp0 -87.9 162.66 16.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.821 0.819 . . . . 0.0 111.949 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -118.35 150.13 40.03 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 114.275 -1.33 . . . . 0.0 109.995 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.6 p -133.33 67.07 1.54 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 120.661 0.267 . . . . 0.0 111.528 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -58.23 -26.32 62.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.043 0.449 . . . . 0.0 110.853 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.7 p -88.69 3.38 50.97 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.056 -0.52 . . . . 0.0 112.002 179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.519 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 70.31 31.71 68.7 Favored Glycine 0 N--CA 1.451 -0.36 0 N-CA-C 111.333 -0.707 . . . . 0.0 111.333 -179.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.23 133.14 16.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.327 -0.436 . . . . 0.0 109.901 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.81 144.78 25.36 Favored 'General case' 0 CA--C 1.505 -0.787 0 CA-C-O 121.698 0.761 . . . . 0.0 110.3 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -88.77 -25.49 22.24 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.047 -1.433 . . . . 0.0 109.575 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.8 m -101.4 138.8 37.93 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.3 179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.706 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 1.2 t-20 -71.52 160.3 32.96 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.804 -0.635 . . . . 0.0 110.713 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.706 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 83.55 -17.22 26.24 Favored Glycine 0 N--CA 1.445 -0.713 0 CA-C-N 115.37 -0.832 . . . . 0.0 112.614 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 66.2 m -110.94 152.67 26.5 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-O 121.599 0.714 . . . . 0.0 110.464 -179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.3 t -134.45 151.67 51.31 Favored 'General case' 0 C--N 1.308 -1.199 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.652 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.519 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.6 t -79.6 64.51 4.49 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.803 -178.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.786 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 95.4 m-20 -78.68 -61.74 0.51 Allowed Pre-proline 0 C--N 1.316 -0.89 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.643 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.786 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 88.7 Cg_endo -91.29 67.19 1.21 Allowed 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.506 2.137 . . . . 0.0 111.736 179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.436 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 59.1 t90 -47.84 139.77 8.93 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.532 -0.758 . . . . 0.0 110.581 -179.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.436 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 52.9 Cg_endo -95.11 53.29 1.08 Allowed 'Cis proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.115 -1.619 . . . . 0.0 112.71 0.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.571 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 32.3 t -128.76 148.2 33.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.452 0 CA-C-O 121.037 0.446 . . . . 0.0 111.777 -178.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.771 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 99.5 m -89.94 150.36 22.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.671 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.2 p -129.1 122.43 29.89 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.807 178.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.81 HH11 ' HB2' ' A' ' 26' ' ' ASN . 0.4 OUTLIER -89.57 107.87 19.33 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.81 ' HB2' HH11 ' A' ' 25' ' ' ARG . 2.3 t-20 60.68 36.47 19.5 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.037 0.836 . . . . 0.0 109.342 -179.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 83.59 8.03 85.32 Favored Glycine 0 CA--C 1.522 0.513 0 CA-C-N 115.319 -0.855 . . . . 0.0 113.795 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 8.4 mp -116.68 124.1 29.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 117.526 0.663 . . . . 0.0 110.655 179.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 6.5 Cg_exo -74.01 47.73 1.57 Allowed 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.281 2.654 . . . . 0.0 112.573 -179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 7.9 p . . . . . 0 C--N 1.318 -0.771 0 CA-C-O 121.725 0.774 . . . . 0.0 110.491 -179.688 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.57 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 80.1 m . . . . . 0 CA--C 1.511 -0.548 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 99.16 -21.3 46.4 Favored Glycine 0 N--CA 1.444 -0.805 0 CA-C-N 114.974 -1.012 . . . . 0.0 110.879 -179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.57 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 53.9 mp0 -88.86 169.38 11.64 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.464 0.65 . . . . 0.0 111.356 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -125.04 164.74 19.53 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.414 179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.9 p -146.84 65.65 1.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.428 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.2 m-85 -58.6 -24.61 61.34 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.127 0.489 . . . . 0.0 110.924 179.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.8 p -88.26 2.08 53.13 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.983 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.421 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 72.96 29.27 65.18 Favored Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 -179.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -150.51 131.76 14.53 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.719 ' SG ' HG22 ' A' ' 12' ' ' THR . 1.8 t -84.83 140.8 30.92 Favored 'General case' 0 CA--C 1.505 -0.784 0 CA-C-O 121.876 0.846 . . . . 0.0 110.861 -179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.8 m-85 -89.39 -24.58 21.89 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-N 113.642 -1.617 . . . . 0.0 109.634 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . 0.719 HG22 ' SG ' ' A' ' 10' ' ' CYS . 1.5 t -90.99 165.38 13.58 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.275 -0.875 . . . . 0.0 110.29 179.81 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -93.19 156.89 16.56 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.612 0.72 . . . . 0.0 111.109 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 68.07 19.51 72.0 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 114.568 -1.196 . . . . 0.0 113.111 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 81.3 m -136.28 155.74 49.66 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.528 0.68 . . . . 0.0 110.685 179.278 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.1 t -135.33 151.77 50.84 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.967 -1.015 . . . . 0.0 109.45 179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.421 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 4.8 t -81.04 63.89 5.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.09 0.471 . . . . 0.0 111.738 -178.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.787 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 98.4 m-20 -77.21 -61.44 0.67 Allowed Pre-proline 0 C--N 1.317 -0.81 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.739 179.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.787 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 91.3 Cg_endo -92.31 66.89 0.81 Allowed 'Trans proline' 0 N--CA 1.452 -0.946 0 C-N-CA 122.538 2.159 . . . . 0.0 111.853 179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.417 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 58.1 t90 -47.15 139.64 7.19 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.791 -179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.417 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 48.2 Cg_endo -94.71 50.16 1.39 Allowed 'Cis proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.145 -1.606 . . . . 0.0 112.51 0.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.58 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 22.1 t -124.14 151.1 28.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.633 -178.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.821 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 97.8 m -94.46 150.65 20.05 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.804 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 1.1 p -124.47 124.84 43.17 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.158 178.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.67 ' HB3' ' SG ' ' A' ' 15' ' ' CYS . 2.7 ptp180 -104.37 117.56 34.48 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 177.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 59.55 36.04 22.74 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.847 0.832 . . . . 0.0 109.801 -177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.52 15.35 81.49 Favored Glycine 0 CA--C 1.52 0.383 0 CA-C-N 115.213 -0.903 . . . . 0.0 113.576 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.429 ' HA ' HD13 ' A' ' 28' ' ' LEU . 3.3 mm? -122.68 126.47 26.1 Favored Pre-proline 0 C--N 1.327 -0.409 0 CA-C-N 117.209 0.505 . . . . 0.0 110.378 179.518 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -74.94 43.25 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.975 2.45 . . . . 0.0 112.419 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 12.7 p . . . . . 0 C--N 1.316 -0.88 0 CA-C-O 122.35 1.071 . . . . 0.0 109.966 179.992 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' CYS . . . . . 0.608 ' HB3' ' OE1' ' A' ' 3' ' ' GLU . 55.2 m . . . . . 0 N--CA 1.452 -0.343 0 CA-C-O 121.434 0.635 . . . . 0.0 109.728 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 95.35 -15.28 63.6 Favored Glycine 0 N--CA 1.444 -0.786 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.857 179.824 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.608 ' OE1' ' HB3' ' A' ' 1' ' ' CYS . 45.7 mp0 -87.93 162.76 16.71 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.816 0.817 . . . . 0.0 112.067 -179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.4 p -118.46 151.94 36.86 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 114.244 -1.344 . . . . 0.0 109.948 179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 6.5 p -135.09 66.02 1.54 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.634 0.254 . . . . 0.0 111.543 -178.664 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -58.07 -27.15 63.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.969 0.414 . . . . 0.0 110.765 179.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 p -88.98 5.15 45.56 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.073 -0.512 . . . . 0.0 112.165 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.511 ' HA2' ' SG ' ' A' ' 17' ' ' CYS . . . 69.91 31.81 69.9 Favored Glycine 0 N--CA 1.451 -0.327 0 N-CA-C 111.471 -0.651 . . . . 0.0 111.471 -179.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.18 133.04 16.03 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.374 -0.413 . . . . 0.0 110.038 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 t -90.77 145.28 24.92 Favored 'General case' 0 CA--C 1.505 -0.774 0 CA-C-O 121.62 0.724 . . . . 0.0 110.11 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -88.68 -24.74 22.66 Favored 'General case' 0 C--N 1.306 -1.284 0 CA-C-N 114.183 -1.371 . . . . 0.0 109.694 -179.452 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.7 m -103.62 139.56 38.74 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.279 -0.873 . . . . 0.0 110.198 179.218 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASN . . . . . 0.744 ' ND2' ' H ' ' A' ' 14' ' ' GLY . 0.8 OUTLIER -72.08 162.67 29.13 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.488 -179.703 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.744 ' H ' ' ND2' ' A' ' 13' ' ' ASN . . . 81.99 -13.14 39.43 Favored Glycine 0 C--N 1.315 -0.585 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.607 179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 23' ' ' CYS . 80.2 m -115.15 153.79 30.14 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.466 0.651 . . . . 0.0 110.417 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.6 t -134.68 151.27 50.89 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.122 -0.945 . . . . 0.0 109.828 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' CYS . . . . . 0.511 ' SG ' ' HA2' ' A' ' 8' ' ' GLY . 5.1 t -80.05 64.45 4.88 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.86 -178.319 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.791 ' HB2' ' HD3' ' A' ' 19' ' ' PRO . 96.1 m-20 -79.43 -61.73 0.46 Allowed Pre-proline 0 C--N 1.316 -0.871 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.662 179.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' PRO . . . . . 0.791 ' HD3' ' HB2' ' A' ' 18' ' ' ASP . 89.7 Cg_endo -90.79 67.03 1.47 Allowed 'Trans proline' 0 N--CA 1.453 -0.908 0 C-N-CA 122.45 2.1 . . . . 0.0 111.722 179.179 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TRP . . . . . 0.435 ' HA ' ' HA ' ' A' ' 21' ' ' PRO . 60.0 t90 -47.84 139.78 8.95 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.5 -179.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 20' ' ' TRP . 53.4 Cg_endo -95.15 52.65 1.13 Allowed 'Cis proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.093 -1.628 . . . . 0.0 112.714 0.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' O ' ' HD2' ' A' ' 19' ' ' PRO . 28.0 t -128.77 148.93 33.12 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.046 0.45 . . . . 0.0 111.683 -178.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.767 ' HB3' ' HB3' ' A' ' 15' ' ' CYS . 79.9 m -89.95 149.25 22.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.925 -0.58 . . . . 0.0 111.709 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.411 HG23 ' HG3' ' A' ' 19' ' ' PRO . 0.8 OUTLIER -127.05 128.55 46.47 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.523 178.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.592 ' HB2' ' SG ' ' A' ' 15' ' ' CYS . 76.6 ttt180 -106.04 115.44 30.23 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 58.38 42.28 21.66 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.98 0.895 . . . . 0.0 109.457 -178.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 69.04 24.64 75.81 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.028 -0.987 . . . . 0.0 113.489 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 29' ' ' PRO . 95.1 mt -135.62 128.67 18.13 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 122.678 -0.307 . . . . 0.0 110.493 179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 28' ' ' LEU . 5.7 Cg_exo -74.33 49.37 2.02 Favored 'Trans proline' 0 CA--C 1.527 0.146 0 C-N-CA 123.229 2.619 . . . . 0.0 112.312 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--N 1.32 -0.683 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.396 -179.445 . . . . . . . . 0 0 . 1 stop_ save_